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Introduction to the thesis 
 
This thesis addresses several questions concerning the underlying pathophysiology (arterial 
structure and function) of ischaemic stroke amongst the migrant South Asian (originating from 
the Indian subcontinent) populations living in the United Kingdom, through the use of clinical 
and epidemiological approaches that included: cross sectional, retrospective, prospective, case 
control and laboratory-based studies. Chapter one explores the epidemiology of cerebrovascular 
disease amongst South Asians, examining in particular, disease prevalence, incidence, mortality 
rates, distribution of cardiovascular risk and possible pathophysiological explanations for ethnic 
variations in disease rates. Chapter two briefly outlines the study hypotheses and relevant study 
designs. All the epidemiological, pathophysiological and laboratory-based methodologies used in 
the process of data collection are systematically discussed in this chapter including the methods 
used in statistical analysis.  The third chapter examines the distribution of conventional 
cardiovascular risk profile and stroke prevalence amongst South Asian stroke survivors over the 
last decade and specifically examines the magnitude of impact of these risk factors on stroke 
mortality in South Asians. As a first step towards understanding the pathophysiology of 
cerebrovascular disease amongst this higher risk population, chapter four centres upon a 
discussion of the structural properties of the vessel wall in the healthy South Asian population 
compared to that of European Caucasians. A comprehensive analysis of arterial stiffness and 
endothelial function in blood vessels amongst South Asian stroke survivors is presented in 
chapter five and enumerate the reasons for aberrant vessel wall characteristics amongst South 
Asian stroke survivors, specifically examining endothelial nitric oxide axis parameters and 
influence of metabolic, inflammatory and oxidative stress related indices on the vascular 
remodelling process and its mediation and subsequent determination of higher arterial stiffness 
and impaired endothelial function. The final chapter summarises the conclusions of each study 
and discusses potential areas of future research in cerebrovascular disease amongst South Asians.  
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Abstract 
Appraisal of current literature reveals an increased burden of cerebrovascular disease 
amongst the migrant South Asian population living in the United Kingdom (UK) and a 
paucity of data concerning stroke pathophysiology among members of this ethnic group.  
To address these issues, a number of cross-sectional, retrospective, and prospective case 
control studies were performed, examining the stroke characteristics and its underlying 
vascular pathophysiology. The Digital Volume Pulse (DVP) analysis technique and 
laboratory-based studies were used to examine the structural and functional vessel wall 
abnormalities.  
In the initial registry-based studies, looking at a large stroke population, 
prevalence of diabetes was more common in South Asians. Ischaemic stroke mortality 
was associated with diabetes, which raises the question of how diabetes accelerates 
stroke in this population. In cross-sectional studies, we were able to test hypotheses 
related to structural and functional vessel wall characteristics, where South Asians 
demonstrated to have higher arterial stiffness and impaired endothelial function. 
Glycaemic status was independently associated with both impaired endothelial function 
and increased arterial stiffness amongst South Asian stroke survivors. Analysis of the 
endothelially-derived nitric oxide production cascade amongst South Asian stroke 
survivors, demonstrated a significantly lower endothelial nitric oxide synthase (eNOS) 
and nitric oxide (NO) levels compared to European Caucasians. A separate sub study of 
this thesis validates the use of DVP analysis technique within the work of this thesis and 
its clinical utility for finer cardiovascular risk stratification. 
In conclusion, the epidemiological and pathophysiological findings of this thesis 
have important implications for UK South Asians and their high cerebrovascular disease 
burden. Observations within this thesis may aid targeted approaches for the alteration of 
cardiovascular risk profiles, which may aid the prevention of strokes in this high-risk 
community. The findings of this thesis would require validation in a large population-
based community studies. 
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Chapter 1 : Background 
 
1.1 What is “Ethnicity”? 
The word ―ethnicity‖ stems from the Greek word ―ethnos‖ meaning a race or 
nation (Just, 1989) and is conventionally defined as ―a group of people having common 
racial, cultural, religious, or linguistic characteristics especially designating a racial or 
other group within a larger system‖ (The Oxford English Dictionary). Previously, many 
scholars have attempted to define ethnicity using, as a basis for their definition, its social, 
anthropological and subjective contexts. According to Webber et al. (1922) both the 
subjective and collective elements within the concept of ethnicity are, for example, 
explained as properties of ―people who entertain a subjective belief in their common 
descent because of similarities of physical type or of customs or both, or because of 
memories of colonization and migration‖. According to Barth (1969), the concept of 
ethnicity was perpetually renegotiated between the minority group and the majority 
population by both external ascription (labelling by the majority population) and internal 
self-identification.  
According to the above definitions, the terms ―ethnic‖ and ―ethnicity‖ can be 
referred to minority groups whose members belong or are perceived to belong, as a result 
of distinct shared characteristics, which include cultural traditions, languages, diet, life 
styles, geographical and ancestral origins when compared to the majority. However, 
ethnic identity is not continuous, permanent, universal or inherent to individuals. Instead, 
ethnic identity stems from and depends upon interactions between individuals.  Such 
interactions give rise to common beliefs, values, norms and practices.  
Ethnicity is associated with the geographical location of the majority of the 
group, placing the emphasis more upon place than the characteristics of members of the 
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group (Webber, et al., 1922). According to Weber et al. (1922), even if members in 
different ethnic groups migrate to various geographical locations, as long as a balance is 
maintained and the numbers are kept virtually constant or increasing, an ethnic group 
will continue to exist despite its new location.   
Ethnicity is an important variable in epidemiology and health research (Ahdieh 
and Hahn, 1996). In analyzing differences in disease patterns within and between 
populations, certain diseases have a greater incidence in some ethnic groups when 
compared to others (Bhopal, et al., 1999). The reasons appear to be multi-factorial. 
Therefore, a greater understanding, through research, of those relationships which are 
posited to exist between ethnicity and disease will provide greater understanding of 
disease aetiology and enable interventions to be based upon greater knowledge than may 
currently be the case.  Although ethnicity and race are often thought of as being 
controversial variables (Aspinall,2002; Senior and Bhopal, et al., 1994)
 
in epidemiology 
and research, ethnicity (however this is defined) is a recognized risk factor in many 
cardiovascular and cerebrovascular pathologies including stroke (Chaturvedi, 2001). 
1.2 Who are South Asians? 
The people whose ancestry is in the countries of the Indian subcontinent, 
including India, Pakistan, Nepal, Bangladesh and Sri Lanka are encompassed by the term 
―South Asian‖ (Bhopal, et al.,2004). Even though some countries, such as Afghanistan, 
Iran, Myanmar and Tibet, are geographically contiguous with this region, their 
inhabitants are not considered to be South Asian due to social, cultural, religious and 
historical perspectives (see below) (Bhopal, et al.,1991). 
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1.2.1 Social, cultural and economical perspectives of native South Asians  
Seventy percent of the South Asian population live in rural areas and most rely on 
agriculture for their livelihood (The World Bank, 2007). According to the Global Hunger 
Index, South Asia has a higher rate of child malnutrition when compared to other 
countries (The Global Hunger Index, 2006). The people in this region have, as a common 
factor, placed women in a lower status. These factors collectively may account for the 
lower socio-economic status which is seen equally across all the South Asian countries. 
The differences in composition of races and religions in each country may 
suggest that each country is different from the other. For example, 80% of the population 
of India and Nepal are followers of Hinduism whilst the majority in Sri Lanka and in 
Bhutan are Buddhists. Languages also echo this heterogeneity within the region. Even 
though a large number of languages are spoken in the region, most of the languages show 
similarities in words and grammar syntaxes because of the common origins of the 
languages.   
  Even though these differences prevent the South Asians from being uniform and 
homogeneous, common features in the main religions, and resulting influences in 
lifestyles have outweighed the force towards divergence. Due to imperfections in the free 
flow of information and free will of the common citizen, national and regional identities 
still exist. As such, more weight can be placed on the argument that a South Asian 
identity exists where the inhabitants of South Asia share common factors that influence 
their lives. Therefore, even if people in South Asia migrate from the region and people 
from outside South Asia move in to the region, the ethnic identity ―South Asian‖ will 
remain where such a South Asian ethnic group or the minority group is identified in 
relation to the world population as a whole (Oppenheimer, 2001). We can identify that 
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when South Asian people migrate to any other country, they may adopt behaviors and 
practices of the majority but the effects of their previous behaviors will ensure that they 
remain distinct. 
1.2.2 Dietary habits and food intake in native South Asian populations 
Diet has an important impact on cardiovascular disease. Traditional diets 
subscribed to by people of Indian origin are largely low in fat and high in carbohydrate 
(Achaya, 1994). Whilst religion and languages share the same roots and have common 
features despite the seeming variation, diet too shares common features in this region. 
South Asian food is called ―Desi Cuisine‖ which indicates an Indian pedigree since most 
of the foods in Asian countries are derivatives of Indian food even though each food item 
may have, to a certain extent, its own national or regional identity (Achaya, 1994). For 
example, food items made from wheat flour dough are common throughout the countries 
of South Asia even though some additional ingredients, such as scraped coconut or ghee 
or different spices and condiments such as sesame seed, may be added in different 
regions to suit their palettes (Appadurai, 1988). This diet is popular among rural 
populations but may promote glucose intolerance and features of the metabolic 
syndrome. Another notable commonality of South Asian diet is the decreased 
consumption of beef and/or pork for religious reasons.  Pork is prohibited by Islam, 
whilst the cow is held to be sacred by followers of Hinduism.  Taking the life of an 
animal is discouraged in Buddhism. Since most of the populations in each country are 
Hindus, Moslems or Buddhists, consumption of meat is low in this region (Banerji, 
2006). South Asian dietary habits have also been influenced by the colonial history and 
European food habits are also commonly observed in this region. On the other hand, diets 
associated with urbanisation and migration in Indians is thought to include a higher fat 
proportion, which may promote CHD. Both diets are thought to promote adverse effects 
through dyslipidaemias.  
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Chadha et al., (1995) conducted a dietary based survey on urban families living in 
South Asia (Delhi and on rural families from Haryana). Average carbohydrate intake was 
significantly higher in the rural group compared with the urban population. Total dietary 
fat intake was not significantly different between the rural and urban cohorts. However, 
fat intake was lowest in the low socio-economic group and highest in the middle socio-
economic group. Consumption of saturated fatty acids was highest in the rural group as 
was the intake of monounsaturated fatty acid. 
1.3 South Asians in the UK 
Migration of people from the Indian subcontinent followed two periods of mass 
migration to numerous destinations leading to a wide global dispersion of South Asian 
migrants (Jain, 1993). The post war economic recovery in Western countries (UK) 
generated a great demand for labour.  Unlike the indentured labour system, Britain 
allowed the migration of whole families and communities from India during the 1960s 
and 70s through the British Nationality Act of 1948 (Clarke, C., 1990). This enabled 
Indians and other members of the Commonwealth to come to Britain, secure employment 
and gain citizenship. Prior to this, academia had been the only route through which 
Indians migrated to the UK.  
Estimates from the 1991 census showed that Indians formed the largest ethnic 
minority group, representing 1.7% of the ethnic composition of England and Wales 
followed by Black Caribbeans at 1% ((Kohli, 1988, National Statistics UK, 1994).  The 
UK arrival and social features of migrants originating from the Indian subcontinent are 
shown in Table 1.2. Indian migrants cluster in urban areas and reside predominantly in 
London, the West Midlands, West Yorkshire and Lancashire. 
According to the latest statistics, Four percent of the total UK population 
comprised of South Asians (National Statistics UK, 2004). South Asians form the largest 
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ethnic minority group (20%) in inner city areas such as our local Sandwell and 
Birmingham area (National Statistics UK, 2004).
   
1.4 Epidemiology of ischaemic stroke in South Asians 
1.4.1 Introduction 
Stroke is a continuing yet preventable cause of significant morbidity and 
mortality in the Western world (Olesen and Leonardi, 2003) and will rapidly reach 
epidemic proportions in modernising countries such as those across Asia (Manton, et al., 
1988; Tolonen, et al., 2002).  Of particular concern is that mortality from ischaemic 
stroke in the United Kingdom (UK) is at least 1.5 times more common amongst those of 
South Asian origin (Wild and McKeigue, 1997) when compared to the general 
population. One striking observation amongst the global diaspora of South Asians is that 
stroke is not common except for migrants living in the UK (Tolonen, et al., 2002).  
Why is this increased stroke mortality evident amongst South Asian subjects in 
the UK?  Cultural and socio-economic factors may account for part of this excess. Rates 
of cardiovascular disease (CVD) in Fiji (Collins, et al., 1996), Singapore (Hughes, et 
al.,1990) and South Africa (Seedat, et al.,1990) are highest amongst migrant Indians, but 
are largely explained by the excess of coronary heart disease (CHD).  In the UK, CVD 
amongst South Asian migrants is due to both heart disease and stroke, suggesting that an 
environmental basis may, in part, underlie the increased risk of stroke in this population.  
Thus, an examination of those modifiable risk factors that appear particularly 
prevalent amongst ethnic minority groups (South Asians in particular) may explain how a 
rapid transition from subsistence living to a ‗Westernised lifestyle‘ may provide the 
exposure needed for the activation of inherent ethnic traits culminating in ischaemic 
stroke. In addition, rates of stroke in both urban and rural India are lower than those seen 
in metropolitan cities (Dhamija and Dhamija, 1998). This excess of stroke mortality 
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amongst South Asians in Britain is aligned with diabetes mellitus and hypertension, both 
of which show unique patterns of individual susceptibility and severity in this population 
(Patel, et al., 2006). Whilst there have been two comprehensive reviews on stroke 
epidemiology in 1992 (Bonita, et al., 1992) and 2003 (Feigin, et al.,2003) highlighting 
both geographical and ethnic variations in stroke mortality and incidence and case 
fatality rates, neither of these reviews include studies on South Asians.  Hence, there is 
pressing need for a comprehensive review of stroke epidemiology in the South Asian 
population, members of which are known to carry an increased burden of stroke, and 
inequitable health therein (Gill et al.,2007). 
This chapter deals with the specific epidemiological review of ischaemic stroke in 
people originating from the Indian subcontinent (‗South Asians‘), with particular 
attention to the increased risk that is exclusively manifest amongst migrants settled in the 
United Kingdom. 
1.4.2 Literature search methodology 
The aim of this chapter is to present a comprehensive and systematic overview of 
the available literature on cerebrovascular disease in migrant South Asians and selected 
studies from their counterparts in South Asian countries. The term ―migrant South 
Asian‖ was used to represent people originating from the Indian subcontinent (India, Sri 
Lanka, Pakistan, Nepal and Bangladesh). In keeping with the above definition on South 
Asians, a MEDLINE and EMBASE search using the terms (MeSH): (South Asians) OR 
(Indians, Sri Lankans, Bangladeshi, Pakistani, Nepali) AND (Stroke) OR 
(Cerebrovascular accidents) was performed. Due to the paucity of published articles in 
peer-reviewed journals between the period selected initially (1990-2005), the literature 
search was extended to include articles published between the years 1940-2005, 
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including selected published abstracts from South Asian countries, studies with different 
study designs and variable stroke rates.  
In total, 31 representative articles were selected, based upon 28 cross sectional 
and three prospective studies describing
 
at least one demographic, aetiological or 
psychosocial aspect of stroke epidemiology. No formal statistical analysis (such as meta-
analyses) was employed, and data were analysed descriptively, because of the observed 
methodological heterogeneity across the selected studies. 
1.4.3 Incidence of ischaemic stroke in South Asians 
The calculation of stroke incidence among South Asian populations is
 
hampered 
by the lack of population-based studies. Data concerning the incidence of stroke in this 
population group is based mainly upon three studies conducted by Bhattacharya et al. 
(2005), Rao et al. (1971) and by Hsu et al. (1999) (Table 1.3).  
The first reported study in India compared stroke incidence between urban and 
rural populations over a two year period (1969-1971). In this study by Rao et al. (1971), 
the crude incidence rate amongst the urban population was 19.4/100000 compared to 
13/100000 of the rural population. Age adjusted incidence rates and age specific 
incidence rates were not available for comparison. A prospective study by Bhattacharya 
et al (2005) provided other evidence on stroke incidence amongst the rural Indian 
population. In this study (n=20717), 128 first ever stroke cases were detected over a five 
year period. The average annual crude incidence rate was 123.57/100,000 persons.  After 
age adjustment to the 1990 general population, the adjusted rate was 262/100000. In 
comparison the age-adjusted incidence of stroke in this study was much higher than that 
of Western studies (Brown, et al., 1996) conducted during the same time period such as 
those from the USA(145/100000), Italy(136/1000000) and USSR(226/100000) (Feigin, 
et al., 2003).  In contrast to Western studies, age-standardized stroke incidence rates
 
were 
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marginally higher in the female population. In this study by Bhattacharya et al. (2005) 
mean age of stroke onset was 61 years.  In common with Western studies, age specific 
incidence rates showed a progressive increase in incidence, especially in the 5
th
 to 7
th
 
decades (374 to 782/100000).  
One study which compared stroke incidence rates amongst South Asians living at 
moderate altitudes with that of individuals living at lower altitude in India showed lower 
incidence rates amongst those living at a higher altitude (Mahajan, et al., 2004). 
 
The 
reason for this apparent discrepancy is not clear. Moreover this study was based on 
hospital admission rates and cannot be compared with the rates of true population based 
incidence studies.  Differences in altitudes are also likely to be apparent in migrants 
living in different countries across the globe, but it is unclear whether this could explain 
differences in stroke rates between migrant and non-migrant South Asians.   
As mentioned, there is only one reported population based stroke study in the 
migrant South Asians (n=74) in the United Kingdom. This study, by Hsu et al. (1999) 
was based on a survey of 23 general practices with patients (n=129225) in Leicestershire 
during 1996. In this prospective study, calculated crude incidence rates were higher in 
Caucasians (low Asian practices) compared to South Asians (high Asian practices) 
(283.2 vs. 111.18 per 100,000 persons). However, reported age specific incidence rates 
were comparable. The indirect sampling method used in this study does not allow any 
direct comparison of the true incidence rates and may have promoted an underestimation 
of the reported incidence rates amongst South Asians. 
None of the mentioned studies fulfil the criteria for ideal incidence studies 
(Feigin, et al., 2003). Paucity of data, different study designs and the lack of description 
of case ascertainment methods do not allow direct comparison between these studies. 
More importantly, none of these studies clearly present crude and age specific rates in the 
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published manuscripts, which make detailed comparisons and interpretation of the data 
very difficult. Other factors such as aging of population in South Asian countries and 
increased reporting may also confound observed increase in overall stroke incidence seen 
with time in these countries. 
Within the limitations of the afore-mentioned studies, the incidence rates of 
stroke have exponentially increased from 13 per 100,000 persons (in 1969) to 123 per 
100,000 (in 1993) in South Asians, against a decline in rates for other Western 
populations. According to the WHO Global Burden of Diseases Study, the annual stroke 
incidence is projected to increase by 1.5% in 2015 (Essati, et al., 2004)
 
particularly 
amongst the Asian populations in developing countries. Hence, there is an urgent need to 
identify those factors and environmental exposures that have accelerated stroke risk 
among South Asians in the UK. 
1.4.4 Prevalence of ischaemic stroke in South Asians 
Eleven prevalence studies are included (Table 1.4). The majority of these studies 
have been carried out in different areas of India from 1968 to 2001. However, there are 
no stroke prevalence data available from other South Asian countries except Pakistan 
(Asian Acute stroke Advisory Panel, 2000). Two studies directly compared the 
prevalence of stroke amongst migrant South Asians when compared to other ethnic 
groups (Venketasubramanian, et al., 2005; Anand, et al., 2000)
 
.  
The crude prevalence rates of stroke among South Asians living in India vary 
from 52 to 842 per 100,000 for all ages (Table 1.4). As expected, age specific prevalence 
rates also show an exponential rise with age in all studies.  In common with stroke 
studies within Western countries, the majority of the studies (except the study reported 
by Banergee et al (2001), demonstrated higher prevalence rates in males when compared 
to females. prevalence rates have increased three to five fold over the last four decades 
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(for example, 56 per 100,000 as reported by Abram et al (1971) in 1968, when compared 
to 334 per 100,000 which was reported by Banerjee et al (2001). More importantly, rates 
of stroke prevalence have been demonstrated to have significant heterogeneity across 
studies carried out in different parts of India. Distances span some 2400km between the 
East and West of India, similar to that across the North and South. The reasons for 
heterogeneity across studies carried out in different parts of India could be multi 
factorial.
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Table 1.1: Studies comparing stroke incidence rates amongst South Asians 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SA=South Asian, EC=European Caucasian, M=Male, F=Female, CT=Computer Tomography, UK=United Kingdom, WHO=World Health Organization.  
Author Year Method of 
diagnosis of 
stroke 
Study methodology / 
Case ascertainment 
 
Sample 
population 
Investigated 
epidemiological 
aspect 
Key findings 
 Rao et al.  1971 CT diagnosis and 
clinical diagnosis 
based on WHO 
definition.  
Unclear India, Madras 
(n= 258576) 
Comparison of 
stroke incidence 
rates between 
urban vs. rural 
population. 
Crude incidence rate:13 per 100000.Age 
adjusted rates are not available. Males 
had higher rates(15.2) compared to 
Females(10.8) and Urban rates(19.4) 
were higher than Rural rates.(13) 
Bhattacharya  
et al. 
 
2005 CT diagnosis and 
clinical diagnosis 
based on WHO 
definition  
Prospective door-to-
door survey 
India, West 
Bengal 
(n=20842) 
Stroke incidence 
rates in India 
Age-adjusted rate : 262 per 100000. 
Females had higher rates (274) 
compared to males (253). Age specific 
rates showed a proportional increase 
with age 
Hsu et al.  1999 CT diagnosis and 
clinical diagnosis 
based on WHO 
definition  
Prospective general 
practitioner registry 
based case 
monitoring 
UK, 
Leicestershire 
(n =129225) 
Comparison of 
stroke incidence 
rates between SA 
vs. EC 
Age adjusted stroke incidence rates were 
similar between two ethnic groups. 
Crude rates (283.2 vs. 111.18 ) were 
higher in EC, age specific rates showed 
a proportional increase with age 
Mahajan et al.  2004 CT diagnosis Prospective study 
based on consecutive 
hospital admissions 
India,Himalaya 
(High altitude) 
(n= not 
mentioned) 
Stroke incidence 
rates at high 
altitudes 
Males had higher rates compared to 
Females and rates were higher than low 
altitudes. Incidence rates are based on 
hospital admission rates. Therefore not 
comparable with other studies. 
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Within India, there is a mixture of persons with Indo-Aryan, Dravidian and 
Mongolian origins and their lifestyles vary with the religious and climatic conditions of 
the area they inhabit. For example, there are more than 400 languages used across India 
of which 20 of them are considered as ‗official‘ languages.  These different areas 
experience varying degrees of socio-economic influence on physical and social 
morbidity, which underlie practical difficulties in the epidemiological analyses of 
diseases across the Indian subcontinent.  For example, the study by Bharucha et al (1988) 
reported a prevalence of 842 per 100,000 compared to the 147 per 100,000 reported by 
Banergee et al(2001) using a similar study design during the same period. In addition, the 
prevalence of stroke in urban India appears to be higher (Razdan, et al., 1989) than that 
seen in rural areas such as Haryana where the prevalence rate was only 92 per 100,000. 
(Saha, et al., 1993). In Pakistan, Jafar et al (2006) demonstrated comparatively higher 
prevalence rates compared to other Asian studies. However, the targeted sampling 
approach used in this study may have contributed to the disproportionate prevalence rates 
reported in the literature.  
There are only two studies that have directly compared the prevalence rates of 
stroke in South Asians compared to that of other Asians and Europeans. The study by 
Venketasubramanium et al (2005) compared the prevalence of stroke amongst migrant 
South Asians when compared to Chinese and Malays, and found that crude as well as age 
adjusted prevalence rates were similar amongst all ethnic groups (SA:362, Malay:332 
and Chines:376). The response rate of this study was only 67% and it remains unclear 
whether this apparent similarity between the ethnic groups depicts epidemiological 
reality.  A Canadian study by Anand et al (2000) demonstrated lower prevalence rates 
amongst South Asians, whereas Caucasians had the highest stroke prevalence rate 
(1800/100000) compared to South Asians (300/100000) and Chinese (600/100000). 
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Table 1.2: Studies comparing stroke prevalence rates amongst South Asians (I) 
Author Year Method of 
diagnosis of stroke 
Study methodology 
/ Case 
ascertainment 
Sample 
population 
Investigated  
epidemiological 
aspect 
Key data findings 
Anand et al.  2000 Self reported history 
or clinical diagnosis 
by physician 
 
population based, 
cross sectional 
Canada 
(n=985) 
Comparison of stroke 
prevalence rates 
between SA vs. EC 
and Chinese 
Crude prevalence rates were similar 
amongst ethnic groups: SA: 300, EC: 
1800 and Chinese: 600 per 100000 
population (P=0.13).Age adjusted rates 
are not reported. 
Venketa-
Subramaniu
m et al.  
2005 Clinical diagnosis 
using WHO 
definition  
Population based, 
cross sectional 
Singapore 
(n=15606) 
Comparison of stroke 
prevalence rates 
between SA vs. 
Malaysian and 
Chinese 
 
Crude as well as age-standardized rates 
were similar amongst ethnic groups ( 
SA:362, Malasian:332,Chinese:376 ) per 
100000 population 
AASAP  2000 Unclear Based on national 
health records of 
individual country 
Nine Asian 
countries ( India 
was the only SA 
country )  
 
Comparison of stroke 
prevalence between 
nine Asian countries 
Crude prevalence in India ranges from 
90-222 per 100000. Thailand and Taiwan 
had higher reported prevalence rates ( 
690 and 1430 ) per 100000 
Health 
Survey 
England  
2005 Clinical diagnosis 
using WHO 
definition  
Population based 
door to door health 
survey 
Stratified 
proportionate 
sample from 
general 
population 
 
Comparison of stroke 
prevalence rates 
amongst ethnic 
groups 
Crude prevalence in South Asians ( 
Indian: 1100,Pakistani:1800, 
Bangladeshi:1800) were lower than 
EC(2400) per 100000 population 
       
SA=South Asian, EC=European Caucasian, M=Male, F=Female, CT=Computer Tomography, UK=United Kingdom, WHO=World Health Organization.  
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Table 1.3: Studies comparing stroke prevalence rates amongst South Asians (II) 
SA=South Asian, EC=European Caucasian, M=Male, F=Female, CT=Computer Tomography, UK=United Kingdom, WHO=World Health Organization
Author Year Method of 
diagnosis of stroke 
Study methodology 
/ Case 
ascertainment 
Sample 
population 
Investigated main 
epidemiological 
aspect 
Key data findings 
Bharucha et al.  1988 Clinical diagnosis 
by a neurologist  
Population based 
door to door survey 
India 
Bombay 
(n=14,010) 
Stroke prevalence  
 
Crude prevalence was 842 per 100000 
population. Age specific rates were 
higher in men 
Banergee et al.  2001 Clinical diagnosis 
by a neurologist or 
CT imaging 
Population based 
cluster survey 
India 
Calcutta 
(n=50291) 
Stroke prevalence Crude prevalence was 147 and age 
adjusted rate was 334 per 100000 
population. Females had higher 
prevalence in all age groups 
Razdan et al.  1989 Clinical diagnosis 
by a neurologist  
Population based 
survey 
India, rural 
Kashmir 
(n=63645) 
 
Stroke prevalence in 
rural India 
Crude prevalence was 143 per 100000. 
11% of the people were in the 15-40 age 
group. 
Saha. et al.  1993 Clinical diagnosis 
using WHO 
definition  
Community based 
house to house 
survey 
India, 
Eastern 
(n=20842) 
 
Stroke prevalence in 
rural India  
Crude prevalence was 147 per 100000 
and age specific prevalence showed an 
increasing frequency with age. 
Dhamija et al.  1998 Unclear Population based 
survey 
India, Haryana 
(n=51165) 
 
Stroke prevalence in 
rural India 
Crude prevalence was 92 per 100000, age 
specific rates and population 
characteristics not available 
Jafar et al. 2006 Self reported history Community survey 
and target sampling 
Pakistan 
(n=500) 
 
Pakistan 
Karachi 
Crude prevalence was 4800 per 100000, 
age specific rates and population 
characteristics not available 
Abraham et al. 1971 Unclear Population based 
survey 
India, Madras 
 
Prevalence Crude prevalence was 56 per 100000, age 
specific rates and population 
characteristics not available 
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Similar findings have been reported from a recent health survey in the UK. The 
prevalence rates of ischaemic stroke in migrant South Asians were significantly lower 
(Indian: 1100, Pakistani: 1800 Bangladeshi: 1800 and European Caucasians: 2400 per 
100000 population) compared to the general population (Department of Health, 2005). 
These results appear to contradict the higher CHD prevalence which has been observed 
in South Asian populations (Gupta, et al., 2008).  In addition, rates reported in the Indian 
studies also appear to be lower than the reported rates in other Asian (200-769/100000) 
(Liu, et al., 2007) as well as Western studies (400-1000/100000). Although the reasons 
for this disparity may well be multifactorial, part of the explanation rests with higher 
mortality rates and the consequent under-estimation of prevalence rates in the South 
Asian population. However, poor study designs, small sample sizes, poor case 
ascertainment methods, recording and publication biases and lack of quality in data 
presentation in the published studies may further restrict critical appraisal, interpretation 
and comparison of stroke rates between countries as well as amongst ethnic groups.  
1.4.5 Stroke mortality in South Asians 
Ischaemic strokes accounts for more than 10% of all deaths globally and are the 
third most common cause of mortality in developed countries (Bonita, et al., 1992). 
There are ethnic variations reported in stroke mortality, mainly comparing Caucasians 
and Afro-Caribbeans living in developed countries (Kissela, et al., 2004). A small 
number of cross sectional studies from UK and official statistical audits from India 
provide data on rates of ischaemic stroke mortality in the South Asian population (Table 
1.6), (Figure 1.1). 
 17 
Table 1.4: Studies comparing stroke mortality rates amongst South Asians 
  
Author Year Source of data of 
stroke 
Study 
methodology / 
Case 
ascertainment 
Sample 
population 
Investigated main 
epidemiological 
aspect 
Key data findings 
Bhopal et al.  2005 National mortality 
data by country of 
birth 1994-1997 
population survey 
and registry 
analysis 
UK 
Newcastle 
SMR, comparing 
EC vs. SA 
SMR was higher in SA (155) compared to EC 
(100) and Bangladeshis had highest SMR(281)  
Wild et al.  1997 National mortality 
data by country of 
birth 1970-1992 
Cross sectional 
survey and registry 
analysis 
UK Trends in SMR 
comparing EC vs. 
SA, AfroCar.  
AfroCar males had highest SMR (271) 
followed by SA (226) in 1970-72. Rates have 
significantly dropped in all ethnic groups in 
1989-92 period. 
Balarajan  
et al.  
1991 National mortality 
data by country of 
birth 1970-89 
Cross sectional 
survey and registry 
analysis 
UK Trends in SMR 
comparing EC vs. 
SA  
SMR was 53% higher in SA males compared 
to EC in 1970. SA males showed the lowest 
reduction in stroke rates (3%) compared to EC 
(28%) between 1972-83 period 
Balarajan et al.  1997 National mortality 
data by country of 
birth 1988-92 
Cross sectional 
survey and registry 
analysis 
UK SMR comparing 
SA Bangladeshi 
men vs. EC 
Bangladeshi men had highest SMR ( 267 ) 
compared to EC 
Hsu et al.  1999 Prospective study Registry based 
case monitoring 
UK, 
Leicestershire 
30 day and 1 year  
stroke mortality 
SA had a better survival at 30days (78%) as 
well as after one year (68%) follow up 
compared to EC (68% and 55%)  
UK=United Kingdom, SA=South Asian, EC=European Caucasian, AfroCar=Afro-Caribbean, M=Male, F=Female, SMR=Standard Mortality Ratio
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Figure 1.1: Secular trends in the Standard Mortality Ratio amongst South Asians in 
the UK 1970-1992  
 
* Based on national census data: Wild, et al (1997); Bhopal, et al (2005); Balarajan, et al.(1997); Gill, et al 
(2007).  
Official census data from the UK in 1981, 1991 and 2001 have persistently shown 
inequalities in ischaemic stroke mortality amongst the South Asian population. 
According to the three cross sectional studies (Bhopal, et al., 2005; Balarajan, et al., 
1991) based on the national census data in the UK, the average Standard Mortality Ratio 
(SMR) in South Asians were 55% and 41% higher in males and females respectively 
when compared to the Caucasian population (Figure 1.1). The average SMR for the 
South Asians between the age groups 20-69 years was 155 for males and 141 females. 
While rates of mortality from stroke have been declining in the UK population as a 
whole between 1970-1992, (Figure 1.1) the rate of decline was ten times less in South 
Asians compared to the Caucasian population.  
Gill et al (2007) reported an intra-ethnic variation in ischaemic stroke mortality in 
South Asians (Figure: 1.2, below). It was noted in particular that Bangladeshi born men 
living in the UK had the highest mortality rate (SMR: 201) compared to other South 
Asian populations (SMR: 155). There were no significant gender differences reported in 
the stroke mortality rate amongst the South Asian population except amongst the 
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Bangladeshi population, where males had a significantly higher SMR compared to 
females. 
Figure 1.2: SMR amongst South Asian subgroups in the UK: 2004 
 
Based on national census data: Based on national census data: Wild, et al (1997); Bhopal, et al (2005); 
Balarajan, et al (1997); Gill, et al (2007).   
Based on a one-year ischaemic stroke mortality study by Hsu et al. (1999) 
ischaemic stroke mortality was significantly lower in South Asians compared to the 
Caucasian population. There are limited studies which report ischaemic stroke mortality 
rates in the Indian subcontinent. Short-term (30-day) stroke mortality in a rural hospital-
based study in India was 32% in 1968, which declined to 12% in 1982 (Dalal, et al., 
2006).  The Global Burden of Disease study reported that 61,900 deaths (6.5% of all 
deaths) were accounted for by strokes in the year 1990. In the UK based South Asian 
stroke study (Hsu, et al., 1999) only 78% South Asians survived at the end of 28 days. In 
comparison, reported mortality rates from western countries (Geramny 11%, Norway 
10%, France 12% and Australia 12%) are significantly lower than that of South Asian 
stroke populations (Feigin, et al., 2003). Possible explanations for the observed 
differences amongst South Asians may include variations in the management, type and 
severity of ischaemic stoke compared to Caucasian stoke populations. 
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However there is no significant evidence to support the assertion that stroke 
mortality rates in the migrant South Asian population differs when compared to non-
migrant populations in their country of origin, mainly due lack of comparison studies 
between these two groups.  However, higher rates of stroke mortality in migrant South 
Asians in the UK are consistent with reported higher risk of CHD in these subjects.   
1.4.6 Predictors of Stroke Severity in South Asians 
Ethnicity has been reported as an independent predictor of stroke severity (Jones, 
et al., 2000). Evidence from USA-based studies reveals a direct relationship between 
stroke severity and other contributory factors such as in-hospital mortality, duration of 
hospital stay, poor Glasgow Coma Scale (GCS) score and incontinence during acute 
presentation (Kuhlemeier and Stiens, 1994). Apart from the Leicestershire Stroke Study 
(Hsu, et al., 1999), which reported a significant association between development of 
incontinence during the acute stage and 28 day stroke mortality in South Asians, there 
appears to be no other studies available to infer a relationship between the severity of 
stroke and South Asian ethnicity.  
1.4.7 Stroke sub-types in South Asians 
Population-based studies have shown significant differences in stroke sub-types 
in the White populations compared to that of the Black populations (Friday, et al.,1989; 
Wityk, et al.,1996; Gorelick, et al.,1984).
  
The majority of published South Asian stroke 
studies have not enumerated the stroke classification or type of infarction, perhaps due to 
limited imaging facilities in South Asian countries. This may also be explained by the 
limited number of population-based studies.   
Of the few available studies (Table 1.5), one Pakistan-based stroke study showed 
prevalence rates of 66% for ischaemic strokes, 21% for intra-cerebral haemorrhage and 
8.3% for subarachnoid haemorrhage (Syed, et al.,2003). One study carried out in India 
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also showed a significant increase in the prevalence of hemorrhagic strokes of 32% 
(INTERSTROKE-India Study Group, 2006).  Two other studies from South Asian 
countries also showed similar distribution of stroke sub-types (Vohra, et al., 2000). In the 
absence of direct comparative studies, prevalence rates from the above three studies 
imply a higher risk of hemorrhagic stroke in the South Asian population compared to that 
of the Caucasian population (21% (Ebrahim, et al., 2006) vs. 6.4% (Bamford, et al., 
1990). The only two South Asian studies which classified their stroke population 
according to the TOAST taxonomy found a higher prevalence of lacunar strokes (42.7% 
and 68%) compared to large vessel infarctions (26% and 10%) (Syed, et al., 2003; Deleu, 
et al., 2006) and lower occurrence of cardio-embolic strokes (6.1%).  Whilst lower 
prevalence of cardio-embolic strokes may be directly related to significantly lower atrial 
fibrillation rates amongst South Asians (see section below). The higher occurrence of 
lacunar infarctions in the South Asian population has not been previously highlighted, 
but the increased prevalence of diabetes and hypertension in the South Asian population 
probably accounts for this excess risk of developing small vessel disease (Kaul, et al., 
2002). Further studies are therefore necessary amongst South Asian stroke survivors and 
the wider South Asian population.  
1.4.8 Management of stroke amongst South Asians 
Variations in standards of stroke management are held to vary depending upon 
the ethnicity of the sufferer (Goldstein, et al., 2003). As with other ethnicity-related 
epidemiological data concerning stoke, most of the evidence comes from literature 
comparing Black, Hispanic and White populations in the USA. 
In the majority of reported studies, ethnic minority groups appeared to experience 
a lower standard of care when compared to the indigenous white population (Stansbury, 
et al., 2005).  Nonetheless, there are inconsistencies in all stages of the data at different 
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levels of stroke management (from acute presentation, imaging, pharmacological 
treatment and rehabilitation to patient discharge). Indeed Bhopal (2005)
 
suggests that, the 
standards of care for stroke survivors in the UK during all phases of the illness are 
lamentably poor whatever one‘s ethnicity (Bhopal and Rahemtulia, 2005).  
There are only a small number of studies that examine issues of stroke 
management in the migrant South Asian population in the UK (Bourke, et al., 2006). 
There have been very few studies available for analysis from any South Asian countries 
(Brainin, et al.,2007).  It is held that there are delays in access to health care which affect 
the South Asian population and result in South Asians being less likely to receive 
appropriate treatment (Brainin, et al., 2007). This is despite Hsu et al (1999) reporting 
that South Asians were more likely seek early hospital treatment following an acute 
stroke compared to Caucasians. Similarly, according to two Indian based studies only 
29.5% (Nandigam, et al., 2003) and 14.5% (Pandian, et al., 2004) reached hospital within 
three hours (cut off time for thrombolysis) following an ischaemic stroke. However these 
rates are no different to that of Western populations (Bourke, et al., 2006). One of the 
contributory factors compounding poor standards of stroke care particularly amongst 
South Asians is the existence of barriers to communication (Feder, et al.,2002) which can 
delay treatment as a result of an inability express symptoms or communicate effectively, 
which results in a consequent inability to establish a medical history of the event.  Feder 
et al. (2002) also described the influence of the socio-economic status of South Asians 
and its influence on the provision of culturally appropriate and sensitive health care. In 
common with the ethnic minority groups in the USA, South Asian stroke patients in the 
UK are more likely to have radiological investigations than the Caucasian population 
(Nandigam, et al., 2003). For example, a South Asian stroke study carried out among 
members of the Bangladeshi population showed a higher number of both CT and MRI 
scans being performed in this group compared to that of Caucasians (Nandigam, et al., 
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2003). Possible explanations include atypical presentation on admission and the 
unreliability of clinical symptoms resulting in the deferment of a correct clinical 
diagnosis until further investigations are carried out.  There was, however, no disparity 
observed in the pattern of referrals for rehabilitation or carotid endarterectomies 
(Nandigam, et al., 2003).  
The evidence from the USA (Bourke, et al., 2006) as well as the UK (Nandigam, 
et al., 2003) suggests that the management of stroke among ethnic minority groups 
including South Asians was hampered by lack of adequate service provision.  This 
situation is made worse because of non-individualized treatment strategies and relatively 
small number of trials involving South Asians, particularly in cardiovascular research 
(Gammon and Gunarathne, 2008).   This relative lack of proactivity may have a profound 
impact on both the general population and South Asian migrants who, because of higher 
stroke risk, do not enjoy the advantage of a more leisurely approach to stroke 
management.   
1.4.9 Prevalence of cardiovascular risk profile in South Asian stroke populations 
Hypertension, diabetes mellitus, smoking and atrial fibrillation (AF) are the most 
common known conventional risk factors for stroke (Bamford, et al., 1990; Sacco, et al., 
2001). The prevalence of these risk factors is known to differ among various ethnic 
groups (Burchfield, et al., 1994; Cruickshank, et al., 1987) and is also associated with 
manifestations of different stroke sub-types (Zhang, et al. 2006). 
South Asian migrants have been reported to a have a high prevalence of central 
obesity, hyperinsulinaemia, hypertriglyceridaemia and low HDL cholesterol, but less 
hypercholesterolaemia and general obesity relative to the general UK population 
(Cruickshank, et al., 1991; Sewdarsen, et al., 1991). These cross-sectional studies 
highlight the ethnic variations observed in cardiovascular risk factor profiles. 
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1.4.9.1 Hypertension 
Elevated blood pressure is the most significant known risk factor for stroke in 
terms of strength of association and consistency of findings (Sacco, et al., 2001). The risk 
of stroke in the presence of hypertension is increased by three-fold (Zhang, et al. 2006). 
Migrant South Asian populations in the UK are known to have a higher risk of 
hypertension (Khattar, et al., 2000; Bhopal, et al., 1999; Whitty, et al., 1999). The 
prevalence of hypertension in the South Asian population has been reported to be in the 
region of 30%, and is also reported to be significantly higher than in the Caucasian 
population (Gupta, et al., 2008).  Higher prevalence rate of hypertension has also been 
reported in a comparative South Asian stroke study in the Quatar where rate was more 
than 70% (Deleu, et al., 2001) (Table 1.7)  
Whilst large studies in stroke are lacking, the disproportionately higher CHD 
mortality rates in South Asians in the UK have been related to hypertension (Khattar, et 
al., 2000). However, mean blood pressure levels, the use of antihypertensive therapy and 
secular trends in blood pressure amongst South Asians appear to be comparable with 
European Caucasian counterparts (Lyratzopoulos, et al., 2005). Longitudinal studies also 
show that hypertension is a strong risk factor for CHD in Indians living elsewhere (Patel, 
et al., 2008b). More population based prospective studies are needed to further explore 
the impact of migration, on hypertension-related morbidity & mortality amongst migrant 
South Asians. 
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Table 1.5: Studies comparing stroke types and risk factors amongst South Asians 
 
Author Year Methodology population Investigated main 
epidemiological aspect 
Key findings 
De Silva et al  2001-03 Prospective Singapore Types of stroke and risk 
factor prevalence 
75% of SA had hypertension. 
Syed et al  2003 Cross sectional Pakistan Type of stroke Ischaemic strokes (lacunar strokes:42.7%,large 
artery:26.9 and Cardiac:6.1% ) were more common 
than hemorrhagic strokes 
Deleu et al  2001 Cross sectional Qatar Type of stroke and Risk 
factors 
SA and Arabs had more lacunar strokes (68%), and 
Arabs had more diabetes and multiple risk factors. 
Vohra et al 2000 Retrospective Pakistan Type of stroke and Risk 
factors  
Ischaemic strokes were more commoner than 
haemorrhagic strokes  
Moussoutta 
et al  
1997-05 Retrospective USA Type of stroke and Risk 
factors  
SA were younger and had higher prevalence of 
diabetes and intracranial atherothrombotic 
infarctions but lower prevalence of hyperlipidaemia 
compared to European Americans 
Kaul et al  2000 Retrospective India Stroke types, Risk factors, Patients with diabetes had more lacunar strokes. 
hypertension was the commonest risk factor  
Bourke et al 1997-02 Cross Sectional UK Risk Factors and stroke 
management 
Bangladeshi SA had higher prevalence of diabetes 
compared to EC and lower level of stroke care 
UK=United Kingdom, USA=United States of America, SA=South Asian, EC: European Caucasian.
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1.4.9.2  Diabetes mellitus 
Diabetes is a continuing global epidemic, particularly concentrated within the 
Indian subcontinent (King, et al., 1998) (Ramachandran, et al., 2001) such that dispersed 
migrant populations consistently show a major propensity to develop the disease (Dowse, 
et al., 1990; Ramaiya, et al., 1995). Their diabetes prevalence that is much higher 
(approx. 10-15%), compared to the general British population (approx. 4%) (Simmons, et 
al., 1989), and appears to equal rates in some parts of India (Verma, et al., 1985). 
Amongst resident Indians, rates of diabetes appear to be associated with urbanisation 
(Ramachandran, et al., 1997), reportedly lower in rural parts of India (Ramachandran, et 
al., 1992). However, a direct comparison of Indian migrants to rural contemporaries in 
villages of origin in India showed no differences in the rates of glucose intolerance 
(Patel, et al., 2006). Moreover, despite varied lifestyle approaches, cross-sectional studies 
from Fiji (Collins, et al., 1996) and Tanzania (Seedat, et al., 1990), also question whether 
urbanisation has a role in explaining the high prevalence of diabetes amongst Indian 
populations. Hence, not only is diabetes more common amongst South Asians compared 
to other ethnic groups (Patel, et al., 2007a), but it is likely that this is an inherited risk 
factor in this population (Moussouttas, et al., 2006). 
The prevalence of diabetes is much higher among stroke sufferers and is the 
second most common risk factor in South Asian stroke patients (Kaul, et al., 2000; Delu 
et al., 2001). Glycaemia is associated with poorer clinical outcomes in patients with acute 
ischaemic stroke (Baird, et al., 2003). Increased prevalence of diabetes amongst South 
Asian patients with stroke may explain their poorer survival, in-particular associated with 
underlying hypertension (Khattar, et al., 2000). While the presence of diabetes calls for a 
more stringent management of blood pressure, the underlying pathophysiology that 
accelerates the risk of stroke is not clear. Moreover, the magnitude of cerebrovascular 
 27 
risk from diabetes may differ between migrant and non-migrant populations of South 
Asians, especially amongst those living in the UK.  
1.4.9.3 Atrial fibrillation 
The prevalence of atrial fibrillation (AF) in stroke patients ranges from 10-29% in 
population based studies (OXVASC-16%, France Dijon -29%, Manhattan-19%, West 
Birmingham-10%, South London-21%) (Tolonen, et al., 2002). Conway et al. (2003) 
reported a lower prevalence of AF in the SA population compared to that of Caucasians 
(11.8% vs. 34.6%). Compared to other risk factors, the prevalence of AF in South Asians 
has remained lower and has been shown to have minimal impact on the stroke outcomes. 
(Conway, et al., 2003). However, the reasons for this observed disparity have not been 
fully explained and warrant further investigation.  
1.4.9.4 Dyslipidaemia 
Hyperlipidaemia is a risk factor, which is present in more than 25% of stroke 
patients (Feigin, et al., 2003). However, the association between hypercholesterolemia 
and stroke is not clear and one meta-analysis of 45 prospective cohort studies reported no 
significant association between total cholesterol and ischaemic stroke (Prospective 
Studies Collaboration Group 1995), although a trend was evident. Trials of LDL 
cholesterol lowering with statins however report a 20% relative risk reduction for stroke 
(Libby, et al., 2004). 
South Asians are known to have an atherogenic lipid profile, which includes 
raised triglycerides, low HDL cholesterol and raised Lipoprotein (a) levels (Sewdarsen, 
et al., 1991).  In two South Asian stroke studies, more than 50% of the stroke patients 
had elevated total cholesterol levels 
 
(Tuomilehto, et al., 1993; Deleu, et al., 2006).  In 
Caucasians, the prevalence of hyperlipidaemia ranges from 28.7% (in Dijon, France) to 
29.5% (in Oxford) and 32% (in Manhattan, USA) (Feigin, et al., 2003). A similar trend 
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has been reported in South Asians in the United Arab Emirates, where hyperlipidaemia 
has become the second most modifiable risk factor after hypertension (Deleu, et al., 
2006). However, low HDL levels in South Asians may be more important than higher 
cholesterol levels in the aetiology of CVD (Sewdarsen, et al., 1991).   
In a study by Sharobeem et al. (2007), South Asian stroke survivors were found 
to have significantly higher apolipoprotein B to AI ratios, and higher Lipoprotein (a) 
compared with ethnically matched healthy controls. This study highlights the importance 
of dyslipidaemic management in the treatment and prevention of stroke in a multi-ethnic 
population, even where the underlying basis for disease aetiology appears to be different. 
Other than the mentioned major risk factors, coronary heart disease, smoking and 
heart failure are also important comorbidities in stroke (Bamford, et al., 1990). South 
Asians in the UK are more prone to premature, more extensive CHD which also carries a 
poorer prognosis (Patel, et al., 2008a). There are limited data on heart failure and 
increased risk of stroke in South Asians (Singh and Gupta, 2005). In one case controlled 
study by Deleu et al. (2006), 19.6% of the South Asian stroke patients had regional wall 
motion abnormalities but the mean ejection fraction was more than 60% and was not 
significantly different to the compared Arab population. The prevalence of heart failure 
appears to be lower in South Asians compared to recently reported studies from Western 
populations (Divani, et al., 2009). There are very limited data however, which 
demonstrate an association between heart failure and increased stroke burden 
independent of underlying risk factors amongst this population.  
Lifestyle factors such as smoking and tobacco use are important in ischaemic 
strokes (Moulton, et al.,1991). The overall rate of daily cigarette/bidi smoking observed 
amongst South Asians range from 9-20% where very higher rates are observed amongst 
Bangladeshi male populations (Glenn, et al., 2009). One population based prospective 
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study conducted by Bhatacharya et al. (2005) demonstrated an adverse impact of 
smoking on stroke incidence amongst the South Asian population independent of other 
conventional risk factors.  Recent evidence has supported the role of novel risk factors in 
determining stroke aetiology.  For example, elevated Lipoprotein (a), higher C-reactive 
protein (CRP) and homocysteine (HCY) concentrations which are particularly raised 
amongst migrant South Asians are believed to further enhance the risk of developing 
CVD (Libby, et al., 2004; Tan, et al., 2002). 
1.4.10 Conclusions 
In general, the incidence of stroke appears to be higher in the South Asians than 
European Caucasians and has increased exponentially over the last five decades. 
Comparable rates of stroke prevalence may indicate higher stroke mortality consequent 
upon disease severity and other co-morbidities. However, studies from India as well as 
the UK indicate a significant heterogeneity of stroke epidemiology even amongst the 
South Asian population. In India, for example, there is a perceptible rural-urban gradient 
in stroke prevalence which can be partly explained by adverse socio–economic 
circumstances, dietary and lifestyle habits which have been transformed particularly 
during last two decades.  There are no reported migration-related studies to examine the 
impact of migration on stroke incidence in South Asians particularly those living in 
Western Europe. 
The prevalence of haemorrhagic stroke among South Asians appears to be higher 
when compared to European Caucasians. This may be intimately associated with higher 
prevalence of hypertension. However, the increased prevalence of lacunar strokes 
appears to suggest a greater prevalence of small vessel disease in South Asians, which 
may be a consequence of abnormal metabolic and glycaemic processes.  
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Based on the available literature, SA stroke survivors appear to have an aberrant 
cardiovascular profile compared to EC. Diabetes and hypertension are the most prevalent 
risk factors in SA stroke survivors.  The clustering of these risk factors and their effect on 
vessel wall characteristics in South Asians may contribute to their higher burden of 
disease and differing manifestations of stroke in this population. The work with in this 
thesis is to explore and explain some of these possible pathophysiological mechanisms.  
There are also limited data examining the differences of stroke management 
amongst South Asian stroke survivors, but some support the existence of inequalities in 
the standard of care available to the South Asian population in the UK.  However, the 
existence of barriers to communication, and other issues rather than ethnicity per se may 
serve to obfuscate the cause of lower standards of care among South Asians. However 
poor study designs, small sample sizes, poor case ascertainment methods, recording and 
publication biases and lack of quality in data presentation in the above discussed 
published studies may restrict critical appraisal, interpretation and comparison of stroke 
rates between countries as well as amongst ethnic groups.  
 
1.5 Pathophysiology of stroke amongst South Asians 
1.5.1 Pathophysiology of ischaemic stroke 
Cerebral perfusion can be compromised by several pathophysiological conditions 
that are associated with atherosclerosis of the extra and intra-cranial blood vessels 
(Capron, et al., 1988; Prati, et al., 1992). Endothelial dysfunction, increased vessel wall 
stiffness and inflammation are some of many factors known to play a significant role in 
the pathogenesis of ischaemic stroke (Febbraio, et al., 2001).  
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1.5.2 Endothelial dysfunction and Arterial stiffness  
 
The endothelium is a thin monocellular layer that covers all the inner surface of 
the blood vessels. The endothelium regulates homeostasis by controlling the production 
of prothrombotic and antithrombotic components, activation of cytokines (angiotensin II, 
endothelin-1) and modulates vascular tone by effecting smooth muscle cell relaxation ( 
NO mediated)  or contraction to cause vasodilatation or vasoconstriction (Furchgott et 
al., 1980). Cardiovascular risk factors (Sorensen et al., 1994; Celermajer et al., 1993; 
Williams et al., 1996), inflammation, arterial pressure changes, sheer stress and oxidative 
stress (Ross et al., 1999; DeGraba, et al., 1992) are believed to alter the endothelial cell‘s 
capacity to maintain homeostasis and vascular tone and leads to the so-called endothelial 
"dysfunction", predisposing development of atherosclerosis.    
Endothelial dysfunction is considered a key stage in the development of 
atherosclerosis initiating luminal narrowing and ischaemia in coronary and cerebral 
vascular beds (Quyyumi et al., 1997; Cai, 2000; Al Suwaidi, et al., 2000; Halcox, et al., 
2002; Schächinger, et al., 2000). It is independently associated with cardiovascular 
events (Yeboah et al., 2007) and has been shown to be predictive of developing future 
stroke in Caucasians (Holmes, et al., 2003). However, there are limited data available on 
its utility in determining stroke outcomes and its prognostic value in South Asians stroke 
survivors.  
The extent of the endothelial dysfunction appears to correlate with conventional 
risk factor burden, although there is considerable variation in the magnitude of 
dysfunction observed in individuals with similar risk factor profiles (Quyyumi, et al., 
1998). Previous in-vitro and in-vivo studies using different invasive methods support the 
contention that persons with diabetes (Williams et al., 1996; Clarkson, et al., 1996), 
hypertension (Panza, et al., 1993) and hypercholesteremia (Sorensen et al., 1994; 
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Chowienczyk, et al., 1992), appear to have impaired endothelial function. Novel risk 
factors such as lipoprotein (a), hyperhomocystinemia (both risk factors for stroke), and 
genetic and ethnic heterogeneity presumably account for some of this variability.  
Endothelial dysfunction leads to further damage to physical properties of the 
arterial media which contains smooth muscle cells, elastin and collagen, and the eventual 
loss of arterial elasticity (Halcox et al., 2009), compliance and distensibility - leading to 
increased arterial stiffness. Increased arterial stiffness has been directly associated with 
increased risk of ischaemic strokes (Blankenhorn, et al., 1994; Bots, et al., 1997) as well 
as all cause and cardiovascular mortality (Schroeder, et al., 1999).  Also, Laurent et al 
demonstrated the increased risk of fatal outcomes in acute ischaemic stroke with the 
presence of increased arterial stiffness (Laurent, et al., 2001).  
Abnormal arterial stiffness has been demonstrated in people with diabetes and 
hypertension (Woodman, et al., 2003; Megnien, et al., 1992; Salomaa, et al., 1995). In 
addition, large arterial stiffness may also increase with hyperlipidaemia (Wilkinson, et 
al., 2002), inflammation and oxidative stress (Toikka, et al., 1999). However, there is 
little evidence available on the effects of these risk factors on small artery stiffness and 
associated stroke and cardiovascular risk (Brooks, et al., 1999; Hassan, et al., 2003) in 
South Asians especially in relation to strokes due to intra-cranial small vessel disease. 
Endothelial function in humans is measured by many techniques (Donald et al., 
2006; Gerhard-Herman, et al., 2002) including assessment of the vasodilator response to 
sheer stress ( Doshi et al., 2001). Invasive methods include using intra-arterially 
administered agents such as, acetylcholine (Furchgott et al., 1980) or salbutamol (Dawes, 
et al., 1997), the action of such drugs being dependent on the ability of the endothelium 
to release vasodilator mediators such as nitric oxide (NO) (Joannides et al.,1995; Ignarro 
et al., 1987). The gold standard non invasive method to measure endothelial function is 
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based on the principle of reactive hyperemia (FMD)( Doshi et al., 2001). Many methods 
to assess endothelial function can be invasive, time consuming and difficult to perform 
(Donald et al., 2006; Barac, et al., 2007). Studies have confirmed that endothelial 
dysfunction and arterial stiffness can also be assessed by using non invasive techniques 
(Wilkinson et al., 2002; Donald et al., 2006). These methods have been used as surrogate 
markers for arterial damage (Deanfield et al., 2005). Detailed accounts of these non 
invasive methods are described in a different section below. 
1.5.3 Impact of conventional risk factor burden on abnormal vessel wall 
characteristics 
Persons with established CVD risk factors such as diabetes (Williams et al., 1996; 
Calver, et al., 1992) and hypertension (Perticone, et al., 2001) are known to have 
impaired endothelial function and carry a greater CVD risk. Diabetes and hypertensive 
disease are both associated with accelerated atherosclerosis as well as age-related 
arteriosclerosis or ‗vascular ageing‘ (Cruickshank, et al., 2002; Laurent, et al., 1994).  
The latter are known to cause structural changes in vessel wall characteristics (Oliver, et 
al., 2003). Indeed, the actions of early initiators of atherosclerosis on the vessel wall are 
manifested as increased arterial stiffness (O‘Rourke, et al., 1999).  
Glycaemic status has a profound impact on the endothelium in both 
microvascular and macrovascular beds (Guerci, et al., 2001). Indeed, diabetes accounts 
for the majority of excess mortality and morbidity relating to athermatoous disease 
(Shang et al., 2010). Glycaemic status also has an impact on endothelium-derived Nitric 
Oxide (NO) production (Calver, et al.,1992), causing a blunted smooth muscle relaxation 
response in small to medium-sized vessel walls with a consequent increase in vessel tone, 
thus contributing to increased arterial stiffness (Chowienczyk, et al.,1999). In the 
presence of diabetes NADPH oxidase production in the vascular beds are increased, 
thereby enhancing the production of reactive oxygen species and the related oxidative 
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stress (Föstermann, et al., 2006). These factors are known to increase NO catabolism, 
impair cGMP activity and consequent endothelial damage (Münzel, et al., 2005). 
The principal physiological factors that contribute to increased arterial stiffness 
other than age include the mean arterial blood pressure (Bramwell, et al., 1922; 
Armentano, et al., 1995), which is defined as the average pressure throughout the cardiac 
cycle (Oblouck, et al., 1987). The mean arterial pressure contributes to vascular changes 
independent of age and probably has a greater impact on the small-to-medium size 
muscular arteries, leading to higher peripheral vascular resistance. 
Despite comparable mean arterial pressure levels , antihypertensive therapy usage 
(Bhopal, et al., 2002) and changing trends in blood pressure (Lyratzopoulos, et al., 2005)
,
 
there is still a markedly greater burden of cerebrovascular and cardiovascular morbidity 
from hypertension in South Asians in the UK compared to the general population (Patel, 
et al., 2008b). Migration from the Indian subcontinent to the UK and residence therein, 
may confer an adverse risk exposure to blood pressure in this group (Lane, et al., 2001). 
The pathophysiological basis for this disparity, however, has not been explained 
(Agyemang, et al., 2007). 
1.5.4 Role of endothelial-derived Nitric Oxide (NO) in the regulation of arterial 
wall characteristics 
People with impaired endothelial function are known to have decreased nitric 
oxide production. Endothelium-derived nitric oxide (Palmer, et al.,1987) is synthesized 
from the substrate L-arginine via endothelial Nitric Oxide Synthase (eNOS) 
(Föstermann, et al., 1994;Busse,et al.,1998; Fleming, et al., 2004) and it exerts its cellular 
mechanisms via cyclic Guanylate Mono Phosphate (cGMP) (Bauersachs, et al., 1998) 
second messenger interaction (Melichar, et al., 2004). The NO plays an essential role in 
maintaining vascular tone, blood pressure (Ohashi, et al., 1998), and lower levels are 
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thought to be involved in atherogenesis (Maxwell et al., 1998; Wolf, et al., 1997). In 
addition vascular protective mechanisms of NO include the reticence of platelet 
aggregation, leukocyte adhesion (Kubes P, et al., 1991), and smooth muscle cell 
proliferation (Garg, et al., 1989). Given that the majority of the endothelium-derived NO 
production depends on eNOS concentration, reducing the availability of eNOS also 
exerts similar impact on the vascular homeostatic mechanisms (Feng, et al., 2002). The 
dysfunctional eNOS-NO pathway is considered an important early indicator of 
cardiovascular risk amongst higher risk populations with both prognostic and diagnostic 
implications (Hare, 2004). Patients with impaired endothelial function are known to have 
increased risk of cardiovascular disease (Halcox et al., 2002; Rossi, et al., 2003) 
including strokes (Lip et al., 2002; Corrado, et al., 2008)
 
and reduced NO bioavailability 
and eNOS expression has been well demonstrated with many other stroke populations 
(Cheng, et al., 2008; Kim, et al., 2007). 
However, there are very limited data examining the molecular interactions of 
endothelial-derived nitric oxide production amongst the South Asian stroke population 
investigating the influence on the vessel wall characteristics.   
1.5.5 Role of inflammation and oxidative stress in the pathogenesis of stroke and 
vascular function 
Chronic sub-clinical inflammation is now recognized to play a central role in the 
pathogenesis of CVD and stroke (Rost, et al. 2001). Specifically, C-reactive protein 
(CRP) is an inflammatory component involved in the atherogenesis (Montaner, et al., 
2003). Several studies have also shown that CRP is predictive of stroke. (Di Napoli, et 
al., 2001)
 
and myocardial infarction (Arici, et al., 2001; Chung, et al., 2001). Interleukin 
6 (IL6) and Tumour Necrosis Factor (TNF alpha), are also correlated with the 
development of CVD (Pradhan, et al., 2002). 
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Systemic inflammation measured by CRP plays a major role in all stages of 
athero-thrombosis
 
and provides a critical pathophysiological link between plaque 
formation and acute rupture, leading to occlusion and infarction (Lhermitte, et al., 1968). 
The degree of inflammation could vary in different vascular beds in the cerebral blood 
supply where atherosclerotic process in the intracranial arteries may have differential 
characteristics to that of extra-cranial large arteries 
 
(Lammie, et al., 1999). Furthermore 
the degree of inflammation indicated by elevated markers of inflammation (Kalra, et al., 
2005) and other metabolic factors such as oxidative stress and glycaemic status could be 
different amongst ethnic groups. However there is very limited data on its role in the 
development of stroke and its predictive value in predicting stroke outcomes in South 
Asians (Somani, et al., 2006). 
Heme-oxygenase (HO 1) is an inducible protein which acts as a rate-limiting 
enzyme that catalyzes the degradation of heme into biliverdin, iron and carbon monoxide 
(CO). These metabolites are known to have a protective action against oxidative stress-
mediated injury. Increased levels of expression of HO 1 have been reported in many 
cardiovascular conditions (Duckers, et al., 2001; Kapturczak, et al., 2004) but there are 
very limited data available in relation to cerebrovascular disease. It is postulated to have 
a role in modulating the vascular tone in pathological conditions such as ischaemia 
(Duckers, et al., 2001). Ameriso et al (2005) demonstrated a higher level of expression of 
HO 1 in patients with carotid atherosclerosis. However its prognostic value and clinical 
relevance of use of HO in South Asian stroke patients have not been previously 
investigated. 
1.5.6 Ethnic differences in pathophysiology of stroke amongst South Asians 
Ethnic variations in arterial stiffness, endothelial damage and inflammation are 
known to exist (Young, et al., 2007) but there are very limited data available on 
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pathophysiological differences in arterial stiffness (Din, et al., 2006), endothelial damage 
and inflammation in South Asian stroke survivors. 
 
In addition, its relationship to stroke 
and disease outcomes have been hampered by lack of population based studies amongst 
South Asian stroke survivors. Available literature on healthy South Asians suggests that 
they have an excess risk of cardiovascular disease associated with increased arterial 
stiffness (Din, et al., 2006) and endothelial damage (Raji, et al., 2004) compared to that 
of Caucasians. It is evident that south Asians are more susceptible to small vessel disease 
and to acquiring lacunar type of strokes (Deleu, et al., 2006). However, it is not clear 
whether this can be totally explained by the known ethnic differences in traditional CVD 
risk factors. Therefore, it is reasonable to assume that proposed differences in arterial 
stiffness and endothelial damage along with clustering effect of other aberrant metabolic, 
inflammatory, eNOS-NO axis parameters may account for this disparity (Figure 1.3).  
Figure 1.3: Proposed underlying pathophysiological mechanisms contributing to 
abnormal vessel wall characteristics amongst South Asians.  
 
*Adopted and modified from: http://www.google.co.uk/search?hl= m&xhr=t&q=endothelial+function: 
accessed on 8th January 2008. 
Increased arterial stiffness and wave 
reflections
Increased thrombosis
Inflammatory cytokines ( IL6,TNF) Oxidative stress (HO) Metabolic ( Apo A , B)
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Measurements of indices of arterial stiffness and endothelial dysfunction in South 
Asian stroke survivors should aid better cardiovascular risk stratification amongst South 
Asians and enable clinicians to instigate a more sensitive and holistic approach towards 
their risk factor control. This thesis intends to examine the differences in prevalence of 
cardiovascular risk profile and related underline pathophysiological processes in South 
Asian stroke survivors.  The next section looks at the current evidence for any 
association between arterial stiffness and ethnicity to aid accurate interpretation of the 
findings of the pathophysiological studies within this thesis work. 
1.6 Arterial stiffness and ethnicity  
1.6.1 Introduction: 
Current evidence suggests an association between arterial stiffness, ethnicity and 
underlying genetic polymorphisms (Kingwell, et al., 2007). Other recent studies serve to 
support the hypothesis that arterial stiffness is, in part, an inherited and dynamic trait and 
the molecular pathways regulating arterial stiffness are not completely understood 
(Yasmin, et al., 2006). This section explores measures of arterial stiffness among 
different ethnic groups including South Asians. 
1.6.2 Methods: literature review strategy 
A MEDLINE and EMBASE search was performed using the terms (MeSh) : 
(Ethnicity ) OR (South Asian, Indian, Sri Lankan, Bangladeshi, Pakistani, European 
Caucasian, African, Afro-Caribbean, Chinese, Japanese, Hispanic), AND (Arterial 
stiffness) OR (Pulse Wave Velocity (PWV)), Augmentation Index (AI), Stiffness Index 
(SI), Pulse Pressure (PP)).  For the purpose of this review, 17 representative studies were 
selected, based upon 15 cross sectional and two prospective studies describing
 
ethnic 
variation in arterial stiffness. We did not perform a meta-analysis or statistical 
calculations to combine or analyze the data, and only reviewed and analyzed 
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descriptively, because of the methodological heterogeneity of measurements of arterial 
stiffness and differing study designs. 
1.6.3 Arterial stiffness and Ethnicity 
The majority of US-based studies compare ethnic variations in indices of arterial 
stiffness between White and Black American populations (Table 1.8). A genetic twin 
study by Young et al. (2007) examined the heritability of arterial stiffness (measured as 
PWV) and its dependence on ethnicity. This study showed no relationship between 
ethnicity or gender and the degree of arterial stiffness but indicated substantial 
heritability.  Furthermore, more than 25% of this heritability was explained by genetic 
makeup. Hlaing et al. (2006a) also found no differences in arterial stiffness between 
White Americans and Afro-Caribbean Americans. Both these studies sampled a younger 
(20-25 years) and healthier population compared to other published studies by Chen et 
al., (2006) and Din-Dzietham et al. (2004), both of which demonstrated significantly 
higher arterial stiffness in a middle-aged Afro-Caribbean population which also had other 
established cardiovascular risk factors.  Similarly, a study by Lemogoum et al. (2006) 
demonstrated increased arterial stiffness in response to smoking in African-Americans. 
Two large population-based studies (the Bogalusa Heart Study (2006) and the 
ARIC Study (2004)) used PWV to measure arterial stiffness and both showed greater 
PWV values in non-Whites when compared to Whites, whilst MAP and lipid 
abnormalities predicted increased arterial stiffness. In the UK, Kalra et al. (2005) 
compared indices of arterial stiffness amongst healthy age- and gender-matched Afro-
Caribbeans and European Caucasians and demonstrated no ethnic difference in the 
measurement of arterial stiffness. In contrast, Chaturvedi et al. (2004) compared high-
risk populations and demonstrated that Afro-Caribbean persons with diabetes had 
increased indices of arterial stiffness compared to age- and gender-matched diabetic 
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American Caucasians. This study demonstrated a disproportional impact of glycaemic 
status on vessel wall characteristics, leading to higher arterial stiffness and an increase in 
cardiovascular risk amongst Afro-Caribbeans. 
Other studies have revealed further inconsistencies in the measurement of arterial 
stiffness amongst Chinese, Japanese and Russian populations. Nonetheless, Foo et al. 
(2007) showed comparable arterial stiffness measurements between Singaporean Chinese 
and Caucasian ethnic groups. Indices of arterial stiffness were significantly higher in 
those Chinese who recently migrated to Australia compared to those Chinese who 
migrated some decades ago (Dart, et al., 1995).   
Table 1.8: Ethnicity related studies on arterial stiffness ( I ) 
Study Year Design and Number Arterial stiffness 
measurement method 
Ethnic groups 
compared 
Main outcome 
Young et al. 2007 Healthy population Twin 
Study,Cross sectional 
(n=702), Age 12-30 years 
Aorto radial and aorto 
dorsalis pedis Pulse 
wave velocity 
Blacks Americans and 
American Caucasians  
Individual differences in the arterial 
stiffness was substantially heritable, 
and >25% of this heritability is 
explained by genes. No ethnic or 
gender differences 
Foo et al.  2007 Healthy population,Cross 
sectional (n=67), Age < 12 
years 
Pulse transit time Singapore Caucasians 
and Singapore Chinese  
Arterial stiffness between two groups 
were not significantly different  
Heffernan et al.  2007 Healthy population,Cross 
sectional (n=24),                    
Age 21-23 years  
Carotid femoral and 
femoral dorsalis pedis 
pulse wave velocity  
African-Americans and 
American Caucasians  
African American men had 
significantly higher resting aortic 
stiffness. 
Brown et al. 2007 Population with risk factors          
Cross sectional (n=283),              
Age 30-62 years 
Augmentation Index 
and Carotid femoral 
pulse wave velocity  
Remote Indigenous and 
European Australians  
Indigenous Australians have higher 
indices of peripheral and central 
arterial stiffness than European 
Australians of similar 35% of the risk 
was not explained by traditional CVD 
risk factors 
Hlaing et al. 2006 Healthy population,  Cross 
sectional  ( n= 491) ,                 
Age 20-22 years  
Arterial pulse pressure American Caucasians, 
,Hispanic and Black 
Americans 
No variation between ethnic groups. 
Male had higher arterial stiffness 
Chaturvedi et al.  2006 Population with diabetes 
mellitus, Cross sectional 
(n=303), Age 40 to 65 years 
Carotid femoral pulse 
wave velocity  
African Caribbean‘s and 
European Caucasians  
African Caribbean‘s with diabetes had 
increased stiffness compared to 
Europeans 
Chen et al. 2006 General population, Cross 
sectional, (Bogalusa Heart 
study), (n=900) , Age 24-43 
years 
Carotid femoral Pulse 
wave velocity 
African-Americans and 
American Caucasians  
African-Americans had higher pulse 
wave velocity. However ethnicity 
didn‘t independently associated with 
PWV but with systolic blood pressure 
Hlaing et al.  2006 Healthy population   
Prospective study (9 years)               
(n=487). Age 7 to 16 years  
Arterial pulse pressure African-Americans and 
American Caucasians  
African-Americans who were before 
the age of 10 years had increased 
arterial stiffness 
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Table 1.9: Ethnicity related arterial stiffness studies (II) 
 
Study Year Design and Number Arterial stiffness 
measurement method 
Ethnic groups 
compared 
Main outcome 
Liu et al. 2005 Healthy population, Cross 
sectional study , (n=475)            
Age 40-60 years  
Brachial pulse wave 
velocity 
Japanese and Russians  Russians had higher arterial stiffness 
compared to Japanese at a younger age  
Kalra et al. 2005 Healthy population,Cross 
sectional (n=164), Age 30-75 
years 
Stiffness index and 
Carotid intimal medial 
thickness 
Afro-Caribbean and 
European Caucasians 
 
Afro-Caribbean‘s had comparable 
Stiffness index  to European 
Caucasians but had higher carotid 
intimal medial thickness 
Chaturvedi et al. 2004 Population  with risk factors, 
Cross sectional (n=202),             
Age 40-64 years  
Carotid femoral and 
radial pulse wave 
velocity  
Afro-Caribbean and 
European Caucasians 
 
African Caribbean‘s had increased 
Carotid femoral pulse wave velocity 
but not  Carotid radial pulse wave 
velocity 
Chen et al.  
 
2006 Healthy population, Cross 
sectional (n=403), Age 25-37 
years 
Common carotid artery 
Petersons and Youngs 
elstic modulus 
African Americans and 
American Caucasians  
African Americans had higher arterial 
stiffness associated with lower eNOS 
G894T polymorphism 
Din-Dzietham et 
al.  
2004 Healthy population   
Prospective study   (3 years )   
(n=2727), Age 45-64 years 
Mean beta stiffness 
index (Echo tracking)  
African Americans and 
American Caucasians  
African Americans had higher arterial 
stiffness particularly at early age 
Ferreiraet al.  
 
1999 (Hypertensive population )   
Cross sectional (n=120)             
Age 40-60 years 
Carotid femoral pulse 
wave velocity  
African Americans and 
American Caucasians  
African Americans with hypertension  
had increased arterial stiffness  
Dart et al. 1995 Healthy population, Cross 
sectional (n=83) 
 
Aortic pulse wave 
velocity and the aortic 
elastic modulus  
migrants Chinese and 
Australian Chinese 
inhabitants 
Migrant Chinese had increased arterial 
stiffness and duration of Australian 
residence was associated with increase 
stiffness. 
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In this same study, increasing duration of Australian residence appears to be 
accompanied by an increase in arterial stiffness associated with dietary and lifestyle 
differences but without accompanying differences in cardiovascular risk. Also, 
cardiovascular mortality rates in Russia have become the highest in the world (Davydov, 
et al., 2007), whilst amongst the Japanese, mortality rates have remained at relatively 
lower level. In a comparative study, Liu et al. (2005) demonstrated increased PWV in 
apparently healthy Russian population compared to age and gender matched Japanese 
population, possibly providing a pathophysiological basis for their higher cardiovascular 
risk. 
Based on available evidence, complex disparities (related in part to ethnicity) 
exist concerning arterial stiffness, especially in studies from developed countries, which 
principally compare Afro-Caribbean and Caucasian groups.   
The available literature however does reveal similar disparities in arterial stiffness 
amongst Afro-Caribbean groups who are older and have established risk factors. 
Comparable degrees of arterial stiffness in younger, healthier populations and differences 
in age and gender-matched older populations hints at the disproportionate impact of 
conventional cardiovascular risk factors on vessel wall characteristics which are 
cumulative and become manifest later in life. This may indicate an adverse genetic 
susceptibility of certain ethnic groups, which is responsible for increased arterial stiffness 
and consequently, a higher cardiovascular risk. However, the majority of the studies 
demonstrate lack of robust study designs comprising elements of functional genomics, 
larger sample sizes, and longitudinal approach. More importantly, methods of patient 
recruitment, study designs and studied age groups were variable, demonstrating a 
significant methodological heterogeneity. There also appears to have been a variation in 
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the measurements and methods used to measure different indices of arterial stiffness 
amongst different ethnic groups.   
1.6.4  Conclusion 
Current evidence suggests an association between arterial stiffness and ethnicity. 
There appears to have been a variation in the measurement of different indices of arterial 
stiffness amongst different ethnic groups such as in Afro-Carribeans. Research 
undertaken to date has not been entirely successful in explicating the underlying 
causative mechanisms of increased arterial stiffness in certain ethnic groups. In 
particular, there are very few studies involving higher CVD risk ethnic groups such as 
Asians who are likely to have abnormal indices of arterial stiffness. There are no studies 
examining vascular structure and function in South Asian stroke survivors. More 
comparative studies are needed to comprehensively examine the arterial structure and 
function amongst South Asians. The findings of this review further highlight the paucity 
of pathophysiological studies amongst South Asian stroke survivors and provide a firm 
basis for the proposed studies within this thesis work.  
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Chapter 2 :   General Methodology  
 
2.1 Study Rationale 
Preceding chapter highlights the evidence for higher rates of ischaemic strokes 
and related stroke mortality amongst South Asians compared to European Caucasians. 
What is the reason for this observed disparity?  Based on the available evidence (Chapter 
1) a pathophysiological explanation for this ethnic variation in disease rates is not 
apparent.  
In the UK, Coronary Artery Disease (CAD) amongst South Asian migrants is due 
to both hypertension and diabetes (Chapter 1.3), suggesting that an aberrant 
cardiovascular risk profile may in part underlie the increased risk of stroke in this 
population. As discussed in the former sections (Chapter 1.5), diabetes, hypertension, 
inflammation and oxidative stress can have a profound impact on the endothelium in both 
microvascular and macrovascular beds by altering the intra-cellular metabolic processes. 
Dysfunctional endothelium has a direct influence on endothelium-derived Nitric Oxide 
(NO) production, causing a blunted smooth muscle relaxation response in vessel walls 
with a consequent increase in vessel tone, thus contributing to increased arterial stiffness 
(Figure 1.3). Literature on other ethnic groups indicates an association between increased 
arterial stiffness and ischaemic stroke mortality (Chapter 1.6). 
Therefore, as a step towards understanding the pathophysiology of 
cerebrovascular disease amongst this higher risk population, my thesis intends to 
examine the differences in prevalence of cardiovascular risk profile and vessel wall 
characteristics, specifically examining the arterial stiffness, endothelial function and 
related: metabolic, inflammatory and oxidative stress indices amongst South Asian stroke 
survivors. 
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2.2 Main hypotheses & Study outline 
 
Hypothesis 1 
The cardiovascular risk profile in South Asian stroke survivors differs to 
counterparts in the general population, and these differences may explain variations in 
mortality. 
Hypothesis 2 
Arterial stiffness and  indices of endothelial dysfunction are higher amongst 
South Asians stroke patients compared to Caucasian counterparts, and differences in 
CVD risk profile and related biochemical ( Nitrate, eNOS and cGMP) , inflammatory ( 
Interleukin (IL6), High sensitivity C-reactive protein (hsCRP), Tumour necrosis factor (TNF alpha)), 
metabolic (Apo lipo protein (Apo A), Apo lipo protein B(Apo B)), and oxidative stress (oxidised 
Low Density Lipo-protein (oxLDL), Haem-Oxygenase (HO))  abnormalities may explain these 
aberrancies. 
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Study Outline 
 
 
 
Assessment of clinical utility of arterial 
stiffness indices in a population with 
higher CVD risk: A Validation study 
Analysis & comparison of CVD risk 
profile & mortality in a large South Asian 
stroke population. 
 
Measurement of indices of Arterial 
structure and function in a South Asian 
Stroke population 
 
 
Measurements of biochemical, 
inflammatory, oxidative stress & metabolic 
indices in South Asian stroke population 
and their relationship to arterial stiffness 
and function 
 
Measurement of indices of Arterial 
structure and function in a Healthy South 
Asian population  
 
     South Asian Stroke epidemiology  
Vascular Pathophysiology 
Molecular & biochemical interactions 
Study 2: Cross sectional study: Chapter: 2 
 
Study 1: Retrospective analysis of Registry 
data: Chapters: 3 
 
Study 3: Case control study: Chapter: 4  
Study 4: Case control study: Chapter: 5  
Study 5: Case control study: Chapter 5  
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2.3  Aims & Objectives: 
 
Study 1: Retrospective analysis of Registry data (Chapter 3): 
Literature appraisal (Chapter 1) indicates a significant paucity of comparative 
cardiovascular risk profile data in South Asian stroke survivors. Therefore, as a step 
towards understanding the pathophysiology of cerebrovascular disease amongst this 
higher risk population, the objective of this study was to determine the differences in the 
prevalence of cardiovascular co-morbidities and their association with mortality 
compared to other ethnic populations in the UK by retrospectively analysing registry data 
of a larger stroke population in West Midlands, a home to a larger South Asian migrant 
population. 
Study 2:  Validation study (Chapter 2): 
 Pathophysiological understanding of stroke and CHD is closely allied with 
accelerated atherosclerosis and age-related arteriosclerosis which are known to alter 
vessel wall characteristics. Measures of arterial stiffness indices are accepted as 
independent markers of CVD. Arterial stiffness indices derived from Digital Volume 
Pulse (DVP) is a non invasive indirect technique of measuring arterial stiffness 
peripherally. The objective was this study was to determine the repeatability & 
reproducibility of DVP technique, in view of using this technique to assess arterial 
structure and function in a higher risk South Asian stroke population.   
Study 3: Case control study (Chapter 4): 
Literature review on arterial stiffness and ethnicity (Chapter 1.6.3) highlighted the 
significant paucity of available data on indices of arterial structure and function amongst 
South Asians. According to available evidence, there is a markedly earlier progression of 
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disease in South Asians, suggesting that the pathogenesis of sub-clinical atherogenesis 
and premature arteriosclerosis is manifest even in apparently healthy individuals. The 
principal objective of this study is to firstly determine the structural characteristics of the 
vessel wall amongst healthy SA compared to that of EC.  
Study 4: Case control study (Chapter 5): 
The main aim of this study is to understand the underlying vascular 
pathophysiology of South Asian stroke survivors. Given the higher prevalence of 
diabetes and hypertension amongst SA compared to EC and adverse impact of these risk 
factors on endothelium & vessel wall characteristics, the objective of this study is to 
comprehensively examine the vascular risk indices (arterial stiffness and endothelial 
function) amongst SA stroke survivors to compared to EC. In addition this study also 
intends to examine the impact of inflammation, metabolic status and oxidative stress 
parameters on arterial stiffness and function.  
 
2.4  Study Designs: 
 
2.4.1 Study Design 1: Retrospective analysis of Registry data 
A stroke registry was developed using patients‘ information system and electronic 
case notes to determine prevalence of cardiovascular risk profile in a multi ethnic 
population admitted to Sandwell and West Birmingham NHS Trust over a nine-year 
period. Data from the stroke registry was combined with five years follow up data 
obtained from the national mortality tracing system to determine events-free survival 
rates amongst a multi ethnic population admitted to our Sandwell and West Birmingham 
NHS Trust over a five-year period.  
 50 
The hospital discharge coding (International Classification of Disease (ICD) (10
th
 
revision) was used for the identification of patients admitted with any form of stroke 
(ICD: 160-169) during the period between 1997 and 2005. Patients with a diagnosis of 
haemorrhagic strokes (ICD: 160, 161 and 162) and unspecified aetiology (ICD: 164) 
were excluded from the study cohort and patients with a cerebral infarction (ICD: 163) 
were selected for the registry. Using information of our local Hospital Activity Analysis 
Coding register, patient‘s age at date of admission, sex, ethnic group, and established 
CVD risk factors (AF [ICD:148], hypertension [ICD: 110-115], diabetes mellitus [E10-
14], myocardial infarction [ICD:121], and peripheral vascular disease [ICD:170 and 173] 
were added to the registry. To minimise any inaccuracies electronic hospital case records, 
which composed of discharge letters, CT reports and investigation results, were retrieved 
in the first instance using the patient‘s hospital number identified from the ICD coding 
based database. Original paper-based case notes were only retrieved in about 15% of the 
patients to complete if any missing information. To validate the database and minimise 
any inaccuracies in coding, in pre-identified 12.4% of the patients (patients who were 
pre-screened for NIASTAR clinical trial; EudraCT No: 05/Q1606/148) the diagnosis of 
stroke [ICD 163] were cross-referenced with computerized CT reports and final 
diagnosis details on the hospital computer system. In addition, 160 of these patients the 
diagnosis of ischaemic stroke [ICD: 163] were crosschecked with stroke unit data 
collection sheet final diagnosis details, which is completed by a consultant stroke 
physician based on clinical and radiological information. Thirty-day case fatality data, 
based on the all cause mortality, obtained from the National Health Tracing Services was 
added to this database (NHS strategic tracing service 2006). This ICD coding system has 
been proved free of errors for definitive diagnoses (George and Maddock, 1979), 
although errors are found in the coding of non-specific diagnoses such as 'viral infections' 
or 'gastroenteritis'. (Please see limitation section for details) 
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Classification of stroke type (Ischaemic / haemorrhagic / unspecified aetiology) 
was based on the radiological and clinical evidence available for ICD coding at the time 
of patient discharge or death. Diagnosis of stroke had been defined on clinical symptoms 
supported by a cerebral imaging (usually a CT scan) in accordance with the WHO 
criteria for diagnosis of acute stroke (Hatona, et al., 1976). According to our hospital 
practice, which is based on standard national guidelines(NICE, 2006), each patient 
admitted with symptoms and signs of stroke will be examined by a senior physician prior 
to routine blood tests and special radiological investigations (CT/MRI) for the diagnosis 
of acute stroke and its pathological type within 48 hours. Each patient will undergo at 
least one ECG recording and twice daily blood pressure measurements. Coding of 
hypertension based on the defined blood pressure > 140/90mmHg on at least two 
separate readings. Diabetes diagnosis based on the relevant clinical history and 
biochemical evidence of at least 02 measurement of Fasting Blood sugar readings > 
7.2mmol/l Patients with a total cholesterol level > 5mmol were considered as 
hyperlipidaemic. Diagnosis of atrial fibrillation depends on the clinical evidence 
supported by a 12 lead ECG. History of myocardial infarction was based on ECG 
evidence supported by elevated cardiac troponin levels. Echocardiographic evidence for 
diagnosis of valve lesions was mandatory to be given a diagnosis of valvular heart 
disease. Diagnosis of peripheral vascular disease is based on the patient‘s clinical 
symptoms and signs, supported by any radiological evidence of vascular abnormalities.  
2.4.2 Design 2: Cross sectional/Case control studies 
 
2.4.2.1 Study Population: Healthy & Risk factor controls 
Information from the 2001 census revealed that between 20 and 25% of the 
300,000 population of Sandwell are from South Asian ethnic minority groups [including 
Bangladeshi (1.21%), Indian (9.14%) and Pakistani (2.95%) populations]. SA were 
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defined by self-reported ethnicity as being Indian, Pakistani, Sri Lankan, Nepalese, and 
Bangladeshi, and whose grandparents (at least three) also originated from the Indian 
subcontinent (Chapter 1.2).  
Volunteers who initially participated in community based cardiovascular risk 
screening clinics in Sandwell and West Birmingham area (West Midlands, UK) were 
invited to attend the vascular research clinic. Using a representative sampling approach, 
volunteers who expressed their willingness to participate in the study and had similar 
socio-economic backgrounds based on the Townsend deprivation index were recruited in 
a subsequent visit. The total cohort (aged 30 to 75 years) comprised apparently healthy 
people without any known established risk factors & people with established risk factors.  
All healthy subjects were free from any documented cardiovascular disease or 
cerebrovascular disease. None of the healthy subjects were on any regularly prescribed 
cardiovascular medications at the time of the study. This was established by the 
elicitation of a full medical history and the completion of a comprehensive physical 
examination performed by a qualified medical practitioner. Any person with abnormal 
blood pressure measurements (>140/90mmHg), fasting blood sugar level (>7.2 mmol/l) 
or a total cholesterol level (>5mmol/l) were excluded from the healthy cohort. 
Demographic data including details of smoking habit and alcohol consumption were 
collected.  
SA risk factor controls were categorised as either having an established diagnosis 
of hypertension, diabetes, hyperlipidaemia and who were receiving treatment or  
evidence of abnormal mean blood pressure measurement (>140/90 mmHg), raised 
fasting plasma glucose (>7.2 mmol/l), raised serum cholesterol (>5mmol/l), according to 
the Joint British Societies 2 guidelines (JBS 2, 2005) but without any established 
cerebrovascular disease (past medical history of stroke or transient ischaemic attack). 
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Patients with a history of severe heart, renal or respiratory failure, established chronic 
inflammatory or lung disease (e.g. asthma, chronic obstructive airway disease) or 
ischaemic heart disease (ongoing anginal symptoms, currently on prescribed anti-anginal 
medications, past medical history of myocardial infarction, coronary artery bypass graft 
or percutaneous coronary intervention)  were excluded from risk factor control group. 
2.4.2.2 Study Population: Ischaemic Stoke survivors 
South Asian stroke patients with a diagnosis of ischaemic stroke, who were 
initially admitted to Sandwell and West Birmingham NHS Trust (Sandwell and City 
Hospitals) between 2005 and 2007, were invited to participate in the study after three 
months of the initial presentation. Of the responders, the first consecutive 100 patients 
who attended the initial screening visit were prospectively recruited for the vascular sub 
study. Based on the power calculations (for vascular measurements) at least 60 people 
were required in each group. Therefore using the same stroke unit database , age, gender 
and post code (same area) matched Caucasian stoke patients who were admitted during 
the same period were invited and of the responders, the first attended 60 patients were 
recruited for this vascular sub study. After excluding  the patients who had died or who 
developed a second stroke with in the first three months period, 28% of the South Asian 
and 6% of the Caucasian stoke patients who originally invited and agreed to participate 
in the study did not attend the subsequent  screening visit.  
2.4.2.3 Evidence and criteria used for stroke classification 
The diagnosis of stroke was established on the basis of clinical symptoms 
supported by a cerebral imaging (CT scans) in accordance with the WHO criteria for 
diagnosis of acute stroke (Hatona, et al., 1976). In keeping with local hospital practice, 
which is based on standard national guidelines (NICE, 2007), each patient admitted with 
symptoms and signs of stroke was examined by a stroke physician prior to routine blood 
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tests and radiological investigations (CT) in order to confirm the diagnosis of acute 
stroke and its pathological type within 72 hours. All CT scans were reported by a neuro-
radiologist and each patient‘s clinical condition, including the quality of life (EQ5D, 
Glick, et al., 1999), motor function (Modified Rankin Scale (MRS) (Wolfe, et al., 1991) 
and stroke severity (Scandinavian Neurological Stroke Scale [SNSS]; Côté, et al., 1989 ) 
and neurological deficit, was recorded on a standard Performa. Each patient underwent at 
least one ECG recording and twice daily blood pressure measurements and subsequently 
had carotid duplex scan imaging. Based on the above information, ischaemic stroke 
subtypes were classified according to TOAST (Adams, et al., 1991) and Bamford 
(Bamford et al., 1991) criteria by a qualified stroke physician (Table 2.1). 
Table 2.1: Evidence and criteria used for stroke classification  
 Clinical evidence Radiological evidence Other 
evidence 
TOAST classification 
Large vessel Cortical, subcortical, 
cerebellar or brain stem 
symptoms and signs (aphasia, 
apraxia, neglect) 
Lesions on CT >1.5cm in 
cortex, sub cortex or 
brain stem with 
compatible symptoms 
Carotid 
duplex:> 50% 
stenosis. 
Small vessel Signs and symptoms of a 
lacunar syndrome (pure motor, 
pure sensory, sensori-motor 
hemiparesis or dysarthria and 
clumsy hand syndrome) 
Lesions on CT <1.5cm 
suggestive of lacunar 
infarctions with 
compatible symptoms 
Absence of 
large vessel 
disease or 
embolic 
disease 
Cardio-
embolic 
Clinical signs of large vessel 
disease, AF, Atrial flutter 
Lesions on CT >1.5cm in 
cortex, sub cortex or 
brain stem with 
compatible symptoms 
ECHO 
confirmed 
embolic source 
Bamford classification 
TACI New higher cerebral function dysfunction (dysphasia / dyscalculia /apraxia / 
neglect /visuospatial problems) plus  (Homonymous visual field defect) plus  
(Ipsilateral motor and/or sensory deficit of at least two areas of face, arm and 
leg) 
PACI Two of the three components of TACI, or isolated dysphasia or other cortical 
dysfunction, or motor/sensory loss. 
POCI Cranial nerve deficit with contralateral hemiparesis or sensory deficit, or 
disorders of conjugate eye movement, or isolated cerebellar stroke, or 
isolated homonymous hemianopia. 
LACI Pure motor or pure sensory deficit affecting two of three of face, arm, and 
leg, or sensorimotor stroke or ataxic hemiparesis or dysarthria plus clumsy 
hand, or acute onset movement disorders. 
(TACI: Total Anterior Circulation Infarct, PACI: Partial Anterior Circulation Infarct,    
  POCI: POsterior Circulation Infarct, LACI:LACunar Infarct )  
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2.4.3 Ethical Approval & Consent: 
This study was approved by the West Birmingham local research Ethics 
Committee (Appendix 1). Sandwell & West Birmingham NHS Trust Research & 
Development department evaluated & audited this study and offered a favourable 
opinion. This theses study proposal was awarded a R&D research grant in the annual 
Gaisford Research competition in 2007. Written informed consent was obtained from all 
patients and controls enrolled in the study. 
2.5 Measurements 
2.5.1 Anthropometric measurements 
Following consent, participants were invited to be assessed for the measurement 
of body weight (Seca floor scales) and height (Leicester height measure, Seca Ltd, 
Birmingham, UK), where the subject was measured without shoes in light clothing, and 
advised to stand in a posture to accommodate their heads to be in the vertex plane for 
height assessment . However, to measure weight amongst the stroke patients who were 
unable to stand, Seca 958 Digital Chair Scale (UK) was used where height was recorded 
using a metal tape in the supine position.  Body mass index was calculated as BMI = 
weight (kg) / (height (m))
2  
The subject‘s waist hip ratio was measured using a metal tape. The waist was 
chosen as the narrowest circumference above the umbilicus and below the ribs of a 
subject. The hip was measured over clothing (assessed for thickness) and chosen as the 
widest circumference around the buttocks and was again measured in duplicate (Larson, 
et al., 1984). The WHR was calculated as follows: WHR= waist girth (cm) / hip girth 
(cm). 
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2.5.2 Pathophysiological measurements 
2.5.3 Blood pressure measurement 
Systolic and diastolic brachial arterial blood pressure levels were measured in 
both arms at one minute intervals in the first instance and repeated in the arm with the 
higher blood pressure measurement with the validated semi-automatic Omron HEM-
705CP (Omron Healthcare Europe, Mannheim, Germany) using appropriate sized cuffs, 
after more than five minutes sitting. The mean of the last two blood pressure levels was 
used in the analysis. Heart rate was recorded from the last recorded blood pressure 
reading. Mean arterial blood pressure was calculated by adding one-third of the diastolic 
pressure to the pulse pressure.  
2.5.4 Measurements of arterial stiffness  
Arterial stiffness can be estimated from the models of the circulation to derive 
systemic arterial stiffness (Nichols, et al., 2005) or can be directly measured non-
invasively, at various sites along the arterial tree (Van Bortel, et al., 2002). A major 
advantage of the regional and local evaluations of arterial stiffness is that they are based 
on direct measurements of parameters strongly linked to wall stiffness.  
The measurement of PWV is generally accepted as the most simple, non-invasive, 
robust and reproducible method to determine arterial stiffness (Benetos, et al., 1993). 
Carotid-femoral PWV is a direct measurement, and it corresponds to the widely accepted 
propagative model of the arterial system (Latham, et al., 1985). PWV is usually measured 
using the foot-to-foot velocity method from various waveforms. These are usually 
obtained, transcutaneously at the right common carotid artery and the right femoral artery 
(carotid-femoral‘ PWV), and the time delay or transit time measured between the feet of 
the two waveforms. 
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In recent times other different methods have been developed to measure regional 
arterial stiffness by means of assessing wave form reflections non-invasively (Adji, et al., 
2004). Repeatability and reproducibility of these different methods have been evaluated 
in many cross sectional study designs (O‘Rourke, et al., 2002) compared to gold standard 
PWV technique (Table 2.1). Of these methods, stiffness index measured by digital 
volume pulse analysis (DVP) technique has been demonstrated to have a good agreement 
with PWV measurements and can be easily performed in day-to-day clinical practice. 
Table 2.2: Comparison of sensitivity and specificity and reproducibility of different 
methods compared to direct carotid femoral pulse wave velocity (PWV) technique 
 Area ROC Sensitivity 
(%) 
Specificity 
(%) 
CV 
(%) 
Augmentation index 0.99 100 93 11.3 
Stiffness index 0.95 87 87 12.3 
Central PWV 0.91 73 93 7.6 
Central PP 0.78 53 80 15.6 
Distal PWV 0.68 67 64 22.4 
Brachial PP 0.46 33 60 8.0 
 
PP: Pulse Pressure, PWV: pulse wave velocity. Adapted from Assessment of  central and peripheral 
arterial stiffness.Woodman, et al., (2005) American Journal of Hypertens,18: 249-26 
Arterial stiffness was measured using the Digital Volume Pulse analysis (DVP) 
technique. The Digital Volume Pulse (DVP) analysis method is a non-invasive technique 
of measuring pulse wave reflections to determine the arterial stiffness peripherally 
(Millasseau, et al., 2006). Arterial stiffness using the above method has been proven to be 
a validated, reproducible technique with minimal intra-observer variation (Millasseau, et 
al., 2006). The Stiffness Index derived from this method has been demonstrated to have a 
good correlation to PWV (Woodman 2005; Sollinger, et al., 2006; Adji, et al., 2004) 
whilst the sensitivity and specificity of this technique is comparable to the PWV method 
in the identification of patients with latent cardiovascular disease (Millasseau, et al., 
2002).  
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2.5.5 Measurement of endothelial function (Δ RI %) 
 
As mentioned previously (Chapter 1) endothelial function in humans can be 
measured by many techniques, including assessment of the vasodilator response to sheer 
stress (reactive hyperemia) (Doshi et al., 2001). Many methods to assess endothelial 
function can be invasive, time consuming and difficult to perform (Donald et al., 2006). 
However, the relatively novel DVP analysis technique is a non–invasive option, similar 
to other non-invasive measurements such Flow Mediated Dilatation (FMD) with minimal 
inter- and intra-observer variation (Millasseau, et al., 2006). This technique is an indirect 
method of determining endothelial function peripherally (Rambaran, et al., 2008) by 
measuring the peripheral pulse waveform changes and wave reflections ( Hayward  et al., 
2002) following non-parenteral administration of salbutamol and glyceryl trinitrate 
(GTN), and has shown initial utility in detecting individuals with impaired endothelial 
function (Chowienczyk, et al., 1999 and Wolfe, et al., 2002). Compared to other non-
invasive methods the potential benefits of this technique are that since measurements are 
taken at the finger tip, the procedure is considerably easier to perform, less operator-
dependent with minimal observer bias. The instrument itself is readily portable and 
inexpensive and can readily lend itself to out-patient or community settings. 
The Reflective Index (RI) is a parameter derived from the analysis of the DVP., 
Endothelium-dependent vessel function can be determined by calculating the relative 
change in reflective index (Δ RI%) following the administration of a Nitric Oxide(NO) 
releasing beta2-receptor stimulant agent such as Salbutamol. For comparison, 
endothelium independent vessel function can be similarly calculated by administration of 
exogenous NO, in the form glyceryl trinitrate (GTN) (Chowienczyk, et al., 1999 ; Kelly, 
et al., 1990). 
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2.5.6 Calculation of the arterial stiffness (SI) and endothelial function (∆RI)  
The DVP waveform consists of a systolic peak (a) and a second diastolic peak(b) 
which is formed by the reflection of the pulse wave from the small arteries in the lower 
body (Figure 2.1) .The time delay (PPT) between the systolic and diastolic peaks is 
related to the transit time of pressure waves from the root of the subclavian artery to the 
apparent site of reflection and back to the subclavian artery. The degree of pulse wave 
reflection (SI) depends on the impedance of the micro-vascular bed and the tone of the 
large and small sized blood vessels. This path length can be assumed to be proportional 
to height (h) and therefore the index of artery stiffness (SI) can be calculated from: SI = 
h/PPT. The RI is the percentage of systolic pulse wave reflected in each cardiac cycle. 
Small artery function can be assessed by measuring absolute change in ∆RI from baseline 
after salbutamol (Rsal) and GTN (RGTN) administration. RI can be calculated from: 
RI=a/b and the endothelial function is determined by: ∆RI= (R-(Rsal)/R)*100. People 
with established risk factors are known to have a dysfunctional endothelium and related 
abnormal wave form response to salbutamol compared to GTN ( Figure 2.1b) 
Figure 2.1a: Derivation of SI and RI by analysing Digital Volume Pulse wave forms  
 
 
X = Forward wave / Systolic peak, Y=  Reflected wave / Diastolic peak, Reflective Index (RI)= (b / a)* 
100, Endothelial function = (RI base line – RI Salbutamol / RI base line)*100 
X 
Y 
a 
b 
PPT 
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Figure 2.1b: Change in pulse wave form following Salbutamol and GTN 
Comparing   Healthy vs. Individual with risk factors  
 
 
2.5.7  Arterial stiffness and endothelial measurement protocol 
Measurements of arterial stiffness and endothelial function were performed in the 
morning following an overnight fast (each subject was instructed to refrain from 
caffeine-containing beverages, alcohol, and smoking in the previous 12 hours) after 
which the DVP was recorded in the person‘s right index finger. Subjects were laid 
supine, resting for at least 20 minutes in a temperature controlled environment (24±1
○
C) 
before the measurements were taken. All the volunteers were advised to refrain from 
talking and sleeping while the measurements were done. Recorded digital pulse wave 
forms were used (PCA 2, MicroMedical, Kent, UK) to generate indices of vessel 
reactivity (RI) and arterial stiffness (SI) using a standard validated protocol (Millasseau, 
et al., 2006). Each person had at least three measurements (recorded for 30 seconds) 
taken one minute apart and an average was calculated and used for the analysis. 
Thereafter, subjects were given a predetermined dose of Salbutamol by inhalation (400 
micrograms via a spacer device) and sublingual GTN (400 micrograms) each separated 
by a washout period of 60 minutes. Relative change in RI was monitored at three minute 
intervals for a total of 15 minutes. Individuals, whose pulse wave recordings could not be 
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Post Salbutamol 
Post GTN 
Time
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adequately assessed or who had SI and RI variation greater than 15% within 
measurements were excluded from the final analysis (11.3%). All of the measurements 
were performed by the same operator. Intra-observer variation (co-efficient of variation) 
of the repeated measurements of SI in the same subject on the same day and six weeks 
later was 5.4% and 7.4% respectively, confirming the findings from recent studies by our 
group and others that the DVP analysis technique has been shown to have acceptable 
repeatability and reproducibility (mean difference (SD)(-0.2(4.9%) (Rambaran, et al., 
2008)  
2.5.8 Quantitative determination of biochemical parameters 
Blood samples were collected after three months from the acute event and were 
taken following an overnight fast, on the same day of the vascular measurements. Blood 
samples were drawn from an antecubital vein to blood tubes with 3.8% sodium citrate, 
EDTA and to plain tubes without any chemicals, mixed by gentle inversion, and stored 
on melting ice. Blood samples were prepared at the Laboratory for Clinical Biochemistry 
Research, Sandwell and West Birmingham NHS Trust. Plasma fractions were separated 
by centrifugation at 4°C for 3000g-minutes within 1 hour of collection . Aliquots were 
stored at -70°C for batch analysis. One aliquot was treated with a cell lysis buffer before 
storage.  
Biomarkers (IL6, hsCRP, TNF alpha, oxLDL, HO, E-Selectin, vWF, Apo A, Apo 
Apo B, NO, eNOS, cGMP ) were measured using the stored blood samples over a six 
months duration. hsCRP, Apo AI, Apo B were measured using an auto analyser (Cobas 
Integra 400, Roche, Switzerland). Measurement of all other bio markers were performed 
by 2-site enzyme linked immunosorbent assay (Please see 2.4., with commercially 
available antibodies from R&D systems (UK) and Mercodia (USA). The lower limit of 
detection for Nitrate (0.54 micromol/L), eNOS(25pg/ml), cGMP(1.14 pmol/mL), 
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HO(0.78ng/mL), oxLDL(<1 mU/l), IL6(0.16 pg/mL), E-Selectin(0.009 ng/mL), 
TNF(0.391 pg/mL) and intra and inter assay CV (%) for all the ELISA assays were less 
than 10%. See below. 
All the ELISAs performed are standardised within the University Department of 
Medicine and Sandwell Medical Research Unit Laboratories, Sandwell and West 
Birmingham NHS Trust, and training was provided by Drs Patel and Blann. Each assay 
demonstrates intra- and inter-assay coefficients of variation of  <10% respectively using 
the methods detailed in the Appendix & below. 
Table 2.2:Intra and inter assay co-efficient variations for measured biomarkers 
 Intra assay CV % Inter assay CV % 
Apo A 2.3 3 
Apo B 3 4.3 
hsCRP 3.4 5.5 
oxLDL 7.3 8.3 
HO <10 <10 
NO 7.7 2.4 
cGMP 7.7 5.6 
eNOS 7.4 4.9 
IL6 5.8 9.1 
eSelectin 6.6 8.7 
TNF alpha 7 8.3 
vWF 6.1 8.9 
2.5.8.1 Measurement of Nitric Oxide level by ELISA technique 
The transient and volatile nature of NO makes it unsuitable for most convenient 
detection methods. However, since most of the NO is oxidized to nitrite (NO2
-
) and 
nitrate (NO3
--
), the concentrations of these anions have been used as a quantitative 
measure of NO production (Moncada, et al., 1989). After the conversion of NO3
-
 to  
NO2
-
, the spectrophotometer measurement of NO2
–
 is accomplished by using the Griess 
Reaction (Schreck, et al., 1991). This assay determines nitric oxide based on the 
enzymatic conversion of nitrate to nitrite by nitrate reductase. The reaction is followed by 
a colorimetric detection of nitrite as an azo dye product of the Griess reaction. The Griess 
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reaction is based on the two-step diazotization reaction in which acidified NO2
- 
produces 
a nitrosating agent which reacts with sulfanilic acid to produce the diazonium ion. This 
ion is then coupled to N-(1-naphthyl) ethylenediamine to form the chromophoric azo-
derivative which absorbs light at 540 nm (Miles, et al., 1996). The concentration of NO is 
indirectly measured by determining both nitrate and nitrite levels in the sample.  
2.5.8.2 Particle enhanced turbidimetric assay 
High sensitivity C-Reactive Protein, Apo A and Apo B were analysed using the 
Cobas  Integra  400 (Roche, Switzerland)  auto analyser. The patient sample (serum) was 
mixed with a reagent containing a suspension of polystyrene latex particles of uniform 
size coated with rabbit anti-human antibodies (PrecinormProtein). High sensitivity C - 
reactive protein, Apo A and Apo B in the sample causes aggregation of the polystyrene 
particles, which is detected and quantified by turbidimetry at 552 nm. Controls (Cat. No. 
20766321/ 348 /624) were used as control material with each run. The manufacturer‘s 
total coefficient of variation is <10% (see above table). 
2.6 Statistics & Validation 
2.6.1 Power calculation 
In view of the paucity of data concerning all the indices to be measured with 
regard to South Asian ethnicity, formal power calculation was not possible. Based on 
previous work by Kalra et al. (2005) and our group, at least 58 people are needed for SI, 
in order to detect a 0.5SD difference across groups with 80% power and α of 0.05.  
Therefore it was required to recruit at least 232 subjects, comprising 116 patients with 
stroke (58 South Asians, 58 European Caucasians) and 116 controls (58 Healthy and 58 
with risk factors). 
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2.6.2 General Statistical methods 
Data were first tested for normality using the Kolmogorov Smirnov test. All the  
normally distributed indices were presented as the mean ± SD, and students‘ t-test and 
one-way ANOVA and post-hoc Turkey tests were used to determine differences between 
groups with continuous variables, and the Chi-square test was used to compare the 
categorical variables. Central tendencies or medians (IQR, interquartile range) were used 
to present non parametric data and Kruskal Wallis  and Mann Whitney U tests were used 
to determine differences between groups. For univariate analysis, Spearman rank 
correlation coefficient (two-tailed) and Pearson correlation coefficient were used to test 
the relationship between the measured biomarkers, arterial stiffness and other 
cardiovascular risk indices. Linear regression models were developed for multivariate 
analysis. All the variables, which were thought to be associated with the dependent 
variable, were included in the univariate analysis and the variables, which were 
significant, were subsequently included in the multivariate analyses. Receiver operator 
characteristics curves was used to evaluate the performance the biomarkers, indices of 
arterial stiffness and endothelial function indices depicted by the mean area under the 
curve with 95% confidence interval. A two-tailed p value < 0.05 was considered 
statistically significant for all comparisons. The range of variation around a mean for a 
particular continuous variable is calculated using 95% confidence intervals (95% CI). 
Data were analysed using SPSS versions v14 or v15 (SPSS Inc. Chicago, IL). (Please see 
individual Chapter methods sections for specific statistical details). 
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 2.6.3 Validation study: Repeatability & Reproducibility of Digital 
Volume Pulse analysis technique & clinical utility in cardiovascular 
disease risk stratification
 
 
 The objective of this validation study was to determine the repeatability & 
reproducibility of non invasive measurement of arterial stiffness and endothelial function 
by using DVP analysis technique & assess its clinical utility in cardiovascular disease 
risk stratification. 
2.6.3.1 Introduction  
Cardiovascular disease (CVD) is the most common cause of morbidity and 
premature mortality in the western world (Wild and McKeigue, 1997) (Chapter 1) and 
has rapidly become an epidemic in the developing world over recent years (Joshi, et al., 
2007). Given the considerable healthcare burden conferred by this disease, the timely 
identification of individuals with an increased risk of CVD is an important consideration. 
The assessment of CVD risk amongst individuals is usually performed by 
calculating ‗risk scores‘, such as the Framingham risk prediction score (Anderson, et al, 
1991) and, more recently, European Society of Cardiology (ESC) HeartScore (Conroy, et 
al., 2003).  Risk score estimations use a combination of ‗established risk factors‘, 
including age, gender, systolic blood pressure, total cholesterol and glycaemic status.  
However, these scores are known to underestimate actual risk within high risk 
populations, which has led to the quest for novel risk markers for finer and earlier risk 
stratification (Danesh, et al., 2004).  
Hence, there is a need for novel risk markers (or biomarkers) which are capable 
of directly examining the underlying pathophysiological processes for refining risk 
stratification and the early identification of younger high risk populations (Dotsenko, et 
al.,2007). To be clinically useful in the prediction of CVD, novel techniques should be 
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closely related to the existing prediction methods.  In addition they should also provide 
an additional value to the existing methods in risk assessment.  
Central to our current pathophysiological understanding of CVD is closely allied 
with accelerated atherosclerosis and age-related arteriosclerosis which are known to alter 
vessel wall characteristics and increase arterial stiffness. Measures of arterial stiffness 
indices are accepted as independent markers of CVD. (Laurent, et al., 1994; Cruickshank, 
et al., 2002). The majority of available methods for measuring arterial stiffness have 
proven to be both technically difficult to perform and time consuming (Laurent, et al., 
2006), specifically in terms of their use in risk assessment amongst large populations and 
in community settings. 
The SI derived from the analysis of Digital Volume Pulse (DVP) is a non 
invasive indirect technique of measuring arterial stiffness peripherally (Millasseau, et al., 
2006). Arterial stiffness measured by the DVP analysis method has been proven to be a 
validated and reproducible technique with minimal intra-observer variation (Chapter 2). 
The SI has been demonstrated to have a comparable sensitivity and specificity to the 
pulse wave velocity method in the identification of patients with latent cardiovascular 
disease (Woodman, et al., 2005). However, its utility in the cardiovascular risk 
assessment process amongst an apparently healthy population has not been investigated. 
We hypothesised that indices of arterial stiffness (SI) measured by DVP 
technique are strongly associated with ESC-based cardiovascular risk scores in an 
apparently healthy population and that the SI is a good discriminator of stratification of 
CVD risk categories amongst the wider population that includes higher risk individuals. 
To test this hypothesis, we measured the indices of arterial stiffness in a representative 
population attending a CVD risk assessment clinic over a one year period. 
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2.6.3.2 Methods  
Using a representative sampling approach, volunteers who originally attended to 
community based cardiovascular screening clinics ( Sandwell and West Birmingham 
Primary Healthcare Trust, West Midlands, UK) and had similar socio-economic 
backgrounds based on the Townsend deprivation index and who expressed their 
willingness to participate in the study were recruited in a subsequent visit. The total 
cohort (aged 30 to 75 years) comprised apparently healthy people without any known 
established risk factors (Please see Chapter 2.4.2.1 for details) and people with 
established risk factors. 
Using the European Society of Cardiology (ESC) HeartScore (High Risk) 
calculator, the absolute CVD risk (%) of developing non fatal coronary heart disease, 
coronary death or stroke over the next 10 years was estimated.  This ESC HeartScore 
algorithm is based on a European population and has been selected as the new standard in 
European CVD risk prediction and management by the Third joint European societies 
task force on CVD prevention in clinical practice (Conroy, et al., 2003). The score is 
based upon the risk factors age, gender, smoking status, systolic blood pressure, and total 
cholesterol levels. (Conroy, et al., 2003). Please see Chapter 2.5.6 for details of the 
measurement of arterial stiffness using DVP analysis technique.   
2.6.3.3 Statistical analysis 
After being tested for normality using the Kolmogorov Smirnov test, arterial 
stiffness indices measured demonstrated a normal distribution. Data are presented as the 
mean ± SD. Student‘s t-test and one-way ANOVA tests were used to determine 
differences between groups with continuous variables, and the Chi-square test was used 
to compare the categorical variables. In univariate analysis Pearson‘s correlation was 
used to observe the relationship between arterial stiffness and other cardiovascular risk 
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indices. Linear regression models were used for multivariate analysis. For the correlation 
analysis of ordinal variables, Polytomous Universal Model (PLUM) ordinal regression 
analysis was used, where the Cox and Snell pseudo R Square values are reported to 
estimate the proportion of the total variation of an ordinal response that is explained by 
variables included in the model. Receiver operator characteristics curves were used to 
evaluate the performance of SI, depicted by the mean area under the curve with 95% 
confidence interval. A two-tailed p value < 0.05 was considered statistically significant 
for all comparisons. Data are reported to three significant figures. (Please see Chapter 
2.6.2 for details). 
2.6.3.4 Results 
 
2.6.3.4.1 Repeatability and reproducibility of SI measurements  
SI was measured a total of three times in each arm at five minutes intervals apart 
in 164 individuals at the same clinic visit. These measurements were repeated in a 
separate clinic visit in 64 individuals, in the same temperature controlled environment in 
six weeks time. Repeated measurements on the same visit, mean difference 
(SD):0.09(0.66)) as well as in the separate visit (0.12(0.93)) demonstrated a good 
agreement (Figure 2.2). 
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Figure 2.2: Bland-Altman test demonstrating the agreement between repeated 
measurements 
(a) Single visit  
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2.6.3.4.2 Baseline characteristics: 
A total of 187 volunteers including 60 people with risk factors were recruited for 
this validation sub study (Table 2.3). 57.7%  were male. As expected, patients with 
established CVD risk factors were older, had higher systolic blood pressure and CVD 
risk scores (P <0.001; Table 2.4). Of the patients with established CVD risk factors, 33% 
had diabetes mellitus, 77.8% had a diagnosis of hypertension and 61% had 
hypercholesterolemia. Of these patients, 38.9% were on regular antihypertensive 
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medications, 11.1% were on anti-diabetes medications, 11.2% were on anti-cholesterol 
treatment and 14.4% were on anti-platelet treatment  
SI was significantly higher in males (P=0.01), as well in smokers (P=0.006), 
those with a history of hypertension (P=0.007), diabetes (p=0.02), hypercholesterolemia 
(P=0.002) and those with a high waist hip ratio (P=0.001), but not with those with a 
higher body mass index (P=0.49). Measurements of SI was also significantly higher in 
people with established risk CVD factors without any gender variation (P <0.01).  
 
2.6.3.4.3 Relationship to ESC based CVD risk stratification  
Patients without complete CVD risk score data (17.6%) were excluded from the 
risk stratification analysis. On univariate analysis there was a positive association 
between SI and CVD risk (Pearson correlation coefficient (r) : 0.56, P=<0.001). On 
linear regression analysis SI was associated with CVD risk scores (Beta (SD):0.58(1.3-
2.0); P<0.001). SI increased in an ordinal fashion across from low risk (<5%), medium 
(5-10%) high (11-19%) and highest risk (>20%) (Pseudo R-Square = 0.30; P<0.001) 
(Figure 2.3). Of the total population, 48.7% had lower-medium CVD risk (<15%) and 
correspondingly lower SI values (mean ± SD: 7.9(1.5) ms
-1
 (Figure 2.3) compared to 
those at high risk (P<0.001).  In addition, male subjects had a higher CVD risk scores 
(P<0.001) and correspondingly higher SI compared to the females (P=0.01).  There was a 
significant difference in the mean risk score levels (P<0.001) and SI between healthy 
volunteers and risk factor controls in both males (P=0.008) and females (P=0.015) 
(Table: 2.3). 
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Table 2.3: Baseline characteristics comparing healthy vs. people with risk factors  
 
Cardiovascular risk factors 
Mean(SD) 
Male  
( n=108) 
Female  
(n=79) 
Healthy 
volunteers  
(n=76) 
Risk 
controls 
(n=32) 
p Value* Healthy 
volunteers 
(n=51) 
Risk controls    
(n=28) 
p Value* 
Age(years) 45.6(13.2) 65.8(10.4) <0.001 45.9(12.5) 63.6(10) <0.001 
Height (m) 1.69(0.1) 1.69(0.2) 0.97 1.59(0.09) 1.58(0.05) 0.12 
Body mass index(Kg/m
2
) 25.5( 3.4) 27.9(3.2) 0.02 26.5(3.1) 26.9(4.4) 0.49 
Waist hip ratio 1.01(0.1) 0.99(0.1) 0.27 0.98(0.1) 0.93(0.1) 0.28 
Mean systolic BP(mmHg) 137(17) 145(15) <0.001 126(16) 150(15) <0.001 
Mean diastolic BP(mmHg) 84(11) 82(13) 0.38 78.(10) 83(10) 0.06 
Mean arterial BP(mmHg) 101(12) 103(13) 0.04 94(11) 106(10) <0.001 
Serum Cholesterol (mmol/l) 4.52(0.85) 4.1(0.4) 0.08 4.49(0.89) 5.1(1.1) 0.01 
Fasting plasma glucose(mmol/l) 4.04(1.59) 3.9(1.2) 0.87 3.55(1.4) 3.3(1.5) 0.67 
Smoking (%) 8.2 11.1 0.44 6.5 8.3 0.45 
Alcohol (%) 9.8 15.6 0.42 8.2 12.8 0.41 
ESC CVD risk score(%) 7.4(6.1) 13.1(5.9) <0.001 4.58(4.6) 11.3(4.7) <0.001 
Stiffness index(ms
-1
) 9.3(2.2) 10.9(2.4) 0.008 8.4(2.1) 10.1(2.4) 0.015 
ESC: European Society of Cardiology, CVD: Cardiovascular disease, BP: Blood Pressure, *p value comparing healthy vs. risk controls; significance at 0.05 level,    
Mean (SD) 
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Table 2.4: Indices of arterial stiffness for the total cohort   
Group characteristics % of  all 
patients  
(n-187) 
Mean arterial 
stiffness ms
-1
 
(SD) 
p value* 
Gender Male 57.7 9.6(2.3) 0.01** 
Female 42.3 8.8(2.2) 
 
Waist hip ratio <0.9 40.1 7.9(1.6) 0.001 
>1 59.9 9.4(2.3) 
     
Body mass index  
(kgm
-2
) 
I(<25) 33.5 9.3(2.5) 0.85 
II( >25) 66.5 9.5(2.2) 
 
Smoking Yes 10.2 10.6(2.5) 0.006** 
No 89.8 9.1(2.2) 
 
Alcohol Yes 9.6 10.1(2.3) 0.5** 
No 90.4 9.6(1.5) 
 
Diabetes Yes 5.6 11.2(2.4) 0.02** 
No 94.4 9.9(2.3) 
     
Hypertension Yes 18.3 10.4(2.2) 0.007** 
No 81.7 9.1(2.5) 
     
Hypercholesterolemia Yes 13.3 10.8(2.8) 0.002** 
No 86.7 9.0(2.2) 
*p value using one way ANOVA across all groups and independent t-test; significance at 0.05 level. SD: 
Standard Deviation. ** p value using chi square
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Figure 2.3: Ordinal association between Stiffness Index and ESC risk score groups    
 
European Society of Cardiology (ESC) HeartScore based cardiovascular disease (CVD) risk groups(%): 
Group I (<5%), Group II (6-15%), Group III (16-19%), Group IV(>20%). Line shows the mean CVD risk 
score 
Figure 2.4: Distribution of SI and CVD risk groups according to tertiles 
 
European Society of Cardiology (ESC) HeartScore based Cardiovascular disease (CVD) risk tertiles (%): 
Tertile I= (<5%), Tertile II =(6-15%), Tertile III= (> 16%). Stiffness Index (SI) tertiles (ms-1): Tertile 1 = 
SI<7.7;  Tertile 2= SI 7.8-9.7;  Tertile 3= SI>9.8 
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2.6.3.4.4  Correlations and multivariate regression 
On univariate analysis (excluding people with established risk factors and 
medications) there was a significant positive association (r) between SI and Age (r= 0.41; 
P<0.001) mean systolic (r= 0.24;P<0.001), diastolic blood pressure (r=0.29;P=0.001), 
pulse pressure (r=0.17;P=0.03) and mean arterial pressure (r=0.34;P=0.003) There was 
no significant association between SI and mean heart rate, body mass index, waist hip 
ratio, fasting plasma glucose and serum cholesterol. In multivariate regression analysis, 
Beta (95% CI) age (0.11(0.04-0.17); P< 0.002), waist hip ratio (8.8(2.3-17.8); P=0.05) 
and mean arterial pressure (0.06(0.01-0.11); P=0.01) independently associated with SI 
but not with serum cholesterol, fasting plasma glucose levels or heart rate.   
2.6.3.4.5  Receiver Operator Characteristic (ROC) curve analysis  
ROC analysis of baseline characteristics to discriminate subjects with higher 
CVD risk, found SI to be the most useful variable in this population (Area Under Curve 
(AUC)(SE) :0.76(0.06), P<0.001) (Figure 2.5) compared to, total cholesterol 
(AUC:0.58(0.07), P=0.17) plasma glucose (AUC :0.62(0.07), P=0.07), mean blood 
pressure (AUC:0.60 (0.06), P=0.15) and waist hip ratio (AUC:0.45(0.04), P=0.35). In 
addition, SI had the discriminatory utility to identify the patients with known diabetes 
(AUC 0.68 (0.04), P<0.001), hypercholesterolemia (AUC 0.66 (0.03), P<0.001) 
hypertension (AUC 0.66 (0.03), P<0.001), and higher waist-hip ratio (AUC 0.69 (0.05), 
P=0.001) but not with higher body mass index (AUC 0.50 (0.06), P=0.92). 
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Figure 2.5: ROC analysis of SI in discriminating high CVD risk group  
 
AUC: Area Under the Curve, SE: Standard Error 
  
2.6.3.5 Discussion 
In this study we demonstrate the repeatability and reproducibility of DVP 
analysis technique to measure arterial stiffness and its clinical utility to stratify CVD risk. 
The current study demonstrates a close association between SI and CVD risk score 
estimation using the ESC HeartScore model. More importantly, the discriminatory 
properties of the SI in identifying higher risk groups were significantly better than those 
of conventional cardiovascular risk indices, such as total cholesterol level and fasting 
blood sugar measurements. 
Screening of the population with ESC HeartScore and Framingham-based risk 
score methods continue to be recommended in many current guidelines (JBS 2, 2005). 
However the absolute levels of cardiovascular risk factors are mathematically combined 
as a holistic approach during risk prediction, with limited direct relationships to 
underlying pathophysiological changes, as in our current analysis known to 
underestimate around 16%-20% of the CVD risk (Danesh, et al., 2004).  This suggests 
that a significant proportion of the apparently healthy but ‗higher risk‘ subjects may be 
Cut off: 10.41 
AUC (SE):0.76(0.06), P<0.001  
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missed in a traditional risk assessment process and highlights the importance of using 
potential new risk markers to aid more conventional cardiovascular risk stratification 
schemes (Sutton-Tyrrell et al., 2005). 
The novel DVP technique used to assess the arterial distensibility of volunteers in 
this study is an easily performable, non-invasive technique with low intra-observer and 
inter-observer variation. This method allows the indirect examination of the structural 
integrity of both large and small arteries simultaneously (Millasseau, et al., 2006)  
(allowing the identification of apparently healthy individuals with sub-clinical 
atherogenesis and premature arteriosclerosis.  Measurements of SI may therefore be more 
useful in the early identification of high risk subjects without established risk indices 
such as high blood pressure or cholesterol levels.  Such people are usually omitted in 
traditional CVD risk assessments.  
As expected, subjects with established risk factors in our study also demonstrate 
higher SI when compared to healthy controls. Moreover, the SI was a better 
discriminator in identifying people with established CVD risk factors (such as 
hypertension, diabetes and hypercholesterolemia) where individual point measurements 
of theses risk indices are less useful, for example, where they are taking medications. 
Whilst the present study highlights the clinical utility and acceptability of DVP 
measurements in a wide spectrum of individuals with and without established risk 
factors, further studies are warranted to assess the utility of SI in clinical practice and to 
monitor treatment efficacy as well as disease progression. 
In our study, the principle factors contributing to increased SI include age and 
mean arterial pressure but not body mass index. This is in keeping with the other 
published studies in which the pulse wave technique was used (Westerbacka, et al., 
2001). 
  
The independent association between waist to hip ratio with increased SI merits 
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careful consideration. Indeed, several studies have reported an association between waist 
to hip ratio and cardiovascular risk factors such as hypertension, and lipid and glucose 
concentrations (Pouliet, et al., 1994). People with a raised waist to hip ratio are also 
known to have varying degrees of insulin resistance (Westerbacka, et al.,2001) and have 
been shown to increase in patients with obesity (Czernichow, et al., 2005). The systemic 
effects of insulin resistance, such as increased adrenergic response, sympathetic tone and 
vascular inflammation are some of other mechanisms that may be involved in increased 
arterial stiffness.  
Limitations: 
The limitations of the current study include the cross-sectional nature of the 
design and use of indirect indices to measure arterial stiffness. However other invasive 
complex measurements of arterial stiffness are not practical to use as a tool to screen 
larger populations in the clinical settings.  In the current analysis, other metabolic, 
inflammatory biomarkers and the impact novel risk indices on arterial stiffness in this 
population have not been examined. Diagnosis of diabetes mellitus was also made on the 
basis of fasting blood glucose measurements and available documented evidence. None 
of the volunteers had an oral glucose tolerance test for specific disease exclusion. In the 
current study CVD risk calculation was based on a European risk score (ESC based 
Heart Score), which does not use HDL cholesterol or diabetes status for risk estimation 
compared to the Framingham (US) based risk calculation which allow finer risk 
stratification of higher CVD risk individuals with lower HDL values and diabetes.  
In addition, the DVP method used to measure arterial stiffness in the current 
study did not provide information on individual contributions that both large and small 
arteries make towards wave reflection and overall arterial stiffness. Further calculation of 
SI is based on the assumption that the subject‘s height is proportional to the path length 
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of the wave reflection. In addition this study may not have the power to discriminate or 
compare the established risk factors such as smoking status between healthy and risk 
factor control groups. Moreover this study does not provide the facility to determine the 
discriminatory utility of SI in different age categories. Using a larger prospective study 
design which used CVD outcomes with combined methods of measurement (Pulse Wave 
Velocity and DVP, for example) would possibly have provided more comprehensive 
details thereby giving greater explanatory power to this study. However, the logistics for 
such a study are also limited by the need to treat individuals recognized to be at increased 
CVD risk. 
 
In conclusion, indices of arterial stiffness (SI) measured using the DVP technique 
is strongly associated with the ESC ‗HeartScore‘ cardiovascular risk score and 
demonstrates the discriminatory utility of the Stiffness index in identifying high risk 
populations. Thus, non-invasive measurement of arterial stiffness may aid the 
identification of individuals with high cardiovascular risk. However there is a need for 
future external validity studies of stiffness index to demonstrate the ability to 
prospectively predict the clinical outcomes over and above those predicted by existing 
CVD risk score estimations.
1
 
                                                 
1 Gunarathne, A., Patel, J.V., Hughes, E.A., et al. (2008).Measurement of stiffness index by digital volume 
pulse analysis technique:. American Journal of Hypertension,21:866-72  
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Chapter 3 : The differences in prevalence of 
cardiovascular risk profile and mortality amongst 
South Asian stroke survivors 
 
Literature appraisal (Chapter 1) indicates a significant paucity of comparative 
cardiovascular risk profile data in South Asian stroke survivors. Therefore, as a step 
towards understanding the pathophysiology of cerebrovascular disease amongst this 
higher risk population, this chapter intends to examine the differences in prevalence of 
cardiovascular risk profile and related stroke mortality in a larger cohort of stroke 
population. 
3.1 Introduction  
 Stroke is a leading cause of premature and preventable death in the UK, 
and accounts for more than 10% of all deaths globally (Tolonen, et al., 2002). Together 
with its well known morbid affliction in survivors, it is a key focus for national 
healthcare and research (Lip, et al., 2007 and Rothwell et al., 2005). The burden of 
ischaemic stroke is more prominent amongst the country‘s migrant communities (Wild 
and McKeigue, 1997) and this relates to the impact of its determinants amongst these 
ethnic minorities, most notably, hypertension and diabetes mellitus. (Raleigh, et al.,1997; 
Khattar, et al., 2000; Cappuccino, et al.,2003; Schulz and Rothwell, 2003; Lane, et al., 
2005; Lane and Lip 2005). Stroke mortality is markedly greater amongst South Asians 
living in Britain, where both men and women have a 40% higher risk of mortality after 
stroke than indigenous European Caucasians (Wild and McKeigue, 1997). Whilst rates of 
mortality from stroke continue to decline in the UK, the rate of regression is markedly 
less in South Asians (Gill et al., 2007). 
Previous epidemiological analyses in the United States have been a valuable 
insight into the relationship between ethnic variations in ischaemic stroke mortality and 
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the disproportionate distribution of cardiovascular (CVD) risk factors in these groups 
(Gillum, et al., 1995 and Gillum, et al., 1999).  
Migrant communities living in the UK have experienced large lifestyle changes, 
the effects of which are likely to explain the insidious CVD risk profiles manifest in 
these ethnic groups (Cruickshank and Alleyne, 1987; Bhatnagar, et al., 1995; Patel, et al., 
2006). Historically, some studies amongst migrant groups in Britain also suggested that 
some CVD risk factors were absent in these groups, specifically hyperlipidaemia 
(Cruickshank, et al., 1991).  However, there is limited information on how trends in CVD 
risk factors and stroke in South Asians have changed in recent years, particularly so in 
the current decade.  
Previous studies in the US have identified aetiological and survival differences in 
stroke amongst principal ethnic groups (Friday, et al., 1989).
  
However, longitudinal data 
demonstrating the association between individual cardiovascular (CVD) risk factors and 
stroke mortality in South Asians in the UK are not available Specifically, the increased 
CVD risk in South Asians populations is thought to be related to an innate susceptibility 
to diabetes mellitus (Patel, et al., 2005).  However, the impact of diabetes on long term 
stroke mortality in South Asian is unknown.   
The objective of the present study was to investigate ethnic differences in the 
CVD risk profile and mortality of stroke admissions to an inner city teaching hospital 
serving a multi ethnic population in Birmingham, United Kingdom. We tested our null 
hypothesis that there would be no significant inter-ethnic differences in the CVD risk 
profile and 30-day all cause mortality of stroke admissions, nor any secular trends that 
were evident over a nine year period (1997-2005). Further, we hypothesised that stroke 
mortality in South Asians was independently related to diabetes, and the strength of this 
association is greater than that for other established CVD risk factors.  
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3.2 Methods 
3.2.1 Study design: Retrospective analysis of stroke registry data  
A stroke registry was developed using patients‘ information system and electronic 
case notes to determine prevalence of cardiovascular risk profile in a multi ethnic 
population admitted to Sandwell and West Birmingham NHS Trust over a nine year 
period (1997-2005). All the patients who initially admitted with a ―first-in-lifetime‖ 
ischaemic stroke to Sandwell and West Birmingham NHS Trust between 1997-2005 
period (International Classification of Disease (ICD) 10
th
 revision, ICD code: 163) were 
included in the study. Please see Chapter 2.4.1 for details on development of the stroke 
registry, diagnostic criteria and definitions.  
Patients who were identified as South Asians (Indian, Pakistani, Sri Lankan, 
Nepalese, and Bangladeshi (self-reported ethnicity)) were included in the five year 
mortality analysis. Data from the stroke registry was combined with five years follow up 
data ( 1997-2001) obtained from the national mortality tracing system to determine 
events-free survival rates amongst South Asians admitted to our Sandwell and West 
Birmingham NHS Trust over a five year period.  
3.2.2 Data Analysis 
Data were analysed in SPSS version v14 (SPSS Inc. Chicago, IL). (Please see 
chapter 2.6 for details). The hospital admission rate within a time-period was calculated 
using the total number of hospital admissions for that period, and the stroke admissions 
for that time as the numerator. Student‘s t test and one-way ANOVA tests were used to 
determine differences between groups with continuous variables and Chi-square test was 
used to compare the categorical variables (e.g. differences in the prevalence of risk 
factors between secular time points). The prevalence of risk factors were age adjusted 
using the age distribution of total hospital admissions (1997–2005). 95% confidence 
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intervals (CI) were calculated for proportions (P) using the formula, CI = √ (P * (1-P) / 
n). 
Kaplan-Meier plots were used for univariate survival analysis. In Multivariate 
analysis, adjusting for patient‘s (age and gender) stepwise Cox regression models were 
developed to identify independent predictors of mortality. For the longitudinal analysis, 
Hazard Ratios (HR) and their 95% confidence intervals (CI) for death were estimated.  
To illustrate the strength of a predictor of mortality, beta (95%CI) values were calculated.  
Statistical significance was accepted at the 0.05 level. 
3.3  Results 
Between 1997-2005, there were 3083 hospital admissions which were first-in-
lifetime-strokes, where complete clinical data and mortality data were available. Of these 
patients, 2405 (78.0%) presented with a non-haemorrhagic stroke, 159 (5.2%) with a 
haemorrhagic stroke and 519 (16.8%) were unspecified. Of all strokes, 46.6% were 
males, who were significantly younger than female patients (mean (SD) 72.1 (10.6) years 
vs. females, 77.1(10.9) years; P < 0.001). South Asians were younger at admission 
compared to European Caucasians. (P < 0.001) (Table 3.1). Afro-Caribbeans were 
excluded from the comparative analysis (11.4%). 
3.3.1 Risk factors  
Amongst those patients admitted with non-haemorrhagic stroke, hypertension 
was the most commonly encountered cardiovascular co morbidity (62.6%) followed by 
diabetes mellitus (35.0%) and atrial fibrillation (27.4%). South Asians had a higher 
prevalence of diabetes and hypertension compared to European Caucasians (P<0.001), 
whereas atrial fibrillation and heart failure were more common in the European 
Caucasian population (P< 0.001). South Asians also had a higher prevalence of 
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myocardial infarction and hyperlipidaemia compared to European Caucasians. (P<0.05) 
(Table 3.2). 
3.3.2 Secular trends in non haemorrhagic stroke admissions  
Between 1997-2005 there was a secular decline in admission rates of non-
haemorrhagic stroke (P<0.001) from 1.6 per 1000 admissions in the period 1997-1999 to 
0.95 in the period 2003-2005.  Between ethnic groups, the magnitude of the secular 
decline in rates of non-haemorrhagic stroke admissions varied, where the decrease 
amongst European Caucasian was greater than those observed in the South Asian 
population (P<0.03). 
3.3.3 Secular trends in cardiovascular risk factors  
Hypertension, peripheral vascular disease and  hyperlipidaemia were all increased 
between secular time periods between 1997-2005 (p < 0.001). Myocardial infarction was 
the only risk factor which showed a significant decrease in prevalence during the same 
periods for the total stroke population (p<0.001). Amongst the South Asians, 
hypertension (p = 0.026), peripheral vascular disease (p = 0.019) and hyperlipidaemia 
(p < 0.001) showed a significant increase during the period 1997-2005. During the same 
period, European Caucasians also showed a significant increase in the prevalence of 
hypertension (p < 0.001), hyperlipidaemia (p < 0.001) and peripheral vascular disease 
(p = 0.003). In contrast, myocardial infarction was decreased in the European Caucasian 
population ( p<0.001). (Figure 3.1, Table 3.1). 
3.3.4 Duration of stay and in-hospital all cause mortality 
The average duration of hospital stay for the total population was 20.9 (SD ±5.2) 
days. Duration of hospital stay was comparable between European Caucasians and South 
Asians ( 20.9 and 21.63 days ). On survival analysis, cumulative event-free survival (all 
cause mortality) over 30 days varied significantly by ethnicity, but significantly 
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decreased in all groups (P=0.031). European Caucasians had the poorest survival 
between1997-1999 (P= 0.02), while South Asians had the poorest survival for the time 
periods 2000-2002 (P= 0.29) and 2003-2005 (P= 0.03) (Table 3.1). 
On Cox regression analysis of 30 day all cause mortality, incorporating age, 
gender, ethnicity and cardiovascular risk factors (hypertension (odds ratio, 95%CI) 1.51 
(1.15-1.97), P = 0.028) and age (1.02 (1.01-1.03), P = 0.001) were independent predictors 
in the first time period. Between 2000-2002, hyperlipidaemia was a non-significant 
predictor of 30 day mortality (P = 0.06). Between 2003-2005, South Asian ethnicity was 
an independent predictor of mortality vs. European Caucasians (2.47 (1.10- 5.54), P = 
0.03). 
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Table 3.1: Secular trends in demographics and Cardiovascular risk profile 1997-
2005 
 
 
1997-1999 
(n=986) 
2000-2002 
(n=690) 
2003-2005 
(n=729) 
P Value 
Mean Age 73.9(10.9) 74.8 (11.0) 75.8 (11.1) < 0.01 
Male 467   (47.4%) 325 (47.1%) 329 (45.1%) 0.02 
Female 519  (52.6% ) 365 (52.9%) 400 (54.9%) 0.53 
Ethnic Group Breakdown n (%) 
Caucasian Male 319 (32.3) 194 (28.1) 218 (29.9) < 0.001 
Caucasian Female 403 (40.9) 264 (38.3) 311 (42.7) < 0.001 
South Asian Male 85 (8.6) 83 (12.0) 75 (10.2) 0.71 
South Asian Female 60 (6.1) 60 (8.9) 57 (7.8) 0.95 
Hospital Admission Rates n(CI) 
Total 1.60 (1.5-1.7) 1.06( 1.0-1.1) 0.95 (0.9-1.0) <0.001 
Caucasian 1.60 (1.5-1.7) 1.06(1.0-1.1) 0.99(0.9-1.0) <0.001 
South Asian 1.19 (1.1-1.3) 0.98 (0.9-1.1) 0.86(0.8-0.9) 0.03 
Risk Factors n (%) 
Hypertension 539 (54.7) 446 (64.6) 515 (70.6) < 0.001 
Myocardial infarction 93 (9.4) 38 (5.5) 26 (3.6) < 0.001 
Peripheral vascular disease 50 (5.0) 31 (4.5) 71 (9.7) < 0.001 
Hyperlipidaemia 33 (3.3) 61 (8.8) 112 (15.4) < 0.001 
Atrial fibrillation 267 (27.1) 177 (25.7) 211 (28.9) 0.38 
Diabetes 367 (37.2) 249 (36.1) 269 (36.9) 0.89 
Ischaemic heart disease 228 (23.1) 156 (22.6) 185 (25.3) 0.41 
Valvular heart Disease 23 (2.3) 14 (2.0) 15 (2.1) 0.89 
Transient ischaemic attacks 72 (5.7) 73 (5.8) 96 (7.7) 0.15 
Duration of stay (days) (SD) 24.8 (1.6) 20.7 (1.6) 17.9 (1.5) < 0.001 
Stroke Mortality Rate (CI) 
 
319 ( 275-364 ) 303 ( 257-349) 273 ( 226-320) 0.03 
 
(P value using chi square analysis, except age of admission where ANOVA is used. Data are n (%)            
or mean (SD) and rates are per 1000 patients per year (95%CI)).  
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Table 3.2: Cardiovascular risk profile by ethnic group 1997-2005 
 
 
 
 
 
 
 
 
 
 
Data are mean (SD) or age adjusted percent (95%CI)  * based on Chi square test across all groups. T; total, M;male, F;female 
 Total sample 
(n=2405) 
 
South Asian 
(n = 420) 
 
European 
Caucasian 
(n=1709) 
p value* 
Age years  (SD) 
 
T M F T M F T M F  
74.7 
(11.0) 
72.1 
(10.6) 
77.1 
(10.9) 
68.8 
(11.4) 
68.3 
(11.3) 
69.4 
(11.6) 
76.7 
(10.5) 
73.4 
(10.3) 
 
79.2 
(9.9) 
 
<0.001** 
Male: Female ratio 
 
 
 
             0.87 
 
                 1.37             0.75 
 
 
Risk Factors n (%) 
Hypertension 62.6 (60.7-64.5) 73.7 (69.5-77.8) 58.6 (56.3-60.9) < 0.001 
Diabetes 35.0 (33.2-36.9) 50.3 (45.6-55.0) 29.8( 27.6-31.9) < 0.001 
Atrial fibrillation 27.4 (25.6-29.1) 11.8 (8.7-14.8) 34.8 (31.9-36.8) < 0.001 
Heart failure 11.6 (10.3-12.9) 7.0  (4.6-9.4) 13.0 (11.4-14.5) < 0.001 
Hyperlipidaemia 9.2  (8.0-10.3) 10.8  (7.9-13.7) 9.2 (7.8-10.5) < 0.01 
Myocardial Infarction 6.4  (5.4-7.3) 9.1 (6.4-11.8) 6.2  (5.1-7.3) 0.03 
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Figure 3.1: Secular trends in the CVD risk profile 1997-2005 by ethnicity 
 
           
    
 
P values using chi square analysis comparing 1997-1999 period vs. 2003-2005 period. 
Error bars show 95% confidence intervals. * p value for Hyperlipidaemia. ** p value for 
Atrial Fibrillation 
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3.3.5 Five year all cause mortality analysis in South Asian stroke patients  
Between 1997 and 2001, there were 1474 first in lifetime stroke admissions, of 
which 340 (23%) were in South Asian individuals.  Complete clinical data and five year 
follow up mortality data were available for 326 patients. Of South Asian patients, 242 
(74.3%) had ischaemic strokes, 8.6% had haemorrhagic strokes, 1.9% had sub-arachnoid 
haemorrhages and 15.3% were unspecified.  Hypertension was the most prevalent risk 
factor, being present in 70.2%, followed by diabetes mellitus in 56.2%.  AF was recorded 
in 7.4 % of the patients, whilst 10.3% had a history of MI. In 21% of the patients, 
diabetes was the only comorbidity present (Table 3.3). In total, 46% of patients had more 
than one risk factor, of which diabetes and hypertension was the most common risk 
factor combination. There were no gender differences in the distribution of CVD risk 
factors.  
At 5 years follow up of the patients who had an ischaemic stroke, 99 subjects 
(40.5%) had died. The median duration of survival for the total population was 150 (IQR 
8.75-924) days.  There were no gender differences in mortality either cumulatively over 5 
years or within each year (log rank test, P=0.49) (Figure 3.2). Cumulative event-free 
mean survival at 5 years was significantly poorer in patients with diabetes without other 
risk factors (log rank test, P=0.009) (Figure 3.3). On univariate analysis, Hazard  Ratio‘s 
for individual risk factors were age:1.01(0.9-1.03); P=0.14, gender:0.86(0.57-
1.3);P=0.49, diabetes:1.7(1.14-2.7); P=0.01, hyperlipidaemia:0.63(0.25-1.5); P=0.31, 
hypertension:0.74(0.47-1.15);P=0.18, myocardial infarction:0.6(0.3-1.1);P=0.17 and  
heart failure: 0.82(0.36-1.8);P=0.64. On Cox regression analysis, incorporating age, 
gender and other CVD risk factors, diabetes mellitus was an independent predictor of 
mortality 1.66(1.02-2.6), P=0.039) (Table 3.4).  
Figure 3.2: All cause mortality in South Asian stroke patients in relation to duration 
of follow up 
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Figure 3.3: Kaplan-Meier plot demonstrating five year event free survival in South 
Asian stroke patients  
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Table 3.3: Cardiovascular risk profile for South Asian stroke patients 
 Total sample 
(n=242) 
Male 
(n = 143) 
Female 
(n=99) 
P value* 
 Age years(SD) 68.0 (10.9) 67.2 (10.2) 69.7 (11.8) 0.13 
 Cardiovascular risk profile % (95% CI)** 
 Hypertension 70.2 (64.4-76.0) 72.7 (65.4-80.0) 66.7 (57.4-76.0) 0.31 
 Diabetes 56.2 (50.0-62.5) 57.3(49.2-65.4) 54.5(44.7-64.3) 0.66 
 Atrial fibrillation 7.4 (4.1-10.7) 5.6 (1.8-9.4) 10.1 (4.2-16.0) 0.19 
 Heart failure 7.4 (4.0-10.8) 7.7  (3.3-12.1) 7.1 (2.0-12.2) 0.86 
 Hyperlipidaemia 7.0  (3.8-10.2) 7.0  (2.8-11.2) 7.1 (2.1-12.3) 0.98 
 Myocardial infarction 10.3  (6.5-14.1) 11.9 (6.6-17.2) 8.1  (2.7-13.3) 0.34 
 
Table 3.4: Independent determinants of five year stroke mortality amongst South 
Asians (Cox regression analysis) 
Variables  Hazard  Ratio 
(95% CI) 
P value* 
Age  1.01 ( .99-1.03) 0.12 
Atrial fibrillation 0.82 (0.19-3.4) 0.64 
Hyperlipidaemia  0.74 ( 0.3-1.87) 0.54 
Hypertension  0.84 (0.52-1.39) 0.51 
Diabetes  1.66 (1.02-2.6 ) 0.04 
Myocardial infarction 0.66 (.368-1.19) 0.17 
Heart failure  0.88(0.38-2.04) 0.88 
3.4 Discussion 
Contrary to our null hypothesis, there was a decline in rates of hospital 
admissions with non-haemorrhagic strokes for the total studied population in recent 
years. However, the prevalence of hypertension and hyperlipidaemia was seen increased 
over the studied period, but may be explained by how the identification of risk factors 
has improved among stroke patients, in line with a holistic approach in CVD risk 
management, specifically in South Asians (JBS 2, 2005). The data here give an insight 
into the changing CVD risk profile amongst ethnic groups in this stroke population but 
may not truly reflect the changes in the general population. In South Asians, the presence 
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of an adverse CVD risk profile is likely to explain why rates of stroke have not fallen to 
the same extent as those seen in other ethnic groups and merits further investigations.  
In recent years, there has been consensus recognition that South Asians are a high 
risk group for CVD, and this may have promoted heightened CVD risk assessments 
specific to this population.  Thus, it would be important to investigate the role of 
dyslipidaemia amongst South Asians in a community-based study, in view of its impact 
on stroke aetiology and pathophysiology. Using a hospital based approach, South Asian 
stroke survivors have been found to have significantly higher Apo lipoprotein B to A 
ratios, and higher Lipoprotein(a) levels when compared with ethnically-matched healthy 
controls (Sharobeem, et al., 2007).  
Given that hyperlipidaemia is a commonly encountered risk factor in CVD, being 
present in more than 25% of the stroke patients, there is the need to determine the 
importance of dyslipidaemic management in the treatment and prevention of stroke in a 
multi-ethnic population.  In two other reported South Asian stroke studies, 50% of the 
stroke patients had elevated cholesterol levels (Deleu, et al., 2006; Anand, et al., 2000)
 
. 
In European Caucasians, the prevalence of hyperlipidaemia ranges from 28.7 to 32%  
(Sacco et al 2001).  In the present study, the prevalence of hyperlipidaemia increased by 
fivefold in South Asians over the 1997-2005 period. This raises the possibility of adverse 
transition of the CVD protective traits in hyperlipidaemia, which were a feature of early 
migrant populations, to a more atherogenic profile as described in the indigenous 
population (Bhatnagar, et al., 1995). The majority of the other stroke studies in UK have 
supported a similar decline in the prevalence of stroke, (Tolonen, et al., 2002) but the 
pace of decline in stroke prevalence in South Asians was not significant, reaching a nadir 
across the three time periods. This is consistent with the demonstrated adverse transition 
of CVD risk profile amongst South Asians shown here. 
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This study also shows a declining trend in in-hospital all cause mortality rates in 
all three ethnic groups during the studied period. This is well comparable to other 
reported studies across the world (Howard, et al., 2001).  
In the UK, ethnic disparity in stroke mortality rates has been reported (Saha, et 
al., 2003). However, highest in-hospital all cause mortality rates in South Asians 
compared to all other ethnic groups in the current study further demonstrate the 
vulnerability of this group to the whole spectrum of CVD which had not been reported 
before
 
(Wolfe, et al., 2006).
 
Long term mortality following a stroke depends on the 
disease severity as well as other comorbidities which have a direct impact on the 
recovery.  The higher stroke mortality in non Asian populations living in the UK has 
been mainly attributed to age, hypertension and atrial fibrillation (Rothwell,  et al., 2005; 
Lee, et al., 2007). This has been confirmed in many previous cross-sectional and recent 
longitudinal studies involving European Caucasian populations (Carter, et al., 2007). The 
Northern Manhattan Study in the USA also revealed similar risk associations with stroke 
mortality (Dhamoon, et al., 2007). However, studies from the East Asian countries depict 
a different scale of risk association. In these studies, the presence of diabetes and 
hypertension at the time of the event strongly predicted stroke outcomes (Pham, et al., 
2007).  This clearly suggests a disparity and different distribution of CVD risk factors 
and their impact on stroke outcomes in the populations in the East when compared to 
those in the West. However, research into established stroke risk factors has not been 
thoroughly investigated in the South Asian population. Indeed there is a paucity of 
longitudinal data demonstrating the impact of these risk factors on South Asian stroke 
survivors. In addition, data on stroke care provisions in these populations are sparse.  
In our five-year mortality analysis, 56% of the South Asian stroke patients were 
diabetic, and the magnitude of adverse risk that this confers to survival is of particular 
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concern. Migrant South Asian populations in UK are known to have higher prevalence of 
diabetes mellitus (McKeigue, et al., 1991; Kain, et al., 2003) which is three- to- nine fold 
higher than in the Caucasian population (Delu, et al., 2000). 
Evidence from migration studies suggests that the change of lifestyle, 
modifications in dietary habits and improvements in socio-economic status in the migrant 
South Asian population have resulted in increased development of the macrovascular 
complications of diabetes (McKeigue, et al., 1991).  The reasons for increased long term 
stroke mortality amongst South Asians with diabetes in the current study are very likely 
to be linked to poor glycaemic control and lack of modification of life style factors 
including dietary habits which are proven to be difficult to control in this population 
(Lanting, et al., 2005). This aspect clearly merits further investigation.  
The Whitehall study reported that impaired glucose regulation doubled the risk of 
death from coronary heart disease among middle aged civil servants (Jarrett, et al., 1986) 
whereas Chaturvedi reported a similar finding amongst South Asians (Chaturvedi
,
 et al., 
1996). In cerebrovascular disease, studies have reported the association between 
abnormal glycaemic status and adverse stroke outcomes in non-South Asian populations 
(Ballotta, et al., 2007; Tracey, et al., 1993; Murros, et al., 1992). We are unaware of 
published long term prognostic data on the impact of diabetes on South Asian stroke 
patients.  
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3.4.1: Limitations 
There are several limitations to the study analyses, including the hospital-based 
retrospective registry nature where the results of this study cannot be directly 
generalisable to all the strokes. The patients who were not admitted to hospital following 
a stroke but were managed initially in the community may not have been included in the 
current registry and may have caused a selection bias and under-estimation of the stroke 
rates. The use of ICD diagnosis codes to select patients with stroke could have resulted in 
over-estimation of ischaemic stroke rates in this population as a result of classification 
errors. This was confirmed in the validation analysis where 2.5% of the patients who had 
a coding for ischaemic cerebral infarction did not have any objective evidence of an 
ischaemic stroke but had an unspecified stroke. Similarly, exclusion of patients with 
unspecified strokes may have potentially resulted in under-estimation of the ischaemic 
stroke rates.  However it is very unlikely these errors may have an impact on the 
comparative analysis of distribution of CVD risk factors amongst studied ethnic groups. 
Also, the reporting of cardiovascular comorbidities such as peripheral vascular disease 
and stroke type is limited by the quality of information that is recorded within case notes 
as a result of recording and reporting errors.  Therefore smoking status and alcohol 
consumption status had not been included in the analysis and may have confounded 
stroke mortality analysis. Finally, reported prevalence rates in this study are purely based 
on the hospital stroke admissions, where there could be an under-estimation of the stroke 
prevalence in the general at-risk population in the community. Indeed patients who had a 
stroke while receiving in-hospital treatment may have not included in the study and may 
have influenced the assumptions made on the in-hospital duration of stay.  
The reasons for decrease in number of stroke admissions over the studied time 
period amongst all ethnic groups may not have been due to true reduction of stroke 
incidence but due to changes in socio-economic and behavioural factors (patients 
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attending other hospitals for treatment, preferring to obtain community based treatment, 
migration to other regions) which are in-particular known to exist amongst South Asians. 
In addition, because this registry was collated retrospectively using an ICD coding for 
primary diagnosis of ischaemic stroke, we were unable to study South Asian sub groups 
separately and adjust for other confounding factors. 
However it is assumed that all these factors may have equally affected all the 
concerned ethnic groups and legitimates the comparison of CVD risk factors between the 
ethnic groups.  Moreover, hospital admission rates in this study are also proportional to 
the prevalence rates reported by Hsu et al (1999) in Leicestershire. Although there has 
been no change of the ICD 10
th
 revision during the period of our study, threshold levels 
for diseases such as hypertension have changed. This could result in an over-estimation 
of the prevalence rates when analysing and interpreting secular trends. Similarly, there 
could also be an over-diagnosis of strokes on admissions, specifically in older patients, 
who are admitted with other co-morbidities. Nonetheless, it may not have contributed to 
the determination of ethnic differences, as one would again assume that changes would 
apply equally to all cohorts. 
The mortality data of the patients who were not admitted to hospital following a 
stroke but were managed in the community have not been included in the current 
analysis. This may have caused a selection bias and under estimation of the mortality 
rates. As a result of the retrospective and coding based nature of this study, we were 
unable to determine and adjust for other factors including impact of treatment in the Cox 
regression mortality analysis. Mortality data in the current study refers to all cause 
mortality, where the underlying specific cause of death was not available for the analysis.  
In conclusion, cardiovascular risk profiles among patients admitted with non-
haemorrhagic stroke have changed over the last decade. In particular, hyperlipidaemia 
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has increased, especially among South Asians, where it showed a fivefold increase. The 
reduced decline in stroke prevalence and 30-day survival of stroke in South Asians in 
recent years warrants further investigations. Long term stroke mortality in South Asians 
is associated with presence of diabetes mellitus. This highlights the importance of further 
prospective & pathophysiological studies to investigate the impact of diabetes on stroke 
mortality, particularly amongst South Asians.
2,3 
  
                                                 
2Gunarathne, A., Patel J.V., Hughes, E.A., et al.(2008). Increased five year mortality in the migrant South 
Asian stroke patients with diabetes mellitus in the United Kingdom:  The West Birmingham Stroke Project. 
International Journal of Clinical Practice, 62:197-201  
 
3Gunarathne, A., Patel J.V., Hughes, E.A.,(2007).Secular trends in the cardiovascular risk profile and 
mortality amongst inner city multi-ethnic population in the UK (1997-2005). Journal of Human 
Hypertension,8:2    
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Chapter 4 :  Assessment of arterial stiffness indices in 
healthy South Asians compared to European 
Caucasians   
 
Literature review on arterial stiffness and ethnicity (Chapter 1.6.3) highlighted the 
significant paucity of available data on indices of arterial structure and function amongst 
healthy South Asians as well South Asians with established cardiovascular or 
cerebrovascular diseases. The principal objective of this chapter is to firstly determine the 
structural characteristics of the vessel wall amongst healthy SA compared to that of EC.  
4.1  Introduction  
South Asians living in the UK have disproportionately higher rates of premature 
mortality from CVD than the indigenous UK population (Chapter 1).  Whilst this excess 
CVD risk is closely allied with cardiovascular comorbidities that include diabetes 
mellitus and hypertensive disease (Patel, et al., 2006), the underlying pathophysiology 
leading to this excess risk remains poorly understood.  This increased CVD burden 
continues to be a source of the disparity in equitable healthcare for this ethnic group. 
Importantly, there is a markedly earlier progression of disease in South Asians (Gill, et 
al., 2007), suggesting that the pathogenesis of sub-clinical atherogenesis and premature 
arteriosclerosis is manifest even in apparently healthy individuals. However, the timely 
identification of those South Asians at increased risk of CVD is a portentous challenge.   
Diabetes and hypertensive disease are both associated with accelerated 
atherosclerosis and age related arteriosclerosis or ‗vascular ageing‘ (Cruickshank, et al., 
2002) which are known to cause structural changes in vessel wall characteristics 
(Laurent, et al., 1994). Importantly, the actions of early initiators of atherosclerosis on the 
vessel wall are manifested as increased arterial stiffness (Oliver, et al., 2003) which is 
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accepted as an independent marker of CVD, having prognostic and clinical  implications 
therein (Cruickshank, et al., 2002).  In addition, recent evidence supports the utility of 
arterial stiffness as a surrogate marker of end-organ damage in hypertensive disease 
(Boutouyrie, 2002).  
As previously highlighted, the principal physiological factors that contribute to 
increased arterial stiffness include age and mean arterial blood pressure (Bramwell, et al., 
1922).  Mean arterial pressure is defined as the average pressure throughout the cardiac 
cycle. The mean arterial pressure contributes to vascular changes independent of age and 
probably has a greater impact on the small-to-medium size muscular arteries, leading to 
higher peripheral vascular resistance, which can be quantified by analysing pulse wave 
reflections (Laurent, et al., 2006).  
I hypothesised that measures of arterial stiffness would be greater amongst 
healthy South Asians compared to their European Caucasian counterparts even in the 
absence of established CVD risk markers. To test this hypothesis, we measured indices 
of arterial stiffness in apparently healthy South Asians and age- and gender- matched 
European Caucasians attending a cardiovascular risk assessment clinic over a one year 
period. 
4.2  Methods  
4.2.1  Case ascertainment: 
Using a stratified sampling approach, hundred volunteers who initially 
participated in community based cardiovascular risk screening clinics in Sandwell and 
West Birmingham area (West Midlands, UK) were invited to attend the vascular research 
clinic ( Please see Chapter 2.4.2 for details ). Of the initial invited population, 90 South 
Asians attended the research clinic. Subsequently, using a similar approach age and 
gender matched 62 European Caucasian healthy volunteers (in keeping with the power 
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calculations) were recruited for the study.  The total cohort (aged 30–75 years) comprised 
healthy people without any known established CHD risk factors. Participants were 
excluded if there was any evidence of documented cardiovascular disease or found to be 
on any regularly prescribed cardiovascular medications. In addition, patients without 
complete vascular measurements were also excluded from the analysis (8%).  
4.2.2 Measurement of arterial stiffness 
Arterial stiffness was measured using DVP analysis technique. Please see Chapter 
2.5.6  for details of the measurement of arterial stiffness using DVP analysis technique.   
4.3 Results 
4.3.1 Baseline characteristics: 
A total of 90 healthy South Asian volunteers and 62 age and gender matched 
healthy European Caucasians were recruited for the study (Table 4.1).  South Asians and 
European Caucasians were matched for age, and comparable for body mass index, waist 
hip ratio, fasting plasma glucose and serum cholesterol. In both groups, the variation of 
systolic and diastolic blood pressures remained within normal range (<140/90mmHg), 
although mean arterial pressure levels were significantly higher in the European 
Caucasians (P =0.048).  
4.3.2 Measurements of arterial stiffness: 
On comparison, South Asians had higher SI compared to European Caucasians 
(P=0.007) (Figure 4.1).  There were no differences in the mean 10 year CHD risk score 
estimates between South Asians and European Caucasians (South Asians: 6.49(0.76) vs 
European Caucasians: 7.1(0.7),  P=0.54)). SI was strongly associated with the 10 year 
CHD risk score in both ethnic groups (Pearson correlation (r), South Asians: r=0.65, 
P<0.001; European Caucasians: r=0.42, P=0.001).  
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Table 4.1: Baseline characteristics of healthy controls  
Risk factor 
 
South Asians               
(n =90) 
Caucasians  
(n=62) 
P Value* 
Mean age (years) 45.2(13.4) 46.7(11) 0.13 
Males (%) 51.1 50.8 0.26** 
Height (m) 164.1(9.9) 170.8(9.3) <0.001 
Body Mass Index ( kg/m
2
) 25.9(3.2) 27.4(4.5) 0.08 
Waist Hip Ratio  0.94(0.08) 0.93(0.08) 0.53 
Systolic blood pressure (mmHg) 134.5(12.3) 135.3(15.3) 0.82 
Diastolic blood pressure (mmHg) 83.6(9.3) 83.58(10.1) 0.97 
Mean arterial pressure (mmHg ) 96.9(11.7) 100.8(10.2) 0.048 
Serum cholesterol (mmol/l) 4.4(1.4) 4.6(0.72) 0.94 
Fasting plasma glucose (mmol/l) 4.9(1.4) 4.5(0.92) 0.43 
Stiffness Index (ms
-1 
) (SE) 9.39(0.23) 8.43(0.27) 0.007 
Reflective Index  70.9(4.24) 70.6(4.21) 0.61 
Current Smokers n (%) 8(8.7) 7(10.4) 0.45 
10 year CHD risk score  6.49(0.76) 7.1(0.7)  0.54 
Data are mean (SD), n(%).*P values using unpaired t test comparing two groups. ** P values using chi 
square test Significance level was accepted as p< 0.05 level: CHD: Coronary Heart Disease 
Figure 4.1: Measurements of arterial stiffness (SI) between South Asians and 
European Caucasians 
 
The ethnic cohorts were combined and stratified into three CHD risk groups: low 
(<5%), moderate (5-15%) and high risk (>15%).The SI increased in an ordinal fashion 
from the lowest to the highest risk group (Pseudo R-Square = 0.30; P<0.001).  In the 
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‗low CVD risk‘ category, percentage of the South Asians who had ―high SI‖ was 
significantly higher than Caucasians (P = 0.04) (Figure 4.1.1) 
Figure 4.1.1: Distribution of stiffness index according to CVD risk groups 
comparing South Asians vs. European Caucasians.  
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4.4.3  Bivariate and multivariate analysis 
In bivariate correlation analysis, age (r=0.43; P<0.001) and mean arterial pressure 
(r=0.3; P=0.003) were independently related to SI. In sub-group analysis of South 
Asians, both age and mean arterial pressure levels showed a similar association (Table 
4.2).  Amongst European Caucasians, there was a significant and positive association 
between SI and WHR (P = 0.01) and smoking (P= 0.01).    
On regression analysis, South Asian ethnicity (Beta (95%CI): 0.31(0.25-0.7); 
P=0.03)), age (0.07(0.03-0.11); P=0.001) and smoking (1.9(1.68-3.2); P=0.003) were 
independent predictors of arterial stiffness variation. In South Asians, after adjusting for 
age and other CVD risk indices, mean arterial pressure independently predicted arterial 
stiffness (Table 4.2).  In a similar analysis of European Caucasians, smoking was an 
independent predictor of stiffness index.  
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Figure 4.2: Association between stiffness index and mean arterial pressure  
 
 
 
 
 
Stiffness Index 
(m/s) 
 
 
 
 
 
 
     Mean blood pressure (mmHg) 
 
SA = South Asian, EC= European Caucasian; Regression plot co-efficient: SA= Y=3.22+0.06x;  
EC=Y=6.02+0.02x. P value comparing regression co-efficient (se) of two groups using a formula derived 
from independent t-test (t = (b1 - b2)/ SE (b1 - b2). 
 
In linear regression analysis to demonstrate the effect of mean arterial pressure on 
SI, a significant ethnic difference was found in the slope of the regression (Figure 4.2) 
for SI vs. mean arterial pressure between South Asians and European Caucasians 
(P<0.001). These results also demonstrate that for a given mean arterial pressure, South 
Asians have a higher arterial stiffness even after adjusting for age (Figure 4.2). 
SA  
EC  
P<0.001 
 104 
 
Table 4.2: Bivariate analysis (R) and Multivariate analysis (Beta) between stiffness index and CHD risk indices  
 
 
 
 
 
 
 
Significance level of the P value was accepted as p< 0.05 level 
Risk indices South Asians European Caucasians 
R** P 
value* 
Beta (95% CI) P value R** P 
value* 
Beta (95% CI) P 
value* 
Age (years) 0.45 < 0.001 0.11(0.04-0.17) 0.002 0.40 < 0.001 0.05(0.01-0.1) 0. 01 
Waist Hip Ratio 0.15 0.15 4.4(1.16-8.8) 0.05 0.32 0.01 3.98(-5.2-8.2) 0.39 
Body Mass Index (kg/m
2
) -0.04 0.76 -0.17(-0.3-0.14) 0.38 -0.01 0.89 -0.09(-0.23-0.03) 0.14 
Fasting plasma glucose (mmol/l) 0.03 0.71 0.02(-0.67-0.73) 0.93 0.24 0.04 0.27(-0.25-0.8) 0.29 
Serum Cholesterol (mmol/l) 0.17 0.11 0.36(.11-0.43) 0.35 0.12 0.51 0.05(0.02-0.22) 0.84 
Mean Arterial Pressure (mmHg) 0.34 0.001 0.06(0.01-0.11) 0.01 0.22 0.05 0.01(-0.03-0.06) 0.55 
Smoking 0.02 0.78 0.8(-1.9-3.6) 0.52 0.32 0.01 2.11(1.5-3.7) 0.01 
Mean heart rate -0.14 0.23 -0.02(-0.11-0.06) 0.58 -0.15 0.002 -0.04(-0.15-0.07) 0.14 
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4.4 Discussion 
This study is consistent with our hypothesis and previous limited, data (Din, et 
al., 2006) and demonstrates higher indices of arterial stiffness in an apparently healthy, 
South Asians compared to the general population. Mean arterial pressure levels in the 
South Asians were significantly lower compared to the European Caucasians, despite its 
association with arterial stiffness in the former.  Possible explanations for this paradox 
of higher arterial stiffness despite lower mean arterial pressure levels in South Asians 
merits careful consideration.   
Structural characteristics of both the arterial wall and its function can be altered 
with exposure to adverse cardiovascular risk indices.  In healthy European Caucasians, 
the extent of the arterial stiffness appears to correlate with conventional CHD risk factor 
burden (Kalra, et al., 2005).  In South Asians, there seems to be a considerable variation 
in the magnitude of impact of CVD burden on the arterial wall characteristics (Din, et 
al., 2006). In the current study, South Asians demonstrated to have a greater arterial 
stiffness for a given blood pressure level after adjusting for other comorbidities 
including age.  It appears that there is an adverse impact of the mean arterial pressure on 
the vascular system. The reasons for this appear to be multi-factorial, and include 
genetic susceptibility and the simultaneous presence of other metabolic, inflammatory 
and oxidative stress related abnormalities (Forouhi, et al., 2001), which are known to 
have a cumulative impact on the vasculature. Few studies have highlighted the 
importance of diet and life style changes in South Asians living in Britain compared to 
the European Caucasian counterparts, which is compounded by transitions in diet and 
lifestyle on migration to the UK (Patel, et al., 2005). Indeed adverse diet and life style 
differences observed in migrant South Asians may further augment this unfavourable 
risk profile (Lean, et al., 2001; Lip, et al., 1996). Such cumulative stressors can reduce 
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the effectiveness of protective mechanisms thereby allowing pathological processes 
such as atherosclerosis to become operative, which in turn increases arterial stiffness. 
Moreover, apparent morphological differences in vessel wall characteristics in South 
Asians (Lip et al., 1999) may also augment the impact of mean arterial pressure on the 
vessel wall, resulting in changes in pulse wave form reflections. 
The technique and method (i.e. DVP) used to assess arterial distensibility in this 
study allows examination of the structural integrity of both large and small arteries 
simultaneously. The observed increase in arterial stiffness in South Asians could, 
therefore, be attributed to both large and small-to-medium vessel wall abnormalities. 
Larger proximal artery stiffness is known to cause elevated systolic blood pressure 
levels (Safar and O‘Rourke, 1999) but South Asians are more prone to develop smaller 
vessel disease (Ajjan
,
 et al., 2007).
  
Hence, normal and comparable systolic blood 
pressure levels in this South Asian cohort suggest that the observed higher stiffness is 
more related to smaller and medium vessels abnormalities than to larger vessels.   
Despite comparable mean arterial pressure levels (Khattar, et al., 2000), 
antihypertensive therapy usage (Bhopal, et al., 2002)  and changing trends in blood 
pressure(Lyratzopoulos, et al., 2005) there is still a greater burden of cardiovascular 
morbidity from hypertension in South Asians in the UK compared to the general 
population (Khattar, et al., 2000). The pathophysiological basis for this disparity 
however, has not been explained. Our findings suggest that higher CHD related 
mortality in South Asians could be related to underlying increased arterial stiffness and 
associated abnormalities. This highlights the importance of further prospective studies, 
exploring the possibility of perhaps reducing the thresholds for diagnosis of 
hypertension in this high risk population as an approach towards prevention of future 
cardiovascular events and complications of hypertension. 
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Current guidelines on the cardiovascular risk assessment for people with 
established cardiovascular disease (CVD) and persons at high risk of developing CVD, 
do not consider specific risk factor targets for South Asians (JBS2, 2005). A paucity of 
longitudinal data is likely to hamper an evidence-based consensus approach for 
ethnically specific CHD management and prevention.  As expected, SI is strongly 
associated with cardiovascular risk scores, in the current study. South Asians had 
comparable 10 year CHD risk scores to European Caucasians using the ESC risk score 
model.  The data presented highlights a basis for use of arterial stiffness measurements 
in the early identification of higher risk individuals who are likely to be considered 
―healthy‖ and ―low risk‖ in the traditional cardiovascular risk assessment process.  
Limitations: 
The limitations in the current study include the cross-sectional nature of the 
design. A large long-term prognostic study would be required to validate the predictive 
value of arterial stiffness in this ethnic group. In keeping with both the available 
literature and the taxonomies used in many other studies, we have used the ethnic 
category ‗South Asian‘.  It is also recognized that classification based purely upon 
geographical origin masks the considerable heterogeneity in the pathophysiology of the 
disease amongst South Asians.  Furthermore, in the current analysis the clustering 
impact of other metabolic, inflammatory biomarkers and novel risk indices on the 
higher arterial stiffness seen in South Asians has not been examined.  In addition, the 
DVP method used to measure arterial stiffness in the current study did not provide 
information on individual contributions that both large and small arteries make towards 
wave reflection and overall arterial stiffness. Using a design in which combined 
methods of measurement (Pulse Wave Velocity and DVP for example) would possibly 
have provided more comprehensive details thereby giving greater explanatory power to 
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this study.
  
Finally, the objective of this study was not to measure function of the small 
vessels by comparing indices of RI pre and post Salbutamol and GTN administration. 
Therefore, absolute baseline data presented on RI may not necessarily confer any added 
usefulness.  
In conclusion, South Asians were demonstrated to have an increased pulse 
wave reflection and systemic arterial stiffness compared to European Caucasians, in 
keeping with our hypothesis.  This may be related to an adverse and disproportional 
impact of the mean arterial pressure on the vascular system. Pathophysiological 
differences in vessel wall characteristics among South Asians may explain their 
increased susceptibility to vascular disease and their higher cardiovascular risk.
4
  
                                                 
4 Gunarathne, A., Patel, J.V., Gammon, B., Hughes, E.A.,(2008). et al.Impact of mean arterial blood 
pressure on higher arterial stiffness indices in South Asians compared to White Europeans. Journal of 
Hypertension, 26:1420-6. 
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Chapter 5 : Structural and functional vascular risk 
indices and related biomarkers amongst South Asian 
stroke survivors compared to European Caucasian 
counterparts 
 
5.1 Introduction 
Given the higher prevalence of diabetes and hypertension amongst SA compared 
to EC and impact of diabetes on SA stroke mortality (Chapter 3), the objective of the 
present chapter is to comprehensively examine the vascular risk indices amongst SA 
stroke survivors compared to EC, and assess the impact of conventional risk indices on 
vessel wall characteristics.  
Indices of arterial stiffness and endothelial dysfunction are accepted as 
independent markers of vascular disease, having both prognostic and clinical 
implications (Perticone, et al., 2001; Laurent, et al., 1994). Established CVD risk factors 
such as diabetes and hypercholesterolemia are known to alter the underlying vessel wall 
characteristics (Oliver, et al., 2003) causing impaired endothelial function (Guerci, et al., 
2001) and increased arterial stiffness (Cruickshank, et al., 2002), with a consequent 
increase in greater CVD risk.  
The identification of the vessel wall characteristics is important
 
because such 
characteristics precede changes in haemodynamic parameters (Anderson, et al., 2005) 
such as mean arterial pressure, which in themselves are strongly linked to adverse
 
cerebrovascular events (Van Bortel, 2002)
 
and provide an insight into the magnitude of 
the vascular dysfunction (Quyyumi, 1998) even amongst individuals with similar risk 
factor profiles. Indeed, the extent of the vessel wall damage appears to correlate with 
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conventional risk factor burden amongst SA (Chapter 3), but only less than a quarter of 
this excess risk had been explained by the presence of conventional risk factors such as 
glycaemic status (Chapter 1). A possible
 
explanation may be that clustering effect of 
inflammatory, oxidative stress and metabolic factors may have an adverse impact on the 
vessel wall properties directly or synergistically with already established conventional 
risk factor burdens. Some of the few available studies have previously reported higher 
prevalence of thrombotic, metabolic and inflammatory (Somani, et al., 2006) markers 
amongst South Asian stroke survivors; however their impact on the vessel wall 
characteristics has not been systematically investigated.  
SA stroke survivors in the UK have an increased prevalence of diabetes and 
hypertension (Chapter 3) and it is likely that these established risk indices primarily exert 
an adverse impact on the endothelium.  
Endothelial dysfunction is considered a key stage in the development of 
atherosclerosis. (Cai, et al., 2000).  It is independently associated with cardiovascular 
events (Al Suwaidi, et al.,  2000; Halcox, et al., 2002;  Schächinger, et al., 2000; 
Schächinger,2001) and has been shown to be predictive of the development of future 
strokes (Holmes, et al., 2003) . People with impaired endothelial function are known to 
have decreased nitric oxide production (Palmer, et al., 1987). Endothelium-derived nitric 
oxide is synthesized from the substrate L-arginine via endothelial Nitric Oxide Synthase 
(eNOS) (Föstermann, et al., 1994; Busse, et al., 1998; Fleming, et al., 2004) and it exerts 
its cellular mechanisms via cyclic Guanylate Mono Phosphate (cGMP) second messenger 
interaction (Bauersachs, et al., 1998).  
Endothelial cell activation can occur physiologically as a part of host defense 
mechanisms or pathophysiologically, where homeostasis of the eNOS-NO pathway can 
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be disturbed by increased expression of chemokines, cytokines and adhesion molecules 
and reduction in NO bioavailability ( Deanfield, et al.,2007). In addition, in the context of 
cardiovascular risk factors, the cellular environment can switch towards production of 
reactive oxygen species (ROS) (superoxide or hydrogen peroxide) based on the 
availability of cofactors such as tetrahydrobiopterin or L-arginine, thereby enhancing 
oxidative stress (Föstermann, et al., 2006).  Asymmetric dimethylarginine (ADMA) 
which is an endogenously derived competitive antagonist of NO synthase is also 
increased in these situations (Vallance, et al., 2004). These processes can lead do ―eNOS 
uncoupling‖ and related endothelial dysfunction ( Deanfield, et al.,2007). 
NO plays an essential role in maintaining vascular tone, blood pressure (Ohashi, 
et al., 1998) and lower levels are thought to be involved in atherogenesis (Wolf, et al., 
1997). Given that the majority of endothelium-derived NO production depends on eNOS 
concentration, reduced availability of eNOS also exerts a similar impact on the vascular 
homeostatic mechanisms (Feng, et al., 2002). The dysfunctional eNOS-NO pathway is 
considered to be an important early indicator of cardiovascular risk amongst higher risk 
populations (Hare, 2004). Patients with impaired endothelial function are known to have 
increased risk of cardiovascular disease (Rossi, et al., 2003) including strokes (Corrado, 
et al., 2008) and reduce NO bioavailability and eNOS expression has been well 
demonstrated with many other stroke populations (Cheng, et al.,  2008;Kim, et al., 2007). 
However there are limited data examining the molecular interactions of endothelially-
derived nitric oxide production amongst the South Asian stroke population and their 
influence on vessel wall characteristics.  
The first objective of the present study was to test the hypothesis that indices of 
arterial stiffness and endothelial dysfunction are higher in SA stroke survivors compared 
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to European Caucasians(EC), and that conventional risk indices may able to explain these 
vessel wall abnormalities. 
With the aim of investigating the adverse impact of eNOS-NO axis determinants 
on underlying vessel wall characteristics amongst South Asian stroke survivors, secondly 
I hypothesised that the endothelium derived NO, eNOS and cGMP levels are 
significantly lower amongst South Asian stroke survivors compared to their European 
Caucasian counterparts and that the reduced availability of nitric oxide is associated with 
greater arterial stiffness and impaired endothelial function.  
To explore the adverse clustering effect of inflammatory, oxidative stress and 
metabolic factors on the vessel wall properties, thirdly I  hypothesised that the levels of 
markers of inflammation ( Interleukin (IL6), High sensitivity C-reactive protein (hsCRP), 
Tumour necrosis factor (TNF alpha)), oxidative stress (oxidised Low Density Lipo-
protein (oxLDL), Haem-Oxygenase(HO), endothelial activation and thrombosis (von 
Willebrand Factor (vWF)) and metabolic status (Apo lipo protein (Apo A), Apo lipo-
protein B(Apo B)) are different amongst South Asian stroke survivors and aberrant levels 
are associated with increased arterial stiffness and impaired endothelial function. 
5.2  Methods  
5.2.1 Case ascertainment 
South Asian stroke patients with a diagnosis of ischaemic stroke, who were 
initially admitted to Sandwell and West Birmingham NHS Trust (Sandwell and City 
Hospitals) between 2005 and 2007, were invited to participate in the study after three 
months of the initial presentation (Please see Chapter 2.4.2.2 for details). SA were 
defined by self-reported ethnicity as being Indian, Pakistani, Sri Lankan, Nepalese, and 
Bangladeshi, and whose grandparents (at least three generations) also originated from the 
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Indian subcontinent (Chapter 1.2). Of the responders, the first consecutive 100 patients 
who attended the initial screening visit were prospectively recruited for the vascular sub 
study. Based on the power calculations (for vascular measurements) at least 58 people 
were required in each group. Therefore using the same stroke unit database , age, gender 
and post code (same area) matched Caucasian stoke patients who were admitted during 
the same period were invited and of the responders, the first attended 60 patients were 
recruited for this vascular sub study. After excluding  the patients who had died or who 
developed a second stroke with in the first three months period, 28% of the South Asian 
and 6% of the Caucasian stoke patients who originally invited and agreed to participate 
in the study did not attend the subsequent  screening visit. Four patients who didn‘t have 
complete vascular measurements were excluded from the final analysis. 
5.2.2  Measurement of Arterial Stiffness & Endothelial function: 
Arterial stiffness & endothelial function was measured using the Digital Volume 
Pulse analysis (DVP) technique. Please see section 2.5.6 for details.  
5.2.3 Quantitative determination of biochemical parameters 
Blood samples were collected after three months from the acute event and were 
taken following an overnight fast, on the same day of the vascular measurements. Blood 
samples were prepared at the Laboratory for Clinical Biochemistry Research, Sandwell 
and West Birmingham NHS Trust. Biomarkers (IL6, TNF alpha, oxLDL, HO, E-
Selectin, vWF, NO, eNOS, cGMP ) were measured by 2-site enzyme linked 
immunosorbent assay, with commercially available antibodies from R&D systems (UK) 
and Mercodia (USA). HsCRP, Apo AI, Apo B, Serum Cholesterol and fasting glucose 
levels were measured using an auto analyser (Cobas Integra 400, Roche, Switzerland). 
Please see section  2.5.8 for details. 
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5.3  Results 
5.3.1 Baseline characteristics: 
Of the cohort of 289 individuals, SA stroke survivors (70.4 % male; mean age 
62.6 SD (13) years) were initially compared to age and gender matched 60 EC 
counterparts (Table: 5.1, 5.2). The majority of the SA stroke survivors were of Indian 
origin (67.4%). Both ethnic groups were comparable for cardiovascular risk profile, 
except for the higher prevalence of diabetes mellitus in SA (47.4% vs. 25.1%; P=0.007) 
and atrial fibrillation in EC (13.3% vs. 3.1%; P=0.04). Among SA there was a lower 
prevalence of alcohol and tobacco consumption (P<0.01) compared to EC. The majority 
were on anti-diabetic (SA: 48.4% vs. EC: 26.8%, P=0.001) lipid-lowering (SA: 88.7% 
vs. EC 94.6%) and anti-hypertensive (SA: 86% vs. EC: 86%) medications. The use of 
warfarin (P=0.04) and dipyridamole (P=0.03) was higher amongst EC stroke patients, 
whilst there was a greater use of sulfonylureas (P<0.001) amongst SA stroke survivors. 
5.3.2 Radiological imaging: 
Of the total cohort, 9.5% of the stroke patients with clinical symptoms of stroke 
had normal CT scans, without any evidence of ethnic variation. Majority of SA as well as 
EC had radiological evidence of fronto-parietal infarctions and did not demonstrate any 
ethnic differences (P=0.69). The majority of the SA had normal duplex scan results 
(76.3% vs. 36.7%; P<0.001). Of the patients with abnormal scan findings, 20.1% EC 
demonstrated evidence of significant carotid artery stenosis (>50%) (Table 5.2). 
According to the Bamford and TOAST criteria, SA had higher small vessel (29.6 Vs 
15.5; P=0.04) and lacunar infarctions (32.6 vs. 13.3; P=0.01) compared to EC.  
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Table 5.1: South Asians vs. European Caucasians with established cardiovascular risk indices  
 
 
 
 
 
 
 
 
 
 
 
P* comparing SA stroke survivors vs. EC stroke survivors, significance at P<0.05 levels using unpaired t-test, P** comparing across all groups, significance at P<0.05 levels 
using one way ANOVA  
 
 
 SA Stroke 
( n=97 ) 
EC Stroke 
( n=60) 
SA Risk 
( n= 59 ) 
SA Healthy 
(n=73 ) 
P value* P value** 
Age 62.6(13) 64(8) 65.2(9) 50(15) 0.91 <0.001 
Fasting plasma glucose (mmol/l) 6.2(1.3) 4.1(0.9) 3.1(1.7) 2.6(1.4) 0.57 <0.001 
Fasting plasma glucose (mmol/l) Diabetics 7.2(0.9) 5.6(1.2) 3.8(1)  <0.001 <0.001 
Fasting plasma glucose (mmol/l) 
Non Diabetics 
5.3(1) 3.6(0.6) 3.4(0.8) 3.3(0.7) <0.001 <0.001 
Body mass index ( Kg/m
2
) 27.7(4.6) 28.8(5.8) 27.9(3.8) 26.2(3.2) 0.02 0.03 
Waist hip ratio 0.95(0.1) 0.94(0.1) 0.93(0.1) 0.91(0.1) 0.23 0.9 
Mean Blood pressure (mmHg) 100.7(12) 110.5(13) 107(11) 100.5(13) 0.9 0.21 
Total Cholesterol (mmol/l) 3.8(0.5) 3.7(0.7) 4.4(0.7) 4.2(0.8) 0.001 <0.001 
LDL (mmol/l) 1.7(0.7) 1.8(0.7) 2.7(0.9) 2.5(0.5) 0.75 <0.001 
HDL (mmol/l) 0.92(0.3) 0.98(0.2) 1.0(0.3) 0.99(0.3) 0.74  0.02 
Mean Systolic pressure (mmHg) 142.3(21) 135.79(20) 141.2(15) 129.4(16) 0.9 0.02 
Mean Diastolic pressure (mmHg) 79.7(11) 79(12) 84.4(11) 82(12) 0.8 0.05 
Heart rate (per min ) 69.2(15) 68.4(11) 70.4(10) 69.5(9) 0.83 1 
Arterial Stiffness (SI)m/s 11.2(2) 9.7(2) 10.1(2) 9.3(2) <0.001 <0.001 
Endothelial function (Δ RI) % 4.3(0.3) 7.9(0.6) 7.2(0.3) 10.2(0.5) 0.001 <0.001 
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Table 5.2: Baseline characteristics comparing South Asians vs. Europeans 
 South Asian 
Stroke 
 
European 
Caucasian Stroke  
P Value 
Male 70.1 65.1 0.49 
Ethnicity 
Indian 67.4   
Pakistani 22.1   
Bangladeshi 10.5   
CVD risk profiles 
Myocardial infarction 15.5 15 0.51 
Ischaemic heart disease 28.6 11.7 0.08 
Hypertension  68 85 0.15 
Diabetes 47.4 25.1 0.007 
Atrial fibrillation 3.1 13.3 0.04 
Heart failure 2.1 5 0.45 
Hyperlipidaemia 86.6 93.3 0.07 
Endarterectomy 3.1 11.7 0.07 
Peripheral vascular disease 2.1 3.3 0.78 
Coronary artery bypass graft 7.2 5 0.58 
Family history of MI 16.5 28.3 0.39 
Family history of  Stroke 18.6 21.4 0.6 
Smoking 13.4 41.7 0.01 
Alcohol 16.5 57.9 0.001 
CVD treatment 
Hypertension treatment 85.9 86 0.49 
Diabetes treatment 48.4 26.8 0.001 
Cholesterol treatment  88.7 94.6 0.79 
ACEI 50.5 50 0.175 
Beta Blocker 18.6 23.3 0.97 
Calcium Channel Blocker 21.6 20 0.34 
Loop Diuretics 8.2 13.3 0.57 
Thiazide Diuretics 11.3 15.6 0.51 
Angiotensin receptor blocker 9.3 5 0.17 
Alpha Blocker 3.1 11.7 0.07 
Aspirin  63.9 80 0.94 
Ticlodipine 1.3 1 0.37 
Dipyridamole 4.1 36.7 0.03 
Clopidogral 13.4 6.7 0.07 
Warfarin 4.1 15 0.04 
Fibrates 1 6.7 0.06 
Insulin 12.4 13.3 0.73 
Sulphonyl urea 21.6 3.3 <0.001 
PPRA γ 5.2 3.3 0.41 
Biguanides 25.8 20.8 0.11 
P value comparing SA vs. EC significance at P<0.05, ACEI: Angiotensin Converting Enzyme Inhibitor; 
CVD:Cardiovascular Disease 
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Table 5.3: Stroke characteristics comparing South Asians vs. European Caucasians  
  
TACI: Total Anterior Circulation Infarct, PACI: Partial Anterior Circulation Infarct, POCI: POsterior 
Circulation Infarct, LACI:LACunar Infarct.*P value comparing SA vs. EC significance at P<0.05, * 
Classified according to Doppler velocities and NASCET criteria ( Barnett, et al., 1991) 
 South Asian 
Stroke 
 
European 
Caucasian Stroke  
P Value 
Bamford classification  
TACI 10.1 15 0.34 
PACI 27 36.7 0.08 
LACI 32.6 13.3 0.01 
POCI 6.7 11.7 0.17 
Unspecified 23.6 23.3 0.29 
TOAST classification 
Large vessel disease 16.7 27.6 0.04 
Small vessel 29.6 15.5 0.03 
Cardio embolic 1.9 8.6 0.18 
Un specified 51.8 48.3 0.68 
Clinical Motor involvement    
Hemi paresis 69.1 68.3 0.89 
Para paresis 1.8 1 0.78 
Mono paresis 9.1 10 0.92 
Clinical Speech involvement    
Aphasic  19.6 13.3 0.26 
Nominal  1.8 1 0.89 
Expressive 16.1 36.7 0.04 
Cranial Nerve involvement 52.7 62.7 0.18 
Incontinence 20.4 13.3 0.31 
CT diagnosis 
Normal 12.3 6.7 0.35 
Infarction 71.4 81.7 0.54 
Age specific changes 0 1.7 0.67 
Not specified 16.3 9.9 0.23 
CT area 
Fronto parietal  42.9 43.3 0.67 
Temporal  4.3 1.7 0.56 
Internal capsule 8.7 6.9 0.78 
Cerebellar 6.5 6.9 0.88 
Basal ganglion 30.4 19.0 0.08 
Un specified 13 3.4 0.15 
Duplex Scan 
Normal 76.3 36.7 <0.001 
>50% stenosis* 2 20.1 <0.001 
<50% stenosis 11.8 26.7 0.003 
unspecified 9.9 16.5 0.01 
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In EC, 27.6% of the strokes were due to cerebral large vessel disease compared 
with 16.7% amongst SA (P=0.04) (Table 5.2).  
5.3.3 Stroke subjects compared to risk factor and healthy controls 
SA stroke survivors had significantly elevated serum cholesterol and plasma 
glucose levels as well as body mass index (BMI) compared to EC (P<0.05). Blood 
pressure parameters were comparable. As expected, compared to risk and healthy SA 
controls, stroke survivors had significantly higher risk indices (P<0.05) but similar waist-
to-hip ratio measurements (Table 5.1)   
5.3.4 Measurements of arterial stiffness and endothelial function 
Indices of arterial structure and function were available for 277 (South Asian, 
217; European Caucasian, 60) individuals. Of the total cohort, arterial stiffness 
measurements (SI) were significantly higher in SA stroke patients compared to EC 
(P<0.001) (Figure 5.1). Compared to healthy controls, all other groups had significantly 
higher SI (P<0.001; Table 5.1).  In post hoc analysis, comparing SA stroke patients vs. 
SA risk factor controls, SI remained significantly higher amongst SA stroke patients 
(P=0.002).  
The endothelium-dependent vascular function of each individual was calculated 
by determining the relative change in RI (Δ RI %) post-salbutamol inhalation. SA stroke 
patients had significantly poorer endothelial function when compared to EC (P<0.001) 
(Figure 5.1). As expected, SA healthy controls had significantly better endothelial 
function compared to groups with risk factors (P=0.001). Analysis of the SA stroke 
patients according to SI and Δ RI % tertiles, revealed that the majority of diabetic SA 
stroke survivors had the highest arterial stiffness and poorest endothelial function (Figure 
5.2) 
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Figure 5.1: Measurements of arterial stiffness and endothelial function comparing 
South Asians vs. European Caucasians 
 
A, Measurements of arterial stiffness (SI) among SA vs EC stroke patients.. B, Measurements of 
endothelial function (RI) among South Asian (SA) vs. European Caucasian (EC) stroke patients P value 
using 1-way ANOVA comparing vascular risk indices SA vs. EC stroke patients. 
  
P<0.001 
P<0.001 
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Figure 5.2: Distribution of endothelial function and arterial stiffness according to 
tertiles  
 
 
Endothelial function tertiles (Δ RI) %: E1: > 8.8, E2:5.3-8.8, E3: <5.2, Arterial Stiffness 
tertiles (ms
-1
): S1 :< 9.1, S2:9.2-11.1, S3 :> 11.2 
 
5.3.5 Correlations and multivariate regression 
On univariate analysis, there was a significant negative association (r) between SI 
and Δ RI (r= -0.28; P<0.001) and SI and age (r=0.27, P<0.001) for the total population. 
SI was significantly associated with fasting plasma glucose (r=0.45, P<0.001), total 
cholesterol (r=0.24, P<0.001), WHR (r=0.3, P<0.001) and mean arterial pressure     
(r=0.2, P=0.002) amongst SA and with a total cholesterol level (r=0.3, P=0.01) amongst 
EC. There was a negative association between endothelial function and fasting glucose 
(r=-0.4, P<0.001), total cholesterol (r=-0.18, P=0.03), BMI (r=-0.2, P=0.007) and WHR 
(r=-0.17, P=0.02) amongst SA but no significant association was apparent amongst EC 
stroke survivors. 
To determine the factors influencing arterial stiffness and endothelial function, 
stepwise multiple linear regression analyses were performed. Conventional 
cardiovascular risk factors: diabetes status, hypertension, hypercholesterolemia, atrial 
Endothelial Dysfunction 
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fibrillation, smoking, higher waist hip ratio, higher age (0=No, 1=Yes), gender (male: 1, 
female: 2) and ethnicity (SA: 1, EC: 2) were included in the models as independent 
variables. Hence, SA ethnicity was introduced to the model as a negative variable 
compared to EC (SA=1 vs. EC=2). In keeping with the original hypothesis, it is expected 
therefore to obtain a ―positive‖ Beta value for endothelial function and a ―negative‖ value 
for higher arterial stiffness for SA ethnicity. 
The results of the regression analysis are demonstrated in table 5.4. The Beta 
value for SA ethnicity was ―positive‖ and statistically significant for endothelial function, 
indicating an independent association between impaired endothelial function and SA 
ethnicity whereas the Beta value for SA ethnicity was ―negative‖ and significant for 
arterial stiffness demonstrating an association between higher arterial stiffness and SA 
ethnicity. Amongst SA, diabetic status independently associated with both arterial 
stiffness and endothelial function. In interaction analysis, SA ethnicity and diabetic status 
together had a significant association with arterial stiffness (F=6.4, P=0.02) but not with 
endothelial function (F=1.5, P=0.22) (Figure 5.3). The strength of the association of these 
variables together did not demonstrate any improvement when statistically compared to 
their individual associations (Table 5.5). In these models, only 25% of the endothelial 
function abnormalities and 31% of the arterial stiffness aberrances were explained by the 
presence of traditional risk factors amongst SA.  
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Table 5.4: Multivariate analysis demonstrating independent predictors of arterial 
stiffness and endothelial function 
  
 
Table 5.5: Interaction analysis of diabetes status and ethnicity demonstrating 
strength of association between arterial stiffness and endothelial function  
 
 
Group Predictors Beta SE P value 
Endothelial function(Δ RI) % 
Stroke Cohort 
( R
2 
= 0.36)
    
 
South Asian ethnicity 3.2(0.8-4) 0.5 0.001 
Diabetic status -1.4(-3.1- -0.9) 0.4 0.004 
Total South Asians 
( R
2 
= 0.25)
    
 
Diabetic status -2.9(-3.5 - -0.5) 0.7 0.001 
Hypercholesterolemia -3.2(-4 - -0.9) 0.8 0.001 
European Caucasians 
( R
2 
= 0.15)
     
 
Diabetic status -2.2(-3.8 - 0.06) 0.9 0.02 
Arterial stiffness(SI) 
Stroke Cohort 
( R
2 
= 0.24)
    
 
South Asian  ethnicity -1(-1.7- -0.3) 0.3 0.002 
Diabetic status 1.1(0.5-1.7) 0.3 0.001 
Total South Asians 
( R
2 
= 0.31)
    
 
Age 0.02(0.006-0.04) 0.009 0.01 
Waist Hip Ratio  4.5(1.9-7) 1.3 0.001 
Diabetic status 
Hypercholesterolemia 
1.3(0.8-1.9) 
0.6(0.1-1.1) 
0.2 
0.2 
0.001 
0.02 
European Caucasians 
( R
2 
= 0.25)
    
 
Male gender  -2(-3.6- -0.7) 0.6 0.004 
Variables F value P Value 
Arterial Stiffness (SI) 
SA Ethnicity 22.003 0.000 
Diabetes 7.9 0.005 
SA Ethnicity* Diabetes 6.458 0.012 
Endothelial Function ( RI) 
SA Ethnicity 43.54 0.000 
Diabetes 11.07 0.001 
SA Ethnicity* Diabetes 1.51 0.22 
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Figure 5.3: Interaction analysis of diabetes status and ethnicity demonstrating 
strength of association between arterial stiffness and endothelial function 
 
On an exploratory analysis 
according to previously reported cut-off points by our group (Chapter 2) and others 
(Rambaran, et al., 2008), the total group was classified as having poor, average and good 
endothelial function and arterial stiffness (Table 5.6).  Of the stroke population 61.3% of 
the SA patients demonstrated to have higher arterial stiffness (SI :> 11 ms
-1
) compared to 
23.3% of the EC (P<0.001). Similarly 57.9% SA stroke survivors had poor endothelial 
function (Δ RI: < 5%) compared to 15% of the EC. 
Table 5.6: Arterial stiffness and endothelial function tertiles comparing South 
Asians vs. European Caucasians 
Vessel wall characteristics Total  
289 (%) 
SA  
229 (%) 
EC 
60 (%) 
P value* 
Endothelial function 
Δ RI(%) 
Poor(<5) 31.1 38.7 15 <0.001 
Average (5-10) 43.8 38.2 63.3  
Good (>10) 25.1 23.1 21.7  
Arterial stiffness 
SI(ms
-1
) 
High (>11) 34.6 35.4 23.3  0.05 
Medium  (9-11) 32.7 39.3 36.7  
Normal  (< 9) 32.7 25.3 40  
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5.3.6 Analysis of indices of eNOS-NO axis 
Levels of eNOS, NO and cGMP were available for 289 participants and were 
non-parametrically distributed, with median values (inter-quartile range) of 1.5(0.7-3.5), 
37.9(18-74) and 111(76-149) respectively.  
5.3.6.1 Relationship to clinical demography and associated comorbidities 
eNOS levels were significantly lower among SA (P=0.001), stroke patients 
(P=0.04) and  hypertensive persons (P=0.04).  Other differences in eNOS levels 
according to clinical features (age, smoking status, wait hip ratio, BMI, diabetes status) 
did not reach significance. Levels of NO were significantly lower in SA (P=0.001), 
diabetics (P=0.001), hypercholesterolemics (P=0.02) and patients with strokes (P=0.003). 
cGMP levels were lower amongst SA (P=0.001). SA stroke patients had significantly 
lower levels of eNOS, NO and cGMP levels compared to EC stroke patients (P=0.001) 
and SA controls (P=0.001) (See Table 5.7 and Figures 5.4 and 5.5). 
 
Table 5.7: Indices of eNOS-NO axis comparing South Asian vs. European 
Caucasians  
 SA  
Stroke  
(n=97) 
EC  
Stroke  
(n=60) 
SA  
Risk 
(n=59) 
SA  
Healthy  
(n=73) 
P 
value* 
P 
value**  
 
e-NOS  
(ng/ml) 
0.8 
(0.4-1.3) 
4 
(2-9) 
1.3 
(0.7-2.2) 
2.5 
(1.1-5.3) 
<0.001 <0.001 
cGMP 
(pmol/ml) 
84.2 
(62-130) 
137 
(107-189) 
118 
(93-148) 
107 
(71-139) 
<0.001 <0.001 
Nitrate 
(umol/l) 
20.7 
(10-42) 
50 
(28-99) 
40.6 
(21-76) 
59.3 
(21-102) 
<0.001 <0.001 
**P value using Kruskal Wallis test comparing differences across all four groups, * P value using  
Mann Whitney U test*, comparing SA stroke vs. EC stroke. 
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Figure 5.4: eNOS and Nitrate concentrations comparing South Asians vs. European 
Caucasians 
 
 
 
 
 
 
 
 
 
Figure 5.5: cGMP concentrations comparing South Asians vs. European Caucasians 
stroke survivors. 
 
P value using one way ANOVA comparing differences across all four groups and using independent t-test 
comparing SA stroke vs. EC stroke.  
In a separate analysis, SA with diabetes (total) were demonstrated to have 
significantly lower NO levels compared SA without diabetes (P=0.001) and EC stroke 
patients with diabetes ( P=0.002). This difference was also apparent but non- significant 
amongst SA with stroke (Figure 5.6). Similarly, eNOS levels were significantly lower 
(P<0.001) amongst SA with hypertension compared to SA healthy controls.  
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Figure 5.6: Nitrate concentration in both ethnic groups comparing patients with 
and without diabetes 
 
 
 P values using independent t-test comparing patient with and without diabetes. Significance at P<0.05 
level. 
 
5.3.6.2 Relationship to arterial structure and function 
With respect to the arterial stiffness and endothelial function tertiles, SA with 
higher arterial stiffness and relatively poor endothelial function had significantly lower 
eNOS and NO levels (P<0.05). This significance was not apparent in the cGMP 
measurements. In sub-group analysis, SA with higher NO and eNOS levels (tertile: 3) 
were demonstrated to have better endothelial function compared to lower NO and eNOS 
concentrations. This difference was more significant amongst people without diabetes 
(Figure 5.7). In ordinal regression analysis NO and eNOS increased in an ordinal fashion 
with arterial stiffness (Pseudo R
2
: NO:0.04, P:<0.001, eNOS:0.06, P=0.01), and 
endothelial function (Pseudo R
2
: NO:0.06, P:<0.001, eNOS:0.11, P<0.001) tertiles 
respectively (Figure 5.8). 
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Figure 5.7: Mean endothelial function amongst South Asians according to eNOS 
and Nitrate tertiles and diabetic status  
 
eNOS tertiles: 1: (<2.9), 2(3-3.4), 3: (>3.4), NO tertiles: I:(<1.2), II:(1.3-1.7), III:(>1.8) 
Figure 5.8: Distribution of NO and eNOS concentrations (95% CI) amongst South 
Asians according to tertiles of arterial stiffness and endothelial function  
 
P values using ordinal regression across tertiles of arterial stiffness and 
endothelial function. Significance at  P<0.05 level. Error bars represent 95% CI. 
Arterial Stiffness tertiles
2.8
3.0
3.2
3.4
lo
g 
eN
O
S 
co
nc
en
tr
at
io
n 
(u
m
ol
/l)



High                   Medium                Normal
Endothelial function tertiles
2.8
3.0
3.2
3.4
3.6
lo
g 
eN
O
S 
co
nc
en
tr
at
io
n 
(u
m
ol
/l)



Poor                Average             Good
Endothelial function tertiles
1.3
1.4
1.5
1.6
1.7
1.8
lo
g 
N
itr
at
e 
co
nc
en
tr
at
io
n 
(u
m
ol
/l)



Poor                    Average                Good
Arterial Stiffness tertiles
1.2
1.3
1.4
1.5
1.6
1.7
lo
g 
N
itr
at
e 
co
nc
en
tr
at
io
n 
(u
m
ol
/l
)



High                   Medium                Normal
Pseudo R2: 0.062, P:0.001 
Pseudo R2: 0.025, P=0.05 Pseudo R2: 0.06, P=0.005 
Pseudo R2: 0.047, P=0.04 
128 
 
 
5.3.6.3 Correlations and Multivariable Regression 
On univariate analysis there was a significant association between NO and 
arterial stiffness (r:-0.21, P=0.001). NO level was also associated positively with 
endothelial function (r=0.2, P=0.001). There was a positive association between eNOS 
level and endothelial function (r=0.3, P=0.001). In a separate analysis eNOS levels 
significantly positively associated with NO (r=0.2, P=0.002).  In multivariate regression 
analysis, after adjusting for age and other cardiovascular co-morbidities, lower NO and 
eNOS levels were negatively associated with increased arterial stiffness [Beta(95%CI):-
NO: -0.46(-0.0.9- -0.006), P=0.04; eNOS:-0.5(-0.1- -0.01), P=0.009]. Independent 
associates for lower NO levels amongst SA were diabetes [Beta(95%CI):-.2.6(-0.3- -
0.05), P=0.009] and hypercholesterolemia [Beta(95%CI):-2.7(-0.3—0.06, P=0.006). 
Independent associates for lower eNOS levels were hypertension [Beta(95%CI):-.2.2(-
0.3- -0.02), P=0.02]  and  hypercholesterolemia [Beta(95%CI):-3.1(-0.4- -0.09, P=0.002) 
respectively. 
5.3.6.4 Receiver Operator Characteristic (ROC) curve analysis  
ROC analysis was performed to asses the discriminatory utility of eNOS, NO and 
cGMP levels in identifying subjects with higher arterial stiffness and poor endothelial 
function.  ENOS and NO levels were found to be the most useful variables in the SA 
population. NO level had a better  discriminatory utility  to identify patients with higher 
arterial stiffness [Area Under Curve (AUC) :0.67(SE 0.04), P=0.001] (Figure 5.9) 
whereas  eNOS was appeared to have the greater utility as a marker in discriminating 
people with poor endothelial function [AUC:0.63(0.04),P=0.001] compared to NO[AUC 
:0.62(0.05),P=0.003], and cGMP[AUC:0.51(0.06),P=0.11] levels.  
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Figure 5.9: Receiver Operating Curve analysis of eNOS-NO axis markers 
discriminating higher arterial stiffness amongst SA. 
 
*P value using chi square comparing SA vs. EC, significance at <0.05 level. SA: South Asian, EC: 
European Caucasian 
5.3.7 Analysis of Inflammatory indices  
Serum hsCRP, TNF and IL6 levels were available for 289 individuals (Table 5.8). 
HsCRP levels were significantly higher amongst females (P=0.05), subjects with higher 
BMI (P<0.001) and strokes (P=0.001) but without any ethnic variation. SA stroke 
patients had significantly higher hsCRP levels compared SA controls (P=0.01) (Table 
5.8). TNF level was significantly higher amongst SA stroke patients compared to EC 
(P<0.001) and controls (P<0.001). Both hsCRP levels and TNF levels were significantly 
higher in South Asians with impaired endothelial function and increased arterial stiffness 
(<0.05), (Tables 5.9 and 5.10). In bivariate analysis TNF alpha levels demonstrated a 
weak association with SI (r=0.16, P=0.01) and Δ RI (r= -0.16, P=0.02).     
IL6 level was significantly higher amongst SA compared to EC (P=0.001). SA 
stroke patients had significantly higher IL6 level compared to EC stroke patients 
(P=0.001) and SA controls (P=0.001), (Table 5.8). However IL6 level was comparable 
across endothelial and arterial stiffness tertiles in both ethnic groups.  
NO:     (AUC:0.67(0.03),P=0.001)  
eNOS: (AUC :0.60(0.03), P=0.01) 
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Table 5.8: Indices of inflammation, oxidative stress, thrombosis and dyslipidaemia comparing South Asian vs. European Caucasians  
 
 
 
 
 
 
 
 
 
**P value using Kruskal Wallis test comparing differences across all four groups, * P value using Mann Whitney U test*, comparing SA stroke vs. EC stroke,  
Significance at <0.05 level, FPG: Fasting Plasma Glucose 
 SA Stroke  
(N=97) 
EC Stroke  
(n=60) 
SA Risk 
(n=59) 
SA Healthy  
(n=73) 
P value* P value**  
 
Markers of inflammation 
hsCRP(mmol/l) 2.4(1-6) 1.9(1-7) 1.6(1-3) 1.3(1-3) 0.3 0.01 
TNF α (pg/ml) 162.6(104-215) 67.6(33-126) 108.5(72-153) 95.5(69-156) <0.001 <0.001 
IL6 (pg/ml) 44.6(23-61) 25.1(14-32) 34.6(16-45) 28.1(17-40) <0.001 <0.001 
Markers of endothelial activation & thrombosis 
E-Selectin (ng/ml) 37.5(21-56) 3.3(1-12) 17.7(13-24) 17.6(13-26) <0.001 <0.001 
vWF(u/dl) 109.4(98-120) 106.9(88-129) 130(117-140) 102(83-130) 0.65 <0.001 
Markers of oxidative stress       
Oxidised LDL(u/l) 60.2(36) 41.4(21) 44.5(24) 56.1(22) 0.01 <0.001 
HO(ng/ml) 9.7(8-11) 9.2(6-10) 6.9(6-9) 6.7(5-8) 0.02 <0.001 
Markers of dyslipidaemia 
Apo A (mmol/l) 1.2(0.2) 1.4(0.2) 1.9(0.1) 2.0(0.2) <0.001 0.03 
Apo B (mmol/l) 0.44(0.1) 0.59(0.1) 0.64(0.1) 0.68(0.2) <0.001 <0.001 
Apo B/A 0.3(0.1) 0.4(0.1) 0.3(0.2) 0.3(0.1) 0.2 0.08 
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Table 5.9: Indices of inflammation, oxidative stress, and thrombosis, according 
tertiles of arterial stiffness amongst South Asians  
 
 South Asians (n=229) 
 High Normal P value 
hsCRP (mmol/l) 2 ( 0.9-4.9) 1.3(0.7-3.4) 0.05 
IL6 (pg/ml) 37.1(21-60) 31.7(19-43) 0.2 
TNF (pg/ml) 147(95-229) 109(70-180) 0.02 
VWF (u/dl) 112(100-134) 103(81-130) 0.03 
E-Selectin (ng/ml) 21.1(14-48) 18.5(13-27) 0.08 
HO (ng/ml) 8.6(6.3-11) 7.2(5.6-9.7) 0.05 
oxLDL(u/l) 56.4(29) 53.6(24) 0.5 
 
Table 5.10: Indices of inflammation, oxidative stress, and thrombosis according 
tertiles of endothelial function amongst South Asians 
 
 South Asians (n=229) 
 High Normal P value 
hsCRP (mmol/l) 2.1(1.1-5.6) 1(0.8-1.8) 0.002 
IL6 (pg/ml) 34.6(19-51) 29(19-46) 0.4 
TNF (pg/ml) 132(92-188) 99(70-148) 0.01 
VWF (u/dl) 112(102-135) 102(79-125) 0.01 
E-Selectin (ng/ml) 25.8(15-40) 18(14-27) 0.008 
HO (ng/ml) 9.3(7-11) 6.9(5.5-9.1) 0.003 
oxLDL(u/l) 55(27) 52(20) 0.6 
 
P value using Mann Whitney U test and independent t-test comparing poor vs. good tertiles, significance at 
<0.05 level 
 
5.3.8 Analysis of indices of dyslipidaemia 
SA stroke patients had significantly lower Apo A and B levels compared to EC 
stroke patients (P<0.001) and SA controls (Table 5.8). Apo B/A levels were comparable 
across all groups. On univariate analysis Apo A levels significantly correlated with 
arterial stiffness (r= -0.32, P<0.001).  
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5.3.9 Analysis of indices of oxidative stress and thrombosis 
SA strokes patients had significantly higher HO levels compared to both EC 
(P=0.02) and SA controls (P=0.001) (Figure 5.10). SA with hypertension (total) had 
significantly higher HO levels compared to people without hypertension (P<0.001), but 
this was not apparent in SA stroke patients. HO levels increased in an ordinal fashion 
across sub groups with and without hypertension (Pseudo R-Square=0.0.03, p=0.04) 
(Figure 5.11).  
SA stroke patients had significantly higher oxLDL levels compared to EC stroke 
patients (P=0.01) and SA controls (P=0.001). oxLDL levels were similar across arterial 
stiffness and endothelial function groups in SA (Tables 5.10 and 5.11). SA stroke 
patients had significantly elevated E-Selectin levels compared to EC stroke patients 
(P<0.001) as well as SA controls (P<0.001). There was no significant difference in the 
levels of vWF between SA and EC. However, vWF levels were significantly raised 
amongst South Asians with poor endothelial function and arterial stiffness (Tables 5.10 
and 5.11). In univariate analysis, HO level negatively correlated with endothelial 
function (r= -0.2, P=0.001) and associated with impaired endothelial function [Beta 
(95%CI): -2(-0.4—0.01). P=0.04], but after incorporating age, gender and other CVD 
risk factors into the model, this association became non-significant. In a separate analysis 
hypertension was significantly associated with HO level [Beta (95%CI):0.06(0.01-0.11), 
P=0.007]. On Receiver Operator Characteristic (ROC) curve analysis in the 
discrimination of subjects with poor endothelial function, HO was a better discriminator 
(AUC (95% CI):0.63(0.5-0.7), P=0.001) than IL6, TNF, vWF, HsCRP and E-Selectin 
levels. 
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Figure 5.10: Serum HO-1 concentration comparing South Asians vs. European 
Caucasians 
 
P value using one way ANOVA comparing differences across all four groups, 
significance at <0.05 level, SA:South Asian, EC:European Caucasian. 
Figure 5.11: Serum Haemo Oxygenase concentrations amongst South Asians, in 
relation to stroke and hypertension status 
 
P value using independent t-test comparing SA with and without hypertension,  
p* using ordinal regression comparing increasing trend across four groups Significance at <0.05 level. 
0.40
0.60
0.80
1.00
1.20
L
o
g
 H
O
 c
o
n
ce
n
tr
at
io
n
 (
n
g
/m
l)






SA Stroke  EC Stroke SA Risk     SA Healthy
0.40
0.60
0.80
1.00
1.20
L
o
g
 H
O
 c
o
n
c
e
n
tr
a
ti
o
n
 (
n
g
/m
l)







   Without Hyp               With Hyp    Without Hyp               With Hyp
SA without Strokes SA with Strokes
P= 0.001 
Pseudo R-Square=0.03, p*=0.03 
 
P=0.05 P=0.07 
134 
 
 
5.4  Discussion 
This is the first study to comprehensively investigate the structural and functional 
properties of the arterial wall in a large population of migrant SA stroke survivors. In 
keeping with our first hypothesis, SA stroke survivors had significantly impaired 
endothelial function and increased arterial stiffness compared to age and gender matched 
EC stroke survivors. More importantly, of all the conventional risk factors, glycaemic 
status was independently associated with both arterial stiffness and endothelial function 
abnormalities.  Given that this thesis work previously reported the higher prevalence of 
diabetes amongst SA stroke survivors compared to EC and impact of diabetes on SA 
stroke mortality (Chapter 3), where people with diabetes had poor five-year post-stroke 
survival rates, the present study provides a pathophysiological insight for these findings. 
 There was a significant interaction between diabetes status and South 
Asian ethnicity (Table 5.5). This supports the contention that diabetes status itself may 
explain, many of the vascular aberrancies observed amongst South Asian stroke 
survivors. Hence, not only diabetes is more common amongst SA compared to other 
ethnic groups (Chapter 3), but also a hereditable risk factor in this population 
(Moussouttas, et al., 2006). In the current study more than 40% of the SA stroke 
survivors had evidence of diabetes and more importantly patients with diabetes had the 
greatest vessel wall abnormalities. On the other hand, endothelial dysfunction 
independently associated with arterial stiffness. Thus, part of the remodeling processes 
that have occurred in the vessel wall could be attributed to a primary defect in the 
endothelium (Guerci, et al., 2001). Glycaemic status has an impact on the endothelium-
derived Nitric Oxide (NO) production, causing a blunted smooth muscle relaxation 
response in the small to medium sized vessel walls with a consequent increase in vessel 
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tone, contributing to increased arterial stiffness (Cruickshank, et al., 2002). This 
hypothesis is further supported by our findings of the current analysis where, following 
the administration of GTN, both groups had similar reflective indices compared to those 
produced post-Salbutamol administration indicating similar dilation of the vessels wall in 
both ethnic groups in the presence of adequate NO availability. Nitric Oxide availability 
is increased using GTN rather than Salbutamol as the former is an external NO donor 
drug whilst the latter acts on the beta adrenoreceptors of the endothelium to release 
endogenous NO where the response is based merely on the functional integrity of the 
endothelium.  
The second objective of my study was to investigate the impact of eNOS-NO axis 
indices on structural and functional properties of the arterial wall and pathogenic role of 
these determinants on cerebral haemodynamics and ischaemic strokes. In keeping with 
the second hypothesis, SA stroke survivors had significantly lower eNOS, NO and cGMP 
levels compared to EC and associated with higher arterial stiffness and poor endothelial 
function. Reasons for low levels of eNOS-NO axis parameters amongst South Asian 
stroke survivors in the current study are multi factorial. Possible explanations include 
down-regulation of the eNOS gene expression (Li, et al., 2001), dysfunction of eNOS 
enzymatic activity or heightened degradation of endothelial NO (Davignon and Ganz, 
2004). The eNOS gene is regulated through multiple mechanisms and entails several 
polymorphisms, some of which bear functional consequences. Recently, many vascular 
genetic studies have demonstrated an association between certain eNOS gene 
polymorphisms (G894T, T-786C) and higher cardiovascular risk amongst certain ethnic 
groups (Mitchell, et al., 2007). Given the findings of the current study, it is likely that 
reduced eNOS levels are associated with an aberrant eNOS gene expression amongst the 
South Asian population. Conversely, other inflammatory processes, oxidative stress and 
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pro-thrombotic markers which are known to regulate eNOS gene expression (Yang, et 
al., 2006), and are thought be more prevalent amongst South Asian stroke survivors 
(Miller, et al.,  2005; Kain, et al., 2005) may also have an adverse synchronised impact 
on the eNOS gene expression and consequent NO production. 
In the current analysis, diabetes as a risk factor was significantly associated with 
reduced levels of eNOS-NO parameters. Although there are many possible mechanisms, 
the most likely explanation appears to be that, in the presence of diabetes, NADPH 
oxidase production in the vascular beds is increased, thereby enhancing the production of 
reactive oxygen species and related oxidative stress (Föstermann, et al., 2006). These 
factors are known to increase NO catabolism, impair cGMP activity and lead to 
consequent endothelial damage (Münzel, et al., 2005).  
In keeping with previous studies (Cheng, et al., 2008), current analysis also 
demonstrated the putative link between the endothelium-derived Nitric oxide synthesis 
pathway and vessel wall characteristics. South Asian stroke survivors with very low 
levels of eNOS and NO were demonstrated to have higher arterial stiffness, indicating 
that part of the remodeling processes that has occurred in the vessel is attributed to a 
primary defect in the endothelium (Guerci, et al., 2001) (the inability to produce 
sufficient NO) causing a blunted smooth muscle relaxation response in the small to 
medium sized vessel walls with a consequent increase in vessel tone, contributing to 
increased arterial stiffness (Chowienczyk, et al., 1999). In addition, both NO as well as 
eNOS levels demonstrated the discriminatory capacity to identify people with increased 
arterial stiffness and poor endothelial function. This suggests that these markers may 
have an added utility in the identification of higher risk individuals (especially South 
Asians), enabling refinement of risk stratification in the community setting. This merits 
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further research. This part of the analysis may also provide a biochemical explanation 
(Calver, et al.,1992) for previous observations. 
Systematical investigation of the influence of inflammatory, metabolic and 
oxidative stress related indices on structural and functional properties of the arterial wall 
was the third objective of this study.  In keeping with our third hypothesis, SA stroke 
survivors had significantly deranged biochemical parameters coupled with abnormal 
vascular risk indices such as arterial stiffness and endothelial function. 
 South Asians with stroke were demonstrated to have increased inflammatory 
markers compared to those of EC as well as healthy controls. In particular, TNFα levels 
were significantly raised in South Asians irrespective of the risk factor burden or stroke 
status and coordinated with an increasing level of arterial stiffness and impaired 
endothelial function. As far as we are aware, this is the first study to report an association 
between increased TNF levels and arterial stiffness, although a small number of studies 
have shown improvement of vascular risk indices following anti TNF drug 
administration amongst people with rheumatoid arthritis (Komai, et al., 2008; Cypiene, et 
al., 2007). hsCRP level is the most validated sensitive clinical inflammatory marker in 
current practice and has been reported to be increased amongst healthy SA populations 
compared EC (Somani, et al., 2006). A small number of studies have also demonstrated 
an association between higher hsCRP levels and increased arterial stiffness, but in 
healthy populations who were not on any treatment (Duprez
,
 et al., 2005; Kampus, et al., 
2005). In the current study we did not observe any significant difference amongst SA 
stroke survivors compared to EC. It is likely that cardiovascular risk treatment may have 
an impact on the measurement of hsCRP levels, reducing the expected differences 
between the two ethnic groups. It is interesting to note that this unexpected finding of 
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comparable hsCRP levels but raised IL6 and TNF levels was also similarly reported in an 
ethnicity-based study investigating the differences between Afro-Caribbeans and EC 
healthy subjects (Kalra, et al., 2007).  
In several recent clinical studies, the apolipoproteins levels, which reflect the 
cholesterol balance between potentially
 
atherogenic and anti-atherogenic lipoprotein 
particles, have been
 
reported to be better predictors of CV risk than any of the
 
cholesterol 
indices (Walldius, G. and Jungner, 2006; Thompson, A. and Danesh, J., 2006). SA stroke 
survivors are known to have elevated Apo B to Apo A ratio compared to that of healthy 
SA (Sharobeem, et al., 2007), however its impact on vascular indices had not been 
previously elucidated.  In the current analysis, SA stroke survivors with impaired 
endothelial function and higher arterial stiffness had significantly lower Apo A and B 
levels but comparable Apo B/A ratio compared to EC. It is possible that the impact of 
anti-cholesterol treatment may have influenced the true Apo A and B levels in both SA 
and EC populations but very unlikely to confound the comparative analysis on vascular 
indices, as both groups were on very similar treatment. 
Haem-Oxygenase is a marker of oxidative stress and known to play significant 
role in the development role arthenogenesis (Kapturczak
,
 et al., 2004) and cardiovascular 
disease (Duckers
,
 et al., 2001). Increased levels of HO expression have been found in 
conditions associated with stroke (Chen-Roetling
,
 et al., 2006), coronary artery disease 
(Chen
,
 et al., 2008), diabetes (Adaikalakoteswari, et al., 2006) and hypertension (Botros
,
 
et al., 2005). However, available literature suggests that levels of HO expression may 
demonstrate different functional properties depending on the concentration and 
environment (Suttner
,
 et al., 1999). For example increased HO levels in an 
atherosclerotic tissue or vascular bed indicate a protective role of HO (Juan
,
 et al., 2001) 
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whereas in brain cells increased levels are associated with cell death (Chen-Roetling
,
 et 
al., 2006). In the present analysis Heme oxygenase-1 (HO) levels were significantly 
elevated in SA stroke patients compared to that of controls as well as EC counterparts. 
More importantly, levels of HO were associated with impaired endothelial function. In 
sub group analysis, SA with hypertension had significantly higher HO levels compared 
to normortensives, and hypertensive status independently predicted higher HO levels. 
These findings are consistent with studies demonstrating raised levels of HO amongst 
hypertensives as a consequence of increasing blood pressure rather than the effect 
(Ishizaka, et al., 1996). In addition, SA stroke survivors also had increased oxLDL levels. 
Recent literature suggests that increased levels oxLDL found in atherosclerotic 
conditions have been known to promote HO expressions (Ishikawa
,
 et al., 1996). 
Although this study is not designed to investigate these molecular interactions and 
vascular functions in different tissue beds, elevated levels of both HO and oxLDL 
amongst SA stroke survivors highly suggest increased evidence HO expression, as a 
result of cumulative oxidative stress status, amongst SA patients with strokes compared 
to that of EC counterparts. 
E-Selectin, one of the studied markers of endothelial activation, was significantly 
elevated in SA stroke cohort, however it did not demonstrate any association with vessel 
wall characteristics. However, levels of E-Selectin levels had been reported to be 
comparable in healthy SA compared to that of EC, even though E-Selectin level in a 
higher risk SA population has not been previously investigated. In keeping with the 
previously published studies (Jaumdally, et al., 2007), levels of vWF did not demonstrate 
any ethnic differences. SA stroke patients with poor endothelial function however had 
significant higher vWF levels and, consistent with the current literature, indicating vWF 
as a marker of endothelial dysfunction (Blann, et al., 1993). 
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The present study also demonstrates the clear differences in the distribution of 
stroke subtypes, whereby SA stroke patients had more small vessel disease (lacunar 
infarctions) compared to more prevalent large vessel strokes amongst European 
Caucasians. This is consistent with other published studies (Syed, et al., 2003) 
particularly amongst a stroke population with higher prevalence of diabetes.  However, 
De Silva et al (2007) recently demonstrated higher rates of intracranial large vessel 
disease even amongst patients with lacunar infarctions using intracranial doppler 
imaging. More studies using more sophisticated imaging methods are needed to 
determine exactly the type of intracranial vascular pathology amongst SA stroke patients. 
Limitations: A potential limitation of this study is that this is not a true population-based 
study, as the majority of the patients were recruited from hospitals and the conclusions 
derived from this study may not be applicable for the total South Asian stroke 
populations. As previously reported (Chapter 1), the majority of the SA are known to 
seek hospital admission early (Hsu, et al., 1999) and no differences have been observed 
in hospital admission rates among SA when compared to other ethnic groups. However, 
assignment of ethnicity is not always reliable and the multiple methods used to identify 
SA ethnicity (self reported ethnicity, identification of South Asian names), minimises 
this potential source of bias. Socio-economic differences amongst two ethnic groups may 
have confounded the analysis including factors such as access to health care, but we 
attempted to minimise this effect by recruiting all the patients from areas with a similar 
deprivation index and from the same geographical region. Another potential limitation of 
this study was stroke sub-typing according to Bamford and TOAST classifications was 
performed by a stroke physician based on the available radiological and clinical 
information (CT reports, Duplex scan reports, and clinical details) at the time of the 
presentation. In our study, 12.3% of the SA and 6.7% of the EC had normal CT scans. 
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One of the reasons for apparently higher normal scan percentages in this study could be 
due very early imaging in some of these patients. In addition, CT scans of the smaller 
percentage of patients who had lacunar infarctions would have been reported as ―normal‖ 
given that this study did not carry out any specialised imaging techniques such as        
MR /CT angiography, subtraction or perfusion-imaging techniques (Anderson, et al., 
1994). There was also discrepancy in the percentages of larger and smaller vessel strokes 
between the two classifications. The reason for this could be multi-factorial, including 
observer and classification errors. An integral disagreement between these two 
classifications is known to exist and had also been reported in previous population based 
studies as well as randomized clinical trials (Anderson, et al., 1994; Lindenstrom, et al., 
2001). The use of more sophisticated imaging techniques (MRI, MR angiography) may 
minimise these errors as previously mentioned. The possible classification errors due to 
bias were minimised by rechecking the stroke types against a standard questionnaire and 
reviewing the case notes accordingly by a second physician.  The documented prevalence 
of cardiovascular risk profile (PVD) was based on the patient‘s past medical history and 
the available evidence from case notes. We didn‘t perform any diagnostic test such as 
ankle brachial index measurements. This may have underestimated the true prevalence 
rates in both ethnic groups. 
Limitations of the current study include the use of single indirect indices to 
measure endothelial function and arterial stiffness. Four percent of the patients didn‘t 
manage to undergo complete vascular assessment protocol due to practical difficulties 
and demonstrate the limitation of using this technique in routine clinical practice. We 
advised patients to withhold most of the potent vasodilatory medications at least 48 hrs 
prior to the vascular measurements. However anti-platelet medication Dipyridamole, 
which is known to have a weak micro-vascular vasodilatory effect, was not asked to stop 
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due to ethical reasons and patients safety. This may have confounded the analysis. A 
study design which utilises combined methods of endothelial assessments (for example, 
FMD, Endothelial progenitor cells, von Willebrand factor analysis) would provide more 
comprehensive results. 
 In addition,  some stroke patients had difficulties in standing up straight (<5%) 
and thus standing height measurements where not possible to be performed, so lying 
values or previous measurements documented on the case notes were used for the 
analysis. However, their weight was appropriately measured using a chair scale. The 
diagnosis of diabetes mellitus was also made on the basis of fasting blood glucose 
measurements and available documented evidence. None of the volunteers had an oral 
glucose tolerance test for specific disease exclusion 
In conclusion, SA stroke survivors in the current hospital-based study have 
higher small vessel disease related cerebrovascular accidents compared to EC. 
Underlying glycaemic status in SA demonstrated to have a disproportionate impact on 
the vascular system, leading to aberrant remodelling of the vessel wall characteristics.  
South Asian stroke survivors were also found to have aberrances related to the 
endothelium-derived nitric oxide synthesis axis, thereby exerting a major impact on 
vessel wall characteristics. More research is warranted to further investigate the 
biochemical and genetic regulation of the eNOS-NO axis amongst South Asians. 
In addition, the results of this study indicate that there are important ethnic 
differences in the markers of inflammation, oxidative stress and metabolic status, where 
clustering effects of these examined indices (Forouhi, et al., 2001) are likely to have an 
aberrant impact on the reported abnormal vessel wall characteristics amongst SA stroke 
survivors. Indeed, adverse diet and lifestyle differences observed in migrant SA may 
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further augment this unfavourable risk profile (Lean, et al., 2001). However, it appears 
that conventional risk factors, such as diabetes and hypertension, remain as the most 
detrimental factors in the aetiology of cerebrovascular disease in South Asians. The 
conclusions derived from this hospital-based study may not be generalisable to the total 
South Asian stroke population and would merit further investigation in a large population 
based study.
 5
 
 
  
                                                 
5Gunarathne, A., Patel, J.V., Kausar, S., et al.(2009).Glycemic status underlies increased arterial stiffness 
and impaired endothelial function in migrant South Asian stroke survivors compared to European 
Caucasians: pathophysiological insights from the West Birmingham Stroke Project. Stroke, 40:2298-306 
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Chapter 6 : General Discussion  
This thesis addressed several questions concerning the increased burden of 
cerebrovascular disease amongst the migrant South Asian population living in the United 
Kingdom using a number of cross-sectional, retrospective, prospective, case control and 
laboratory-based studies on stroke epidemiology and underlying pathophysiology.  
6.1 Discussion Summary: 
6.1.1  Prevalence of conventional cardiovascular risk profile in South Asians stroke 
survivors and impact on all cause mortality 
Current literature appears to indicate that South Asians to have higher prevalence 
of diabetes and hypertension when compared to European Caucasians (Chapter 1). This 
was confirmed in the initial registry-based study, looking at a large South Asian stroke 
population. Further, this study provided insights into the changing CVD risk profile 
amongst South Asian stroke survivors over the last decade. The observed increased 
prevalence of both hypertension and diabetes might be explained by the fact that there 
has been improvement in the identification of risk factors among stroke patients. In 
Chapter 3, the magnitude and impact of risk from cardiovascular comorbidities on 
survival rates amongst South Asian stroke patients was investigated. Mortality following 
a stroke is governed by disease severity as well as other comorbidities, which have a 
direct impact on recovery rates.  In this longitudinal analysis, 56% of the South Asian 
stroke patients were diabetic and cumulative survival at 5 years was markedly poorer in 
those persons with diabetes. This demonstrates the adverse impact of diabetes on long-
term stroke outcomes amongst South Asians. 
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6.1.2  Indices of arterial stiffness in healthy South Asians compared to the general 
population 
Literature review on arterial stiffness and ethnicity (Chapter 1.6) highlighted the 
significant paucity of available data on indices of arterial structure and function amongst 
healthy South Asians as well South Asians with established cardiovascular or 
cerebrovascular diseases.  
In the first case control study, the principal objective was to determine the 
structural characteristics of the vessel wall amongst healthy SA compared to that of EC. 
It was hypothesised that there could be a markedly earlier progression of disease in South 
Asians, indicating that the pathogenesis of sub-clinical atherogenesis and premature 
arteriosclerosis could become manifest even in apparently healthy individuals. My data 
show that apparently healthy South Asians to have higher arterial stiffness compared to 
that of age- and gender-matched European Caucasians. More importantly, mean arterial 
pressure was a significant independent predictor of arterial stiffness. In an exploratory 
analysis, South Asians were demonstrated to have a greater arterial stiffness for a given 
blood pressure category after adjusting for other comorbidities including age. Some of 
the possible reasons for this paradox of higher arterial stiffness despite lower mean 
arterial pressure levels in South Asians have been discussed in detail in Chapter 4 and 
merits further investigations.  
6.1.3  Stroke characteristics amongst South Asian stroke survivors 
Very few previous studies have reported data on stroke subtypes in south Asians. 
In the current study, an attempt was made to classify strokes according Bamford and 
TOAST classifications. The present hospital-based study demonstrates a clear difference 
in the distribution of stroke subtypes, whereby SA stroke patients had more small vessel 
disease (lacunar infarctions) compared to more prevalent large vessel strokes amongst 
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European Caucasians. This is consistent with other published studies and given higher 
prevalence of diabetes amongst South Asians. However, as previously highlighted, the 
used classification methods have potential limitations.  
6.1.4  Indices of arterial stiffness and endothelial dysfunction in South Asian stroke 
survivors  
 The pathophysiology of excess cerebrovascular disease mortality amongst 
South Asian stroke survivors had not been previously investigated. Therefore the 
objective of the second case control study was to examine the structural and functional 
vessel wall characteristics amongst the higher CVD risk South Asian stroke population. 
My data demonstrate that SA stroke survivors to have significantly impaired endothelial 
function and increased arterial stiffness compared to an age and gender matched EC 
population, results which, to the author‘s knowledge, have not previously been replicated 
in other studies. More importantly, of all the conventional risk factors, glycaemic status 
independently associated with both structural and functional vascular abnormalities.   
Given the higher prevalence of diabetes amongst SA stroke survivors compared 
to EC and impact of diabetes on SA stroke mortality (Chapter 3) where people with 
diabetes had poor five year post-stroke survival rates, in this chapter we were able to 
provide possible pathophysiological explanations for findings, that the authors have 
previously reported. According to the interaction analysis of South Asian ethnicity and 
Diabetes status on vascular parameters, Diabetes status and SA ethnicity demonstrated a 
significant interaction in determining increased arterial stiffness but not with impaired 
endothelial function. Reason for this observation could be multi-factorial, including 
underlying aberrant genetic susceptibility and other socio-economic factors. This study 
also indicated that part of the remodeling processes that have occurred in the vessel wall 
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could be attributed in part to a primary defect in the endothelium and consequent but 
related Nitric Oxide availability (eNOS – NO axis).  
6.1.5  Possible biochemical basis for abnormal vessel wall characteristics amongst 
South Asian stroke survivors 
 The biochemical basis for abnormal vessel wall characteristics amongst 
South Asians had not been previously investigated. Recognising the results of the 
previous study (Chapter 5), I specifically investigated the cascade of endothelially-
derived nitric oxide production and its relation to the structural and functional properties 
of the vessel wall, a relationship which may increases the susceptibility to ischaemic 
strokes amongst South Asians. In keeping with the original hypothesis, SA stroke 
survivors had significantly lower eNOS, NO and cGMP levels compared to EC, coupled 
with an increasing gradient of higher arterial stiffness and poor endothelial function. 
More importantly, diabetes was significantly associated with reduced levels of eNOS-NO 
parameters.  
Given the higher prevalence of diabetes (Chapter 3) amongst SA stroke survivors 
compared to EC and the impact of diabetes on increased arterial stiffness (Chapter 5) and 
SA stroke mortality (Chapter 3), the results of this study further emphasize the 
importance of diabetes as perhaps the single most important risk factor amongst South 
Asians and this may provide some pathophysiological and biochemical explanation for 
previous observations. Possible reasons for low levels of eNOS-NO axis parameters in 
this study amongst South Asian stroke survivors have previously been discussed 
(Chapter 5.3.6) and merit further research. The analysis of data from this sub study 
highlights the importance of further investigating the reasons for impaired eNOS activity 
and reduced NO availability, in particular at the examination of degradation of 
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endothelial NO as a result of adverse metabolic, inflammatory or oxidative stress related 
mechanisms.  
6.1.6  Impact of inflammatory, metabolic and oxidative stress related indices on 
structural and functional properties of the arterial wall in South Asian stroke 
survivors. 
Building on the results of the previous studies, a cross-sectional study was carried 
out to systematically investigate the influence of inflammatory, metabolic and oxidative 
stress related indices on structural and functional properties of the arterial wall in the 
migrant SA stroke population. This study suggests that the combined effects of 
metabolic, inflammatory and oxidative stress related abnormalities may contribute to the 
reported (Chapter 5.3.7) abnormal vessel wall characteristics amongst SA stroke 
survivors. However it is likely that these factors may have an adverse impact on the 
vessel wall properties directly or cumulatively with the already established conventional 
risk factor burden.  
In this study, Haem-Oxygenase was used as a marker of oxidative stress, which is 
also known to play significant role in the development of atherogenesis and 
cardiovascular disease. In my analysis, HO levels were significantly higher in SA with 
hypertension compared to normortensives. These findings have important implications 
for the SA stroke population (Chapter 5.3.9), again highlighting the importance of blood 
pressure regulation in CVD risk reduction. In this study, I concluded that the clustering 
effects of the metabolic, inflammatory and oxidative stress-related abnormalities may 
contribute to the reported abnormal vessel wall characteristics amongst SA stroke 
survivors. Conventional risk factors such as diabetes and hypertension, which are more 
prevalent amongst SA still remain as the most detrimental factors in the aetiology of 
cerebrovascular disease.  
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6.1.7  The utility of novel non-invasive vascular indices for early identification of 
high risk populations 
 As previously highlighted, South Asians, both with or without established 
risk factors, have a disproportionately higher cardiovascular risk compared to that of 
European Caucasians. However, currently available risk estimation methods are known 
to underestimate the actual risk within high risk populations. More importantly, the 
majority of available methods have proved to be both technically difficult to perform and 
time consuming, specifically amongst large populations and in community settings, 
factors that led to the two cardiovascular risk stratification sub studies within this thesis 
work. The aim was to assess the usefulness of non-invasive imaging technique (digital 
pulse wave form analysis) to examine the underlying pathophysiological processes for 
early identification of high risk populations. My data ( 2.6.3) appear to demonstrate the 
added utility of the SI and RI in identifying higher risk groups compared to the 
conventional cardiovascular risk indices. More importantly, this study highlights the 
importance of the use of novel risk indices to identify apparently healthy, but with 
underlying higher CHD/CVD risk, populations who may be missed in traditional risk 
assessment processes  
6.2 Limitations Summary: 
Limitations, which are specific to each sub study, have been previously discussed. 
Please see sections 2.6.3.5, 3.4.1, 4.4, and 5.4 for details.  In summary, a major limitation 
of this thesis is that it is not a true population-based study, and the conclusions derived 
may not be applicable for the total South Asian stroke population. Development of a 
stroke registry based on ICD coding and hospital stroke admissions may have caused a 
selection bias and under-estimation of stroke rates. However, it is unlikely these errors 
had a significant impact on the comparative analysis, as they would have equally affected 
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both ethnic groups. Another potential limitation of this study is that stroke sub-typing 
according to Bamford and TOAST classifications was performed purely based on 
available CT and clinical information and may not have the power to identify vascular 
characteristic in stroke subtypes. The use of sophisticated imaging techniques may have 
aided more accurate stroke subtype classification. In addition, the use of indirect indices 
to measure endothelial function and arterial stiffness within this thesis is a potential 
limitation, but these methods have been validated previously and used in many other 
clinical studies. The combined use of other complex vascular assessment methods such 
as PWV and FMD may have given a comprehensive and more accurate assessment of the 
vascular structure and function (Chapter 5.4). I performed many subgroup analyses in 
addition to the original hypothesis testing and this may have caused ―multiple 
comparisons‖. I have not used any specific statistical test such as Bonferroni 
correction to counteract and minimise this effect. This is a potential limitation of the 
study analyses.   
 
6.3  Key findings and Conclusions   
6.3.1 Epidemiological data available on South Asian stroke survivors remain 
limited and the interpretation and appraisal of available studies is restricted by 
methodological weaknesses such as cross-sectional design, small sample sizes, poor case 
ascertainment methods and recording, publication biases.  
6.3.2 My data indicate that the prevalence of diabetes and hypertension are 
higher amongst South Asians stroke patients and there has been a reduced decline in 
stroke admissions in South Asians compared to European counterparts. (Chapter 3) 
These observed ethnicity related disparities warrant further investigation 
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6.3.3 Analysis of registry data (Chapter 3) show that five year all-cause 
mortality in South Asians with ischaemic stroke is associated with presence of diabetes 
mellitus and highlights the possible benefits of early and intensive CVD risk 
modification strategies amongst South Asian stroke survivors.  
6.3.4 A key finding from this hospital-based study was that South Asian stroke 
survivors (when compared to EC) have a higher prevalence of small vessel disease 
strokes, which appears to be related to underlying glycaemic status (Chapter 5).  
Glycaemic status appears to exert a disproportionately negative impact on the vascular 
system, leading to aberrant vessel wall characteristics. There was however a significant 
interaction between diabetes status and South Asian ethnicity. This supports the 
contention that diabetes status itself may explain many of the vascular aberrancies 
observed amongst South Asian stroke survivors.   
6.3.5 My data show that South Asian stroke survivors to have abnormalities 
related to the endothelium-derived nitric oxide synthesis axis, exerting a major impact on 
vessel wall characteristics (Chapter 5). In addition there were important ethnic 
differences in the markers of inflammation, oxidative stress and metabolic status. 
However only HO, TNF alpha and Apo A levels had significant independent associations 
with vessel wall characteristics amongst South Asians.  In particular, HO was a better 
indicator discriminating South Asian stroke patients with poor endothelial function 
(when compared to all other markers studied) indicating its potential usefulness as a basis 
for finer CVD risk stratification.  
6.3.6 Assessment of the vascular parameters in an apparently healthy South 
Asian population demonstrated, South Asians to have increased systemic arterial 
stiffness compared to European Caucasians (Chapter 4). There was an adverse and 
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disproportional impact of age and mean arterial pressure on the vascular system in South 
Asians. Pathophysiological differences in vessel wall characteristics even amongst 
healthy South Asians may explain their increased susceptibility to vascular disease 
including strokes.  
6.3.7 My data appear to indicate the added utility of Indices of arterial stiffness 
(SI) for better CVD risk stratification (Chapter 2.6.3). In addition, DVP analysis 
technique also appears to provide a non-invasive method of measuring vessel wall 
characteristics in clinical practice. 
In conclusion, of all the studied risk factors, diabetes appears to be the most 
detrimental modifiable risk factor in the aetiology of cerebrovascular disease amongst 
South Asians and highlights the benefits of early intensive CVD risk modification 
strategies amongst South Asian stroke survivors with diabetes.   
6.4   Recommendation for future research 
6.4.1 As acknowledged above, the conclusions derived from this thesis are 
based on hospital-based studies and may not be directly generalisable to the total South 
Asian stroke population. Therefore, the important findings of this thesis need to be 
repeated in a large population-based study, the design of which is also capable of 
examining the ethnicity related socio-economic, environmental and genetic factors. 
6.4.2 It was repeatedly demonstrated that diabetes is a detrimental risk factor in 
the South Asian stroke population. However, it remains unclear exactly how diabetes 
contributes to abnormal vessel wall characteristics leading to higher all-cause mortality. 
Possible explanations such as underlying aberrant molecular mechanisms and genetic 
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polymorphisms influencing higher arterial stiffness and impaired endothelial function 
amongst South Asians need to be investigated. 
6.4.3 In the current study, stroke sub-classification was performed according the 
Bamford and TOAST classifications based on the CT imaging and available clinical data. 
However future studies using more sophisticated imaging methods (Diffusion weighted 
CT/MRI, intracranial Doppler imaging and CT angiography) are needed to determine 
more exactly the type of intracranial vascular pathology amongst SA stroke patients. 
6.4.4 South Asian stroke survivors had significantly lower eNOS and NO levels 
positively correlated with an increasing gradient of higher arterial stiffness and poor 
endothelial function. Given that genetic studies on vascular stiffness have recently 
indicated an association between certain eNOS gene polymorphisms (G894T, T-786C) 
and higher cardiovascular risk amongst certain ethnic groups, expression of the eNOS 
gene amongst members of the South Asian population should be investigated. 
6.4.5 Whilst indices of arterial stiffness (SI) measured using the DVP technique 
appeared to demonstrate a discriminatory usefulness in identifying members of high risk 
populations, there is a need for further studies to assess the external validity of the 
stiffness index and its ability to prospectively predict clinical outcomes to a greater 
degree than existing CVD risk score estimations. Further studies are also needed to 
assess the usefulness of arterial stiffness to monitor treatment efficacy and disease 
progression as well as ease of use and cost effectiveness.  
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Appendix 1: Ethics Approval from the Sandwell & West Birmingham ethics committee. 
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Appendix 2: von Willebrand Factor assay procedure 
 
 Microtitre plate coated overnight at 4oC with primary antibody (Rabbit anti-
human vWf polyclonal antiserum, DakoCytomation, UK, 35μl diluted in 20ml 
coating buffer, 100μl per well).Wash plate x3 
 Samples (citrated plasma), and standards with known concentration of vWF 
maintained within the laboratory (250IU/dl, 150IU/dl, 100IU/dl (WHO standard), 
50IU/dL) defrosted. Samples diluted 1/40 with PBS tween. 100μl of standards 
and samples added to wells in duplicate and incubated for 1 hour at room 
temperature. Wash plate x3 
 Conjugation with secondary antibody (Rabbit anti-human vWf polyclonal 
antiserum conjugated to horse radish peroxidase, DakoCytomation, UK, 35ul 
diluted in 20ml coating buffer, 100μl per well) incubated for 45 minutes at room 
temperature. Wash plate x3 
 Substrate produced by mixing 20ml Citrate Phosphate buffer with one 10mg 
ortho-phenylamine diamine tablet and 10μl hydrogen peroxide. 100μl of substrate 
added to each well.  
 Colour development stopped after approximately 30 seconds with 100μl/well stop 
solution. 
 Read with ELISA plate reader set to 492nm. 
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Appendix 3: E-Selectin assay procedure 
 
 Microtitre plate coated overnight at 4oC with primary antibody (Sheep anti-
human E-Selectin polyclonal antiserum, R&D systems, UK, diluted to 1μg/ml in 
coating buffer, 100μl per well). Wash plate x3 
 Samples (citrated plasma), and recombinant standard (recombinant 59kDA 
portion of the extracellular domain of E-Selectin, R&D systems) defrosted. 
Standard diluted to 50ng/ml and 200μl added to the plate in duplicate, then seven 
serial 2/1 dilutions carried out on the plate. Samples diluted 1/5 with PBS tween. 
100μl samples added to wells in duplicate and incubated for 2 hours at room 
temperature. Wash plate x3 
 Addition of secondary antibody (Biotinylated Mouse monoclonal anti-human E-
selectin, R&D systems, diluted to 250ng/ml in PBS tween, 100ul per well) 
incubated for 2 hours at room temperature. Wash plate x3 
 Conjugation with streptavidin-horseradish peroxidase (R&D systems) diluted 
1/100 with PBS tween, 100μl per well, incubate for 20 minutes at room 
temperature in the dark. NB. streptavidin binds avidly to biotin on the secondary 
antibody Wash plate x3 
 Substrate produced by mixing equal volumes of Substrate reagent A (stabilised 
peroxidase solution) and B (Stablised chromogen solution) – R&D systems - and 
immediately adding 100μl to each well. Colour development stopped after 3-5 
minutes with 100μl/well stop solution. 
 Read with ELISA plate reader set to 450nm. 
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Appendix 4: TNF assay procedure  
 
 Microtitre plate coated overnight at 4oC with primary antibody (Mouse anti-
human TNFα, (Duo Set – R&D systems), diluted to 4.0μg/ml with PBS, 100ul 
per well). Wash plate x3 
 Blocking Step: Block with 5% Marvel milk substitute (500mg per 10ml PBS) 
200μl per well, 2 hours at room temperature. Wash plate x3 
 Samples (EDTA plasma) defrosted. Standard (Duo Set, R&D systems) diluted to 
1000pg/ml and 200μl added to the plate in duplicate, then six serial 2/1 dilutions 
carried out on the plate. Samples diluted to 1/5 with PBS Tween, 100μl added to 
wells in duplicate and incubated for 2 hours at room temperature. Wash plate x3 
 Addition of secondary antibody (Biotinylated goat anti-human TNFα, Duo Set, 
R&D systems, diluted to 75ng/ml with PBS tween, 100μl per well) incubated for 
2 hours at room temperature. Wash plate x3 
 Conjugation with streptavidin-horseradish peroxidase (R&D systems) diluted 
1/100 with PBS tween, 100μl per well, incubate for 20 minutes at room 
temperature in the dark. NB. Streptavidin binds avidly to biotin on the secondary 
antibody. Wash plate x3 
 Substrate produced by mixing equal volumes of Substrate reagent A (stabilised 
peroxidase solution) and B (Stablised chromogen solution) – R&D systems - and 
immediately adding 100μl to each well.  
 Colour development stopped after maximum 5 minutes with 50μl/well stop 
solution. 
 Read with ELISA plate reader set to 450nm. Any samples below detection limit 
repeated using neat plasma instead of 1/5 dilution. 
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Appendix 5: Interleukin 6 assay procedure  
 
 Microtitre plate coated overnight at 4oC with primary antibody (monoclonal 
mouse anti-human IL-6 antibody R&D systems, UK, diluted to 4μg/ml with 
coating buffer, 100μl per well). Wash plate x3 
 Blocking Step: Block with 4% Marvel milk substitute (400mg per 10ml PBS) 
100μl per well, 1½ hours at room temperature Wash plate x3 
 Samples (citrated plasma) and standard (R&D systems) defrosted. Standard 
diluted to 1250pg/ml and 200ul added to the plate in duplicate, then nine serial 
2/1 dilutions carried out on the plate. Samples undiluted. 100μl samples added to 
wells in duplicate and incubated for 2 hours at room temperature. Wash plate x3 
 Addition of secondary antibody (Biotinylated goat anti-human IL-6, R&D 
systems, diluted to 50ng/ml with PBS tween, 100μl per well) incubated for 1½ 
hours at room temperature. Wash plate x3 
 Conjugation with streptavidin-horseradish peroxidase (R&D systems) diluted 
1/100 with PBS tween, 100μl per well, incubate for 20 minutes at room 
temperature in the dark. NB. streptavidin binds avidly to biotin on the secondary 
antibody  
 Substrate produced by mixing equal volumes of Substrate reagent A (stabilised 
peroxidase solution) and B (Stablised chromogen solution) – R&D systems - and 
immediately adding 100μl to each well.Colour development stopped after 30 
minutes with 100μl/well stop solution. 
 Read with ELISA plate reader set to 450nm. 
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Appendix 6: Nitrate assay procedure 
 Sample preparation 
All samples were diluted 2-fold using Reaction Buffer (1X). (100 ml sample + 100 
ml Reaction Buffer (1X). 
 Reagent preparation 
All reagents were brought (except Nitrate Reductase) to room temperature before use. 
Distilled water was used when reconstituting to avoid nitrite/nitrate contamination. 
 Used Reagents: 
o Microplates (Part R80-0144) - Two 96 well microplates with removable strips. 
o Nitrate Reductase (Part R80-1347) - 1 vial of lyophilized Nitrate Reductase, 
desiccated. 
o Nitrate Reductase Storage Buffer (Part R80-0255) - 4 mL of a buffer containing 
preservatives. 
o NADH (Part R80256 - inner vial; Part R80-0258 - bottle) - 2 vials of lyophilized 
reduced -Nicotinamide adenine dinucleotide, desiccated.  
o Nitrite Standard (Part R80-0224) - 0.5 mL of a Sodium Nitrite solution (2000 
_mol/L) with preservative. 
o Nitrate Standard (Part R80-0223) - 0.5 mL of a Sodium Nitrate solution (1000 
_mol/L) with preservative. 
o Reaction Buffer Concentrate (10X) (Part R80-0257) - 30 mL of a 10-fold 
concentrated buffer containing detergent and preservative. 
o Griess Reagent I (Part R80-0227) - 12 mL of Sulfanilamide in 2 N HCl. 
o Griess Reagent II (Part R80-0228) - 12 mL of N-(1-Naphthyl) ethylenediamine in 
2 N HCl. 
 NADH Reagent 
1. Reconstitution – NADH was reconstituted with 1.0 mL distilled water. NADH was 
allowed to sit for 3 minutes with gentle agitation prior to use and was kept on ice for 
the duration of the assay. 
2. Dilution – 900ml of NADH was diluted with 1.8 mL of distilled water and kept on 
ice for the duration of the assay. 
 Nitrate Reductase 
1. Reconstitution - Nitrate Reductase was reconstituted with 1 mL Nitrate Reductase 
Storage Buffer. It was vortexed vigorously and was allowed to sit for 15 minutes at 
room temperature. 2. Dilution - Nitrate Reductase was diluted with 10ml of the 
reaction buffer and was placed on ice and was used within 15 minutes of dilution. 
 Assay steps 
1. All reagents were prepared and samples as described previously 
2. 200 ml of Reaction Buffer (1X) was added to the Blank wells. 
3. 50 ml of Reaction Buffer (1X) was added to the zero standard wells. 
5. 50 ml of Nitrate Standard or sample was to the remaining wells. 
6. 25 ml of NADH was added into all standard and sample wells. 
7. 25 ml of Nitrate Reductase was added into all standard and sample wells and was 
mixed well and cover with the provided adhesive strip.8. Incubated for 30 minutes at 
37° C.9. 50 ml of Griess Reagent I was added to all wells except Blank wells. 10.50 
ml of Griess Reagent II was added to all wells except Blank wells. Mixed well by 
tapping the side of the plate gently.11. Incubated for 10 minutes at room 
temperature.12. Optical density (OD) was determined using a microplate reader set 
at540 nm. 
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Appendix 7: eNOS assay procedure 
 Used Reagents: 
o eNOS Microplate (Part 890702) - 96 well polystyrene microplate (12 strips of 8 
wells) coated with a monoclonal antibody against eNOS. 
o eNOS Conjugate (Part 890703) - 21 mL of polyclonal antibody against eNOS 
conjugated to horseradish peroxidase, with preservatives. 
o eNOS Standard (Part 890704) - 40 ng of recombinant human eNOS in a 
buffered protein base with preservatives, lyophilized. 
o Calibrator Diluent RD5K (Part 895119) - 21 mL of a buffered protein base with 
preservatives. 
o Wash Buffer Concentrate (Part 895003) - 21 mL of a 25-fold concentrated 
solution of buffered surfactant with preservatives. 
o Colour Reagent A (Part 895000) - 12.5 mL of stabilized hydrogen peroxide. 
o Colour Reagent B (Part 895001) - 12.5 mL of stabilized chromogen 
(tetramethylbenzidine). 
o Stop Solution (Part 895032) - 6 mL of 2 N sulphuric acid. 
 Reagent preparation 
All the reagents were brought to room temperature before use. 
Wash Buffer – Was warmed to room temperature and was mixed gently until the 
crystals have completely dissolved. 20 mL Buffer was diluted with 480 ml of distilled 
water to prepare 500 mL of Wash Buffer. 
Substrate Solution - Colour Reagents A and B was mixed together in equal volumes 
To be used within 15 minutes  
eNOS Standard – 1ml of eNOS standard was reconstituted with 1 mL of distilled 
water. This reconstitution produces a stock solution of 40,000 pg/mL. Standard was 
allowed to sit for a minimum of 15 minutes with gentle agitation prior to making 
dilutions.900 μL of Calibrator was pipetted to the diluent RD5K (4000 pg/mL tube). 
500 μL of the Calibrator was Pipetted into the remaining tubes. Stock solution was 
used to produce a dilution series. The 4000 pg/mL standard used as the high standard. 
Calibrator Diluent RD5K serves as the zero standard (0 pg/mL). 
 Assay procedure: 
1. all the reagents, working standards and samples were prepared  
2. 100 μL of Assay Diluent RD1W was added to each well. 
3. 100 μL of standard, control, and sample was added per well and incubated for 2 
hours at room temperature on a horizontal orbital microplate shaker (0.12‖ orbit) 
set at 500 ± 50 rpm. 
4. Each well was aspirated and washed repeatedly three times by filling each well 
with Wash Buffer (400 μL) using a squirt bottle, multi-channel pipette. After the 
last wash, any remaining was removed by decanting. Plate was inverted and 
blotted against clean paper towels. 
5. 200 μL of eNOS conjugate was added to each well. And kept for 2 hours at room 
temperature on the shaker. 
6. aspiration/wash step was repeated as in step 4. 
7. 200 μL of Substrate Solution was added to each well and incubated for 30 
minutes at room temperature.50 μL of Stop Solution was added to each well.  
8. Optical density of each well was determined within 30 minutes, using a 
microplate reader set to 450 nm.  
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Appendix 8: cGMP assay procedure 
 Used Reagents: 
o Goat Anti-rabbit Microplate - 96 well polystyrene microplate (12 strips of 8 
wells) coated with a goat anti-rabbit polyclonal antibody. 
o cGMP Conjugate - 6 mL/vial of cGMP conjugated to horseradish peroxidase 
with preservatives and red dye.  
o cGMP Standard - 5000 pmol/vial of cGMP in buffer with preservatives, 
lyophilized.  
o Primary Antibody Solution - 6 mL/vial of rabbit polyclonal antibody to 
cGMP in buffer with blue dye and preservatives.  
o Calibrator Diluent RD5-5 - 21 mL/vial of a buffered protein solution with 
preservatives.  
o Wash Buffer Concentrate - 21 mL/vial of a 25-fold concentrated solution of 
buffered surfactant with preservatives.  
o Colour Reagent A - 12.5 mL/vial of stabilized hydrogen peroxide.  
o Colour Reagent B - 12.5 mL/vial of stabilized chromogen 
(tetramethylbenzidine).  
o Stop Solution - 6 mL/vial of 2 N sulphuric acid. 
 Reagent preparation  
o Substrate Solution - Colour Reagents A and B was mixed together in equal 
volumes to be used within 15 minutes of use.  
o cGMP Standard - The cGMP Standard was reconstituted with 1.0 mL of 
distilled water. This reconstitution produces a stock solution of 5000 pmol/mL. 
standard was mixed to ensure complete reconstitution and allowed to sit for a 
minimum of 15 minutes with gentle agitation prior to making dilutions. The 
500 pmol/mL standard was used as the high standard and Calibrator Diluent 
RD5-5 or served as the zero standard 
 Assay procedure: 
1. All the reagents, working standards and samples were prepared as directed in 
the previous sections. 
2. 150ml of the appropriate diluent was added to the NSB wells and 100 ml to the 
zero standard (B0) wells. Calibrator Diluent RD5-5 used  
3. 100 ml of Standard, control, sample was added to the remaining wells. 
4. 50ml of cGMP conjugate was added to each well. Colour changed to red 
colour. 
5. 50ml of the Primary Antibody Solution was added to each well (excluding the 
NSB wells). All wells except the NSB wells became violet in colour.  
6. Incubated for 3 hours at room temperature on a horizontal orbital microplate 
shaker 500 rpm. 
7. Each well was aspirated and washed (4x) using the wash Buffer 
8. After the last wash, any remaining was removed by decanting. Plate was 
inverted and blotted against clean paper towels.200 ml of Substrate Solution was 
added to each well and Incubated for 30 minutes at room temperature on the 
bench top. 50 ml of Stop Solution was added to each well. The colour in the wells 
changed from blue to yellow. Optical density of each well was determined within 
30 minutes, using a microplate reader set to 450 nm.  
  
163 
 
References: 
 
Abrham, J.(1971). Aspects of cerebrovascular disease in India: India:Diocesan 
Press. 
 
Achaya, K.T. (1994). Indian Food: A Historical Companion. United States of 
America: Oxford University Press. 
 
Adaikalakoteswari, A., Balasubramanyam, M., Rema, M., et al. (2006). Differential 
gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with 
Type 2 diabetes and microangiopathy.Diabetes Medicine,23:666-74. 
 
Adams, H.P. Jr, Bendixen, B.H., Kappelle, L.J.,et al.,(1991).Classification of subtype 
of acute ischaemic stroke. Definitions for use in a multicenter clinical trial. TOAST. 
Trial of Org 10172 in Acute Stroke Treatment.Stroke,24:35-41. 
 
Adji, A. & O'Rourke, M.F.(2004).Determination of central aortic systolic and pulse 
pressure from the radial artery pressure waveform. Blood Pressure Monitoring,115-
121. 
 
Agyemang, C., Bhopal, R., Redekop, W.K.(2007).Does the pulse pressure in people 
of European, African and South Asian descent differ? A systematic review and meta-
analysis of UK data. Journal of Human Hypertension, 3:22. 
 
Ahdieh, L. & Hahn A.(1996). Use of the terms 'race', 'ethnicity', and 'national 
origins'. Ethnicity and Health, 1:95-8. 
 
Ajjan, R., Carter, A.M., Somani, R., et al.(2007).Ethnic differences in cardiovascular 
risk factors in healthy Caucasian and South Asian individuals with the metabolic 
syndrome.Journal of  Thrombosis & Haemostasis,5:754-60. 
 
Al Suwaidi, J., Hamasaki, S., Higano, S.T., et al.(2000).Long-term follow-up of 
patients with mild coronary artery disease and endothelial dysfunction. 
Circulation,101:948-954. 
 
Allchin, B.& Allchin, F.R.(1997).Origins of a civilization: the prehistory and 
early archaeology of South Asia, New Delhi :Viking Penguin Books India. 
 
Ameriso, S.F., Villamil, A.R., Zedda, C., et al.(2005).Heme oxygenase-1 is expressed 
in carotid atherosclerotic plaques infected by Helicobacter pylori and is more 
prevalent in asymptomatic subjects. Stroke,36:1896-900. 
 
Anand, S.S., Yusuf, S., Vuksan, V.,et al.(2000).Differences in risk factors, 
atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the 
Study of Health Assessment and Risk in Ethnic groups SHARE. Lancet,356:279-84. 
 
Anderson, C.S., Taylor, B.V., Hankey, G.J.(1994).Validation of a clinical 
classification for subtypes of acute cerebral infarction. Journal of Neurology, 
Neurosurgery & Psychiatry,1173-9. 
164 
 
 
Anderson, K.M., Wilson, P.W., Odell, P.M.,et al.,(1991).An updated coronary risk 
profile. A statement for health professionals. Circulation,83:356-362. 
 
Anderson, T.J., Uehata, A., Gerhard, M.D., et al.(1995).Close relation of endothelial 
of functions in the human coronary and peripheral circulations.Journal of  American 
College of Cardiology,26:1235-1241. 
 
Appadurai, A. (1988). How to Make a National Cuisine: Cookbooks in 
Contemporary India. Comparative Studies in Society and History ,30;1:3-24. 
 
Arici, M. & Walls, J.(2001).End-stage renal disease, atherosclerosis, and 
cardiovascular mortality: is C-reactive protein the missing link? Kidney 
Interantional,59:407-414. 
 
Armentano, R., Megnien, J.L., Simon, A.,(1995).Effects of hypertension on 
viscoelasticity of carotid and femoral arteries in humans. Hypertension,26: 48-54. 
 
Asian Acute Stroke Advisory Panel.(2000).Stroke epidemiological data of nine Asian 
countries. Journal of Medical Association of  Thailand,83:1-7. 
 
Aspinall, J.(2002). Collective terminology to describe the minority ethnic population: 
the persistence of confusion and ambiguity in usage. Sociology ,36:803-16. 
 
Association of Religion Data Archives. Available at: http://www.thearda.com. 
[Accessed on 2nd July 2009] 
 
Baird, T.A., Parsons, M.W., Phanh, T., et al.(2003).Persistent post-stroke 
hyperglycemia is independently associated with infarct expansion and worse clinical 
outcome. Stroke,34:2208-14. 
 
Balarajan, R.(1991).Ethnic differences in mortality from ischaemic heart disease and 
cerebrovascular disease in England and Wales. British Medical Journal,302:560-4. 
 
Ballotta, E., Meneghetti, G., Manara, R., et al.(2007). Long-term survival and stroke-
free survival after eversion carotid endarterectomy for asymptomatic severe carotid 
stenosis.Journal of Vascular  Surgery,26:54-56. 
 
Bamford, J., Sandercock, P., Dennis, M., Burn, J., and Warlow, C. (1991). 
Classification and natural history of clinically identifiable subtypes of cerebral 
infarction. Lancet,337:1521-6. 
 
Bamford, J., Sandercock, P., Dennis, M., et al., (1990).A prospective study of acute 
cerebrovascular disease in the community: the Oxfordshire Community Stroke 
Project 1981-1986. Journal of  Neurology Neurosurgery & Psychiatry,53:16-22. 
 
Banerjee, T.K., Mukherjee, C.S., Sarkhel, A. (2001).Stroke in the urban population of 
Calcutta: an epidemiological study. Neuroepidemiology,20:201. 
Banerji, C. (2006). Feeding the Gods: Memories of Food and Culture in Bengal. 
India: Berg. 
165 
 
 
Barac, A., Campia, U., Panza, J.A. (2007) Methods for evaluating endothelial 
function in humans. Hypertension, 49: 748-60. 
 
Barth, F.(1969). Ethnic groups and boundaries.Boston: Little Brown. 
 
Bauersachs, J.(1998).Vasodilator dysfunction in aged spontaneously hypertensive 
rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in 
superoxide anion production. Cardiovascualr Research,37:772-779. 
 
Beck, R.B.(2006).World History - Patterns and Interactions, London:Mcdougal 
Littell. 
 
Benetos, A., Laurent, S., Hoeks, A.P.,(1993). Arterial alterations with ageing and 
high blood pressure. A noninvasive study of carotid and femoral arteries. 
Arteriosclerosi & Thrombosis,13:90-97. 
 
Barnett, et al., (1998). Benefit of carotid endarterectomy in patients with 
symptomatic moderate or severe stenosis. North American Symptomatic Carotid 
Endarterectomy Trial Collaborators. New England Journal of Medicine. 12;1415-
25.  
 
Bharucha, N.E., Bharucha, E.P., Bharucha, A.E., et al. (1988).Case-control study of 
completed ischaemic stroke in the Parsis of Bombay: a population-based study. 
Neurology,38:490-2. 
 
Bhatnagar, D., Anand, I.S., Durrington, P.N. et al. (1995) Coronary risk factors in 
people from the Indian subcontinent living in west London and their siblings in India. 
Lancet, 18: 405-9. 
 
Bhattacharya, S., Saha, S.P., Basu, A., et al.(2005).A 5 years prospective study of 
incidence, morbidity and mortality profile of stroke in a rural community of eastern 
India.  Journal of Indian Medical Association, 103:655-9. 
 
Bhopal R., Phillimore, P., Kohli, S.(1991).Inappropriate use of the term   Asian  : an 
obstacle to ethnicity and health research. Journal of  Public Health 
Medicine.13:244-246. 
 
Bhopal, R & Rahemtulla, T.(2005). Persistent high stroke mortality in Bangladeshi 
populations. British Medical Journal,1096-1097. 
 
Bhopal, R., et al.(1999). Heterogeneity of coronary heart disease risk factors in 
Indian, Pakistani, Bangladeshi and European origin populations: cross sectional 
study. British Medical Journal,319:215-20. 
 
Bhopal, R., Fischbacher, C., Vartiainen, E., et al.(2005).Predicted and observed 
cardiovascular disease in South Asians: application of FINRISK, Framingham and 
SCORE models to Newcastle Heart Project data. Journal of  Public Health 
(Oxf),27:93-100. 
 
166 
 
Bhopal, R., Hayes, L., White, M., et al.(2002).Ethnic and socio-economic inequalities 
in coronary heart disease, diabetes and risk factors in Europeans and South Asians. 
Journal of  Public Health & Medicine,24:95-105. 
 
Bhopal, R., Unwin, N., White, M., et al.(1999).Heterogeneity of coronary heart 
disease risk factors in Indian, Pakistani, Bangladeshi, and European origin 
populations: cross sectional study. British Medical Journal, 319:215-20. 
 
Bhopal, R.,(2004).Glossary of terms relating to ethnicity and race: for reflection and 
debate.Journal of  Epidemiology and Community Health,58:441-445. 
 
Blankenhorn, D.H.& Hodis, H.N.Lyman Duff Memorial Lecture: arterial imaging 
and atherosclerosis reversal. Arteriosclerosis & Thrombosis,14:177-92. 
 
Blann, A.(1993).von Willebrand factor and the endothelium in vascular 
disease.British Journal of  Biomedical Sciences,50:125-34. 
 
Bonita, R.(1992) Epidemiology of stroke. Lancet 339:342-44. 
 
Botros, F.T., Schwartzman, M.L., Stier, C.T. Jr,et al.,( 2005).Increase in heme 
oxygenase-1 levels ameliorates renovascular hypertension. Kidney International,68: 
2745-2755. 
 
Bots,M.L., Hoes, A.W., Koudstaal, P.J., et al.(1997).Common carotid intima media 
thickness and risk of stroke and myocardial infarction: the Rotterdam Study. 
Circulation,96:1432-7. 
 
Bourke, J., Sylvester, R., Sharma, P.(2006).Ethnic variations in the management of 
patients with acute stroke.Postgraduate Medical Journal,82:13-5. 
 
Boutouyrie, P., Tropeano, A.I., Asmar, R., et al.,(2002).Aortic stiffness is an 
independent predictor of primary coronary events in hypertensive patients: a 
longitudinal study. Hypertension,39:10-15. 
 
Brainin, M, Teuschl, Y., Kalra, L.(2007).Acute treatment and long-term management 
of stroke in developing countries. Lancet Neurology,6:553-61. 
 
Bramwell, J.C. & Hill, A.V.(1922).Velocity of transmission of the pulse-wave and 
elasticity of the arteries. Lancet,1: 891-2. 
 
British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; 
Primary Care Cardiovascular Society; Stroke Association. JBS 2.(2006).Joint British 
Societies guidelines on prevention of cardiovascular disease in clinical practice. 
Heart, 91:1-52. 
 
Brooks, B., Molyneaux, L., Yue, D.K.(1999).Augmentation of central arterial 
pressure in type 1 diabetes. Diabetes Care, 22:1722-1727. 
 
167 
 
Brown, R.D., Whisnant, J.P., Sicks, J.D.,et al.(1996). Stroke incidence, prevalence, 
and survival: secular trends in Rochester, Minnesota, through 1989. Stroke,27:373-
80. 
 
Burchfiel, C.M., Curb, J.D., Rodriguez, B.L.,(1994).Glucose intolerance and 22-year 
stroke incidence. The Honolulu Heart Program.Stroke,25:951-7. 
 
Busse, R. & Fleming, I.(1998).Regulation of NO synthesis in endothelial cells. 
Kidney Blood Pressure Research,21:264 -266. 
 
Cai, H. & Harrison, D.G.(2000).Endothelial dysfunction in cardiovascular 
diseases:the role of oxidant stress.Circulation Research,87:840-844. 
 
Calver, A., Collier, J., Vallance, P.(1992).Inhibition and stimulation of nitric oxide 
synthesis in the human forearm arterial bed of patients with insulin dependent 
diabetes. Journal of Clinical Investigations,90:2548 -2554. 
 
Cappuccino, F.P., Barbato, A., Kerry, S.M. (2003) Hypertension, diabetes and 
Cardiovascular risk in ethnic minorities in the UK. British Journal of Diabetes & 
Vascualr  Disease, 3: 286-293. 
Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P (1997) Prevalence, detection, 
and management of cardiovascular risk factors in different ethnic groups in south 
London. Heart, 78: 555-563 
Capron,L.(1988). Extra and Intracranial atheresclerosis.In: Tool, J.F. ed. 
2000.Handbook of clinical Neurology.vol.9. pp.91-106. 
 
Carter AM, Catto AJ, Mansfield MW, et al (2007) Predictive variables for mortality 
after acute ischaemic stroke. Stroke, 38: 1873-80. 
 
Celermajer, D.S., Sorensen, K., Ryalls, M., et al.(1993a).Impaired endothelial 
function occurs in the systemic arteries of children with homozygous homocystinuria 
but not in their heterozygous parents. Journal of  American College of Cardiology, 
22:854-8. 
 
Celermajer, D.S., Sorensen, K.E., Bull, C.M.et al.(1994).Endothelium dependent 
dilation in the systemic arteries of asymptomatic subjects relates to coronary risk 
factors and their interaction. Journal of  American College of Cardiology,24:468-
74. 
 
Celermajer, D.S., Sorensen, K.E., Georgakopoulos, D., et al.(1993b).Cigarette 
smoking is associated with dose-related and potentially reversible impairment of 
endothelium-dependent dilation in healthy young adults. Circulation,88:2149-55 
 
Celermajer, D.S., Sorensen, K.E., Gooch, V.M., et al.(1992).Non-invasive detection 
of endothelial dysfunction in children and adults at risk of  atherosclerosis.Lancet, 
340:1111-5. 
 
 
168 
 
 
Chadha SL, Radhakrishan S, Ramachandran K, Kaul U, Gopinath N (1990). 
Epidemiological study of coronary heart disease in urban population to Delhi. Indian 
Journal of Medical Research, 92: 424-430     
  
Chadha SL, Gopinath N, Ramachandran K (1992). Epidemiological study of 
coronary heart disease in Gujaratis in Delhi (India). Indian Journal of Medical 
Research (B), 96:115-121       
   
Chadha SL, Ramachandran K, Shekhawat S, Tandon R, Gopinath N (1993) A three 
year f ollow-up study of coronary heart disease in Delhi. Bulletin of the World 
Health Organisation, 71: 67-72       
  
Chadha SL, Gopinath N, Katyal I Shekhawat (1995) Dietary Profile of adults in an 
urban and a rural community. Indian Journal of Medical Research, 101: 258-67
  
Chandra V, Pandav R, Laxminarayan R, et al.(2000).Neurological disorders. In: 
Jamison DT, Breman JG, Measham AR, et al, eds.(2006).Disease control priorities in 
developing world. Oxford: Oxford University Press,627-44. 
 
Chaturvedi, N. & Fuller, J.H.(1996).Ethnic differences in mortality from 
cardiovascular disease in the UK: do they persist in people with diabetes? Journal of  
Epidemiology & Community Health,50:137-9. 
 
Chaturvedi, N.(2001).Ethnicity as an epidemiological determinant-crudely racist or 
crucially important? International Journal of Epidemiology,30:25-7. 
 
Chaturvedi, N., Bulpitt, C.J., Leggetter, S.,(2004).Ethnic differences in vascular 
stiffness and relations to hypertensive target organ damage.Journal of 
Hypertension,22:1731-7. 
 
Chen, W., Srinivasan, S.R., Li, S.,(2006). Different effects of atherogenic 
lipoproteins and blood pressure on arterial structure and function: the Bogalusa heart 
study. Journal of  Clinical Hypertension,8:323-9.    
  
Chen X, Iqbal N, Boden G (1999) The effects of free fatty acids on gluconeogenesis 
and glycogenolysis in normal subjects. Journal of Clinical Investigation, 103: 365-
372 
 
Chen, Y.H., Chau, L.Y., Chen, J.W.(2008).Serum bilirubin and ferritin levels link 
heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery 
disease in diabetic patients. Diabetes Care,31:1615-20. 
 
Cheng, J., Liu, J., Li, X., et al.(2008).Effect of polymorphisms of endothelial nitric 
oxide synthase on ischaemic stroke: a case-control study in a Chinese population. 
International journal of clinical chemistry,392:46-51. 
 
Chen-Roetling, J. & Regan, R.F.(2006).Effect of heme oxygenase-1 on the 
vulnerability of astrocytes and neurons to hemoglobin.Biochemical & Biophysical 
Research Communications, 350: 233-237, 2006. 
169 
 
 
Chowienczyk, P.J., Kelly, R.P., MacCallum, H., et al.(1999). Photoplethysmographic 
assessment of pulse wave reflection: blunted response to endothelium-dependent 
beta2-adrenergic vasodilation in type II diabetes mellitus. Journal of  American 
College of Cardiology,34:2007-14. 
 
Chowienczyk, P.J., Watts, G.F., Cockcroft, J.R., et al (1992) Impaired endothelium-
dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. 
Lancet, 340: 1430-2. 
 
Chung, M.K., Martin, D.O., Sprecher, D., et al.(2001).C-reactive protein elevation in 
patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial 
fibrillation. Circulation,104:2886-2891. 
 
Clarke, C., Peach, C., Vertovec, C.(1990). South Asians overseas: Migration and 
ethnicity. Cambridge: Cambridge University press. 
 
Clarkson, P., Celermajer, D.S., Donald, A.E. et al (1996) Impaired vascular reactivity 
in insulin-dependent diabetes mellitus is related to disease duration and low density 
lipoprotein cholesterol levels. Journal of  American College of  Cardiology , 28: 
573-9. 
 
Collins, V.R., Dowse, G.K., Ram, P., et al.( 1996).Non-insulin-dependent diabetes 
and 11-year mortality in Asian Indian and Melanesian Fijians. Diabetic Medicine, 
13: 125-132. 
 
Conroy, R.M., Pyörälä, K., Fitzgerald, A.P., et al. (2003) Estimation of ten-year risk 
of fatal cardiovascular disease in Europe: the SCORE project. European Heart 
Journal, 24:987-1003. 
 
Conway, D.S. & Lip, G.Y.(2003).Ethnicity in relation to atrial fibrillation and stroke 
(the West Birmingham Stroke Project). American Journal of Cardiology, 92:1476-
9. 
 
Corrado, E., Rizzo, M., Coppola, G.,et al.(2008).Endothelial dysfunction and carotid 
lesions are strong predictors of clinical events in patients with early stages of 
atherosclerosis: a 24-month follow-up study.Coronorary Artery Disease, 19:139-
44. 
 
Côté, R., Battista, R.N., Wolfson, C., et al.(1989).The Canadian Neurological Scale: 
validation and reliability assessment.Neurology,1989;39:638-43. 
 
Cruickshank, J.K., Alleyne, S.A., et al.(1987).Black West Indian and matched White 
diabetics in Britain compared with diabetics in Jamaica: body mass, blood pressure, 
and vascular disease. Diabetes Care,2:170-9. 
 
Cruickshank, J.K., Cooper, J., Burnett, M.,  et al.( 1991).Ethnic differences in fasting 
plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. 
Lancet ,338: 842-847. 
 
170 
 
Cruickshank, K., Riste, L., Anderson, S.G.,et al.(2002).Aortic pulse-wave velocity 
and its relationship to mortality in diabetes and glucose intolerance: an integrated 
index of vascular function? Circulation,106:2085-1906. 
 
Cypiene, A., Laucevicius, A., Venalis, A., et al.(2007).Non-invasive assessment of 
arterial stiffness indices by applanation tonometry and pulse wave analysis in patients 
with rheumatoid arthritis treated with TNF-alpha blocker remicade 
(infliximab).Proceedings of the  Western Pharmacology Society,50:119-22. 
 
Czernichow, S., Bertrais, S., Oppert, J.M., et al (2005) Body composition and fat 
repartition in relation to structure and function of large arteries in middle-aged adults 
(the SU.VI.MAX study). International Journal of Obesity, 29:826-832. 
 
Dalal, P.M.(2006).Burden of stroke: Indian perspective. International Journal of  
Stroke,1:164-6. 
 
Danesh, J., Wheeler, J.G., Hirschfield, G.M., et al. (2004) C-reactive protein and 
other circulating markers of inflammation in the prediction of coronary heart disease. 
New England Journal of Medicine, 350:1387-97. 
 
Dart, A.M.& Qi, X.L.(1995).Determinants of arterial stiffness in Chinese migrants to 
Australia. Atherosclerosis,117:263-72. 
 
Davignon, J. & Ganz P.(2004).Role of endothelial dysfunction in atherosclerosis. 
Circulation, 2004  15;109:32. 
 
Davydov, M.I., Zaridze, D. G., Lazarev, A.F.,(2007).Analysis of mortality in Russian 
population. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk,17-27. 
 
Dawes, M., Chowienczyk, P.J., Ritter, J.M.(1997) Effects of inhibition of the L-
arginine/nitric oxide pathway on vasodilation caused by betaadrenergic agonists in 
human forearm. Circulation, 95: 2293-7. 
 
De Silva, D.A., Woon, F.P., Lee, M.P., et al.( 2005).Ischaemic cerebrovascular 
disease: Differences between ethnic South Asian and ethnic Chinese patients.  
Cerebrovascualr  Disease, 20:407-9. 
 
De Silva, D.A., Woon, F.P., Lee, M.P.,et al.(2007).South Asian patients with 
ischaemic stroke: intracranial large arteries are the predominant site of 
disease.Stroke,38:2592-4. 
 
Deanfield, J., Donald, A., Ferri,C., et al.(2005). Endothelial function and dysfunction. 
Part I: methodological issues for assessment in the different vascular beds: a 
statement by the working group on endothelin and endothelial factors of the 
European society of hypertension. Journal of Hypertension,23;7–17. 
 
 
 
171 
 
DeGraba, T.,Fischer, M.,Yatsu, F.M.(1992).Atherogenesis and strokes.In: Barnett, 
H.J.M. & Yatsu, F.M 2nd ed. Strokes:pathophysiology,Diagnosis and management. 
New York: Churchil Livingston. 
 
Deleu, D., Hamad, A.A., Kamram, S., et al. (2006) Ethnic variations in risk factor 
profile, pattern and recurrence of non-cardioembolic ischaemic stroke. Archives of  
Medical Research,37:655-62. 
 
Department of Health (2005) Health Survey for England.The Stationery Office: 
London. Available at:http://www.ic.nhs.uk/statistics-and-data-collections/health-and-
lifestyles/health-survey-for-england/health-survey-for-england-2004:-health-of-
ethnic-minorities--full-report. 
 
Desai, S.(1977).British trade and expansion in Southeast Asia, 1830-1914.New 
Delhi:Allied. 
 
Dhamija, R.K. & Dhamija, S.B. (1998) Prevalence of Stroke in a rural community - 
an overview of Indian experience. Journal of the Association of Physicians India, 
46: 351-4. 
 
Dhamoon, M.S., Tai, W., Boden-Albala,B., et al.(2007).Risk of myocardial infarction 
or vascular death after first ischaemic stroke: the Northern Manhattan Study.Stroke, 
;38:1713-4. 
 
Di Napoli, M., Papa, F., Bocola, V.,(2001).C-reactive protein in ischaemic stroke: an  
independent prognostic factor. Stroke,32:917-924. 
 
Di Napoli,M.(2001).Early inflammatory response in ischaemic stroke. Thrombosis  
Research,103:261-264. 
 
Din, J.N., Ashman, O.A., Aftab, S.M., et al. (2006).Increased arterial stiffness in 
healthy young South Asian men. Journal of Human Hypertension,20:163-5. 
 
Din-Dzietham, R., Couper, D., Evans, G.,(2004).Arterial stiffness is greater in 
African Americans than in Whites: evidence from the Forsyth County, North 
Carolina, ARIC cohort. American Journal of  Hypertension,17:304-13. 
 
Divani, A.A., Vazquez, G., Asadollahi, M., et al.(2009).Nationwide frequency and 
association of heart failure on stroke outcomes in the United States.Journal of 
Cardiac  Failure,15:11-6. 
 
Dolan, S.A., Jarman, B., Bajekal, M., et al.,(1995).Measuring disadvantage: changes 
in the underprivileged area, Townsend, and Carstairs scores 1981-91.Journal of  
Epidemiology & Community Health,49:S30-3. 
 
Donald,A., Charakida,M., Cole,J., et al.,(2006).Non-invasive techniques for 
assessment of endothelial function. Journal of the American College of 
Cardiology, 48;1846–1850. 
 
172 
 
Doshi,S., Naka,K.,Payne, N., et al.(2001). Flow-mediated dilatation following wrist 
and upper arm occlusion in humans: the contribution of nitric oxide. Clinical 
Science, 101;629–635. 
 
Dotsenko, O., Chackathayil, J., Lip, G.Y.H.(2007) Cardiac biomarkers: myths, facts 
and future horizons. Expert Review of Molecualr Diagnosetics,7:693-697. 
 
Dowse, G.K., Gareeboo, H., Zimmet, P.Z., et al.(1990).High prevalence of NIDDM 
and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius 
Non-communicable Disease Study Group. Diabetes,39: 390-6. 
 
Duckers, H.J., Boehm, M., True, A.L., et al.(2001).Heme oxygenase-1 protects 
against vascular constriction and proliferation. Nature Medicine ,7: 693 – 698. 
 
Duprez, D.A., Somasundaram, P.E., Sigurdsson, G., et al.,(2005).Relationship 
between C-reactive protein and arterial stiffness in an asymptomatic 
population.Journal of Human Hypertension,19:515-9. 
 
Ebrahim, S., Sung, J., Song, Y.M., et al.(2006).Serum cholesterol, haemorrhagic 
stroke, ischaemic stroke, and myocardial infarction. British Medical 
Journal,333:22. 
 
Erdosy,G.(1995).The Indo-Aryans of ancient South Asia: language, material 
culture and ethnicity. Berlin: Walter de Gruyter. 
 
Ezzati, M., Rodgers, A., Lopez, A. D., et al.(2004). Comparative Quantification of 
Health Risks: Global and Regional Burden of Disease Attributable to Selected 
Major Risk Factors (pp. 2141-2165) Geneva: World Health Organization.Available 
at: http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf.  
[Accessed on 1st January 2008]. 
 
Febbraio, M., Hajjar, D.P.,Silverstein, R.L.(2001).CD36: a class B scavenger 
receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid 
metabolism. Journal of Clinical Investigations,108: 785-791. 
 
Feder, G., Crook, A.M., Magee, P., et al.(  2002).Ethnic differences in invasive 
management of coronary disease: prospective cohort study of patients undergoing 
angiography. British Medical Journal,324:511-6. 
 
Feigin, V. & Hoorn,S.V.(2004).How to study stroke incidence.  Lancet,363:1920. 
 
Feigin, V., Lawes, L.,  Bennett, D.A., et al. (2003) Stroke epidemiology: a review of 
population-based studies of incidence, prevalence, and case-fatality in the late 20th 
century. Lancet Neurology 2:43-53. 
 
Feng, Q., Song, W., Lu, X., et al.(2002). Development of heart failure and congenital 
septal defects in mice lacking endothelial nitric oxide synthase. Circulation,106:873-
9. 
 
173 
 
Fleming, I.&  Busse, R..(2003) Molecular mechanisms involved in the regulation of 
the endothelial nitric oxide synthase. American  Journal of  Physiology,284:R1-
R12. 
 
Foo, J.Y. & Lim, C.S.(2007). Difference in pulse transit time between populations: a 
comparison between Caucasian and Chinese children in Australia. Journal of  
Medical  Engineering & Technolology,16;1-5. 
 
Forouhi, N.G., Sattar, N., McKeigue, P.M.( 2001).Relation of C-reactive protein to 
body fat distribution and features of the metabolic syndrome in Europeans and South 
Asians. International  Journal of  Obesity Related Metabolic Disorders, 25:1327-
31. 
 
Förstermann, U.& Münzel, T.(2006).Endothelial Nitric Oxide Synthase in Vascular 
Disease: From Marvel to Menace.Circulation, 2006,113;1708-1714. 
 
Förstermann, U., Closs, E.I., Pollock, J.S.,(1994).Nitric oxide synthase isozymes: 
characterization, purification,molecular cloning, and functions. Hypertension, 
23:1121-1131. 
 
Friday, G., Lai, S.M., Alter, M., et al.(1989).Stroke in the Lehigh Valley: 
racial/ethnic differences. Neurology,39:1165-1168. 
 
Furchgott, R.F. & Zawadzki, J.V. (1980) The obligatory role of endothelial cells in 
the relaxation of arterial smooth muscle by acetylcholine. Nature, 288: 373-6. 
 
Gammon, B.D. & Gunarathne, A.(2008).It's time to reappraise recruitment of South 
Asians to clinical trials. British Medical Journal,336:46. 
 
Garg, U.C.&Hassid, A.(1989).Nitric oxide-generating vasodilators and 8-bromo-
cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat 
vascular smooth muscle cells. Journal of Clinical Investigations,83:1774-7. 
 
George, L.M. & Maddock, K.(1979).Accuracy of hospital activity notifications for 
infectious diseases. British Medical Journal, 1:1332-39. 
 
Gerald, A.,& Washington, W.(1993).South Asian Summer Monsoon Variability in a 
Model with Doubled Atmospheric Carbon Dioxide Concentration. Science,3(21):01. 
 
Gerhard-Herman, M., Herrington, D., Vallance, P., et al. (2002) Guidelines for the 
ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the 
brachial artery: a report of the International Brachial Artery Reactivity Task Force. 
Journal of  American College of  Cardiology, 39: 257-65. 
 
Gill, P.S., Kai, J., Bhopal, R.S., et al. (2007) Health Care Needs Assessment: Black 
and Minority Ethnic Groups.  In: Raftery J, Stevens A, Mant J (ed).  Health Care 
Needs Assessment. The  epidemiologically based needs assessment reviews. Third 
Series.  Abingdon: Radcliffe Publishing Ltd. Available at: 
http://www.hcna.bham.ac.uk/pdfs/04_HCNA3_D4.pdf. [Accessed on January 1st 
2008]. 
174 
 
 
Gillum, R.F.(1995).Epidemiology of stroke in Hispanic Americans.Stroke, 26: 1707 
-1712. 
 
Gillum, R.F.(1999).Risk factors for stroke in blacks: A critical review. American 
Journal of Epidemiology, 150: 1266-74. 
 
Glenn, B.A., Surani, Z., Chawla, N., et al.(2009).Tobacco use among South Asians: 
results of a community-university collaborativestudy. Ethnicity & Health,14:131-
45. 
 
Glick,H.A., Polsky,D., Willke,R.J., et al.,(1999).A comparison of preference 
assessment instruments used in a clinical trial: responses to the visual analog scale 
from the EuroQol EQ-5D and the Health Utilities Index.Medical Decision 
Making,19:265-275. 
 
Goldstein, L.B., Matchar, D.B., Hoff-Lindquist, J.et al.( 2003).Differences in 
utilization of stroke-related procedures or services. Veterans Administration Acute 
Stroke (VASt) Study. Stroke,34:999-1004. 
 
Gorelick, P.B., Caplan, L.R., Hier, D.B., et al.(1984).Racial differences in the 
distribution of anterior circulation occlusive disease. Neurology,34:54 -59. 
 
Guerci, B., Böhme, P., Kearney-Schwartz, A.,et al.(2001).Endothelial dysfunction 
and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments 
in type 2 diabetes mellitus.Diabetes Metabolism,27:436-47. 
 
Gunarathne, A., Patel, J.V., Potluri, R., et al.(2008a) Increased 5-year mortality in the 
migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: 
the West Birmingham Stroke Project. International Journal of Clinical 
Practice,62:197-201.        
  
Gunarathne, A., Patel, J.V., Potluri, R., et al.(2008b).Secular trends in the 
cardiovascular risk profile and mortality of stroke admissions in an inner city, 
multiethnic population in the United Kingdom (1997-2005).  Journal of Human 
Hypertension, 22:18-23.        
    
Gunarathne, A., Patel, J.V., Gammon, B., et al.(2008c).Impact of mean arterial blood 
pressure on higher arterial stiffness indices in South Asians compared to White 
Europeans.Journal of Hypertension,26:1420-6. 
 
Gunarathne, A., Patel, J.V., Hughes, E.A.,et al.(2008d).Measurement of stiffness 
index by digital volume pulse analysis technique: clinical utility in cardiovascular 
disease risk stratification. American  Journal of  Hypertension,21:866-72. 
 
Gunarathne, A., Patel, J.V., Kausar, S., et al. (2009a). Glycaemic status underlies 
increased arterial stiffness and impaired endothelial function in migrant South Asian 
stroke survivors compared to European Caucasians: pathophysiological insights from 
the West Birmingham Stroke Project. Stroke, 40:2298-306. 
175 
 
 
Gunarathne, A., Patel, J.V., Gammon, B., et al. (2009b). Ischaemic stroke in South 
Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical 
features. Stroke, 40:e415-23. 
 
Gupta R, Prakash H, Gupta VP, Gupta KD (1997). Prevalence and determinants of 
coronary heart disease in a rural population of India. Journal of Clinical 
Epidemiology, 50: 203-209 
 
Gupta, R., Joshi, P., Mohan, V., et al.(2008).Epidemiology and causation of coronary 
heart disease and stroke in India.  Heart, 9416-26. 
 
Halcox, J.P.J., Schenke, W.H., Zalos, G., et al.(2002).Prognostic value of coronary 
vascular endothelial dysfunction. Circulation,106:653-658. 
 
Halcox,J., Donald,A.,Ellins, E., et al., (2009). Endothelial function predicts 
progression of carotid intima-media thickness, Circulation, 119; 1005–1012. 
 
Hare, J.M.(2004).Nitroso-redox balance in the cardiovascular system. New England 
Journal of Medicine, 351:2112-2114. 
 
Hassan, A., Hunt, B.J., O'Sullivan, M., et al.(2003).Markers of endothelial 
dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain,126:424-432. 
 
Hatona, S. (1976).Experiences from a multicenter stroke register: a preliminary 
report. Bulletin of World Health Organization,54: 541-553. 
 
Hayward, C.S., Kraidly, M., Webb, C.M., et al (2002) Assessment of endothelial 
function using peripheral waveform analysis: a clinical application. Journal of  
American College of  Cardiology, 40: 521-8. 
 
Heffernan, K.S., Jae, S.Y., Fernhall, B. et al.(2007).Racial differences in arterial 
stiffness after exercise in young men. American Journal of Hypertension,20:840-5. 
 
Hlaing, W.M. & Prineas, R.J.(2006).Arterial stiffness variations by gender in 
African-American and Caucasian children. Journal of  National  Medical 
Association,98:181-9. 
 
Hlaing, W.M., Koutoubi, S., Huffman, F.G.,(2006).Differences in arterial stiffness 
and its correlates in tri-ethnic young men and women. Ethnicity & Disease,16:837-
43. 
 
Holmes, Jr., Lerman, A., Targonski,P.,et al.(2003). Coronary Endothelial 
Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events. 
Circulation,107;2805-2809. 
 
Howard, G., Howard, V.J., Katholi, C. et al., (2001) Decline in US stroke mortality: 
an analysis of temporal patterns by sex, race, and geographic region.  Stroke, 32: 
2213-20. 
 
176 
 
Hsu, R.T., Ardron, M.E., Brooks, W., et al.(1999). The 1996 Leicestershire 
Community Stroke & Ethnicity Study: differences and similarities between South 
Asian and White strokes. International Journal of Epidemiology, 28:853-8. 
 
http://www.escardio.org/knowledge/decision_tools/heartscore/eu_high/. Accessed 
on 1/05/2007. 
 
Hughes, K., Lun, K.C., Yeo, P.B.(1990) Cardiovascular disease in Chinese, Malays 
and Indians in Singapore 1. Differences in mortality. Journal of Epidemiology and 
Community Health. 44:24-8. 
 
Hyam, R.(1993). Britain's imperial century, 1815-1914: a study of empire and 
expansion. Cambridge: Cambridge Commonwealth. 
 
INTERSTROKE-India Study Group.(2006).An Indian pilot case-control study to 
determine the importance of conventional and emerging risk factors for stroke. 
Available at : http://heart.bmj.com/cgi/content/full/94/1/16. 
 
Ishikawa, K., Navab, M., Leitinger, N., et al.(1996).Induction of heme oxygenase-1 
inhibits the monocyte transmigration induced by mildly oxidized LDL. Journal of 
Clinical Investigations,12:13-18. 
 
Ishizaka, N., de Leon, H., Laursen, J.B.,et al.,(1996).Angiotensin II-induced 
hypertension increases heme oxygenase-1 expression in rat aorta. Circulation,; 
1923-1929:34. 
 
Jafar,T.H.,(2006).Blood pressure, diabetes, and increased dietary salt associated with 
stroke  results from a community-based study in Pakistan.  Journal of  Human 
Hypertension,20:83-85. 
 
Jaffrelot, C.(2004). A History of Pakistan and its Origins.London:Anthem. 
 
Jain, R.K.(1993) Indian communities abroad: themes and literature.New Delhi: 
Mahohar Publishers. 
 
Jalal, A.,(1995). Democracy and authoritarianism in South Asia: A comparative 
and historical perspective.Cambridge: Cambridge University Press. 
 
Jarrett, R.J., Shipley, M.J., Hunt, R.(1986).Physical activity, glucose tolerance, and 
diabetes mellitus: the Whitehall Study.Diabetes Medicine,3:549-51. 
 
Jaumdally, R.J., Varma, C., Blann, A.D.,et al.(2007).Indices of angiogenesis, platelet 
activation, and endothelial damage/dysfunction  in relation to ethnicity and coronary 
artery disease: differences in central versus peripheral levels.Annals of 
Medicine,39:628-33. 
 
Joannides, R., Haefeli,E., Linder, L., et al.( 1995). Nitric oxide is responsible for 
flow-dependent dilatation of human peripheral conduit arteries in vivo.  Circulation, 
91; 1314–1319. 
 
177 
 
 
Jocelyne, G., Karam, Lisel, L., et al.(2009).High-dose atorvastatin after stroke or 
transient ischaemic attack. The Stroke Prevention by Aggressive Reduction in 
Cholesterol Levels (SPARCL) Investigators. Journal of the Cardio Metabolic 
Syndrome,3:1, 68-69 
 
Jones, M.R., Horner, R.D., Edwards, L.J., et al.(2000).Racial variation in initial 
stroke severity. Stroke,31:563-7. 
 
Joshi, P., Islam, S., Pais, P., et al.(2007). Risk factors for early myocardial infarction 
in South Asians compared with individuals in other countries. The Journal of the 
American Medical Association,297:1880-1. 
 
Juan, S.H., Lee, T.S., Tseng, K.W., et al.(2001).Adenovirus-mediated heme 
oxygenase-1 gene transfer inhibits the development of atherosclerosis in 
apolipoprotein E-deficient mice. Circulation,104: 1519-1525. 
 
Just, R.(1989). History and Ethnicity. London: Tavistock. 
 
Kain, K., Bamford, J., Bavington, J.,et al., (2005). Factor XIII--circulating levels and 
Val34Leu polymorphism in relatives of South Asian patients with ischaemic stroke. 
Journal of  Thrombosis & Haemostasis,3:171-3. 
 
Kain, K., Catto, A.J., Grant, P.J.(2003).Associations between insulin resistance and 
thrombotic risk factors in high-risk South Asian subjects. Diabeted 
Medicine,20:651-5. 
 
Kakar, P., Gunarathne, A., Lip, G.Y.(2006).Stroke: ethnic differences do exist. 
Expert Review of Neurotherapeutics. 2006 ;6:1769-71. 
 
Kalra, L., Rambaran, C., Chowienczyk, P., et al.(2005).Ethnic differences in arterial 
responses and inflammatory markers in Afro-Caribbean and Caucasian subjects. 
Arteriosclerosis Thrombosis & Vascular Biology,25:2362-7. 
 
Kampus, P., Kals, J., Ristimäe, T.,et al.(2004).High-sensitivity C-reactive protein 
affects central haemodynamics and augmentation index in apparently healthy 
persons.Journal of  Hypertension,22:1133-9. 
 
Kapturczak, M.H., Wasserfall, C., Brusko, T.(2004).Heme oxygenase-1 modulates 
early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. 
American. Journal of Pathology,165:1045-1053. 
 
Kaul, S., Sunitha, P., Suvarna, A., et al., (2002).Subtypes of Ischaemic Stroke in a 
Metropolitan City of South India (One year data from a hospital based stroke 
registry).Neurology India,2:49-50. 
Keil JE, Britt RP, Weinrich MC, Hollis Y, Keil BW (1980) Hypertension in Punjabi 
females: comparison between migrants to London and natives in India. Human 
Biology, 52: 423-433 
178 
 
Kelly, R.P., Gibbs, H.H., O'Rourke, M.F.(1990).Nitroglycerin has more favorable 
effects on left ventricular afterload than apparent from measurement of pressure in a 
peripheral artery. European Heart Journal, 11:138-44. 
 
Khattar, R.S., Swales, J.D., Senior, R., et al.( 2000).Racial variation in cardiovascular 
morbidity and mortality in essential hypertension.Heart,83:267-71. 
 
Kim, I.J., Bae, J., Lim, S.W., et al.( 2007).Influence of endothelial nitric oxide 
synthase gene polymorphisms (-786T>C, 4a4b,894G>T) in Korean patients with 
coronary artery disease.Thrombosis Research,119:579-85. 
 
King, H., Aubert, R.E., Herman, W.H.(1998).Global burden of diabetes, 1995-2025. 
Diabetes Care, 21: 1414-1431. 
 
Kingwell, B. & Boutouyrie, P.(2007). Genetic influences on the arterial wall. Clinical 
and Experimental Pharmacology & Physiology,34:652-7. 
 
Kissela, B., Schneider, A., Kleindorfer, D., et al.(2004)Stroke in a biracial 
population: the excess burden of stroke among Blacks.Stroke,35:426-31. 
 
Kohli HS (1988). The health of ‗Asians‘ in Britain. National Medical Journal of 
India, 1: 27-29   
 
Komai, N., Morita, Y., Sakuta, T., et al.(2007). Anti-tumor necrosis factor therapy 
increases serum adiponectin levels with the improvement of endothelial dysfunction 
in patients with rheumatoid arthritis.Modern Rheumatology,17:385-90. 
 
Kubes, P., Suzuki, M., Granger, D.N.(1991).Nitric oxide: an endogenous modulator 
of leukocyte adhesion. Proceedings of the National Academy of Sciences,88:4651-
5. 
 
Kuhlemeier, K.V. & Stiens, S.(1994). Racial disparities in severity of cerebrovascular 
events. Stroke,25:2126-31. 
 
Lammie, G.A., Sandercock, P.A.G., Dennis, M.S.(1999).Recently occluded 
intracranial and extracranial carotid arteries: relevance of the unstable atherosclerotic 
plaque.Stroke,30:1319 -1325. 
 
Lane, D.A. & Lip, G.Y.H.(2001).Ethnic differences in hypertension and blood 
pressure control in the UK. Quarterly Journal of Medicine,94:391-396. 
 
Lane, D.A., Lip, G.Y., Beevers, D.G.(2005) Ethnic differences in cardiovascular and 
all-cause mortality in Birmingham, England: the Birmingham Factory Screening 
Project. Journal of  Hypertension, 23:1347-53. 
 
Lanting, L.C., Joung, I.M., Mackenbach, J.P., et al.,(2005).Ethnic differences in 
mortality, end-stage complications, and quality of care among diabetic patients: a 
review. Diabetes Care,28:2280-8. 
 
 
179 
 
 
 
Larsson B, Svärdsudd K, Welin L, et al.,(1984). Abdominal adipose tissue 
distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up 
of participants in the study of men born in 1913. British Medical Journal (Clin Res 
Ed). 288(6428):1401-4. 
                                                                                                                    
Latham, R.D., Westerhof, N., Sipkema, P.,(1985).Regional wave travel and 
reflections along the human aorta: a study with six simultaneous micro-manometric 
pressures. Circulation,72:1257-1269. 
 
Laurent, S., Boutouyrie, P., Asmar, R., et al.(2001).Aortic stiffness is an independent  
predictor of all-cause and cardiovascular mortality in hypertensive patients. 
Hypertension,37:1236-1241. 
 
Laurent, S., Caviezel, B., Beck, L., et al.,(1994) Carotid artery distensibility and 
distending pressure in hypertensive humans. Hypertension, 23:878-883. 
 
Laurent, S., Cockcroft, J., Van-Bortel,L, et al.(2006) European Network for Non-
invasive Investigation of Large Arteries. Expert consensus document on arterial 
stiffness: methodological issues and clinical applications. European Heart Journal, 
27:2588-605. 
 
Lean, M.E., Han, T.S., Bush, H., et al.(2001).Ethnic differences in anthropometric 
and lifestyle measures related to coronary heart disease risk between South Asian, 
Italian and general-population British women living in the west of Scotland. 
International Journal of  Obesity Related  Metabolic Disorders,25:1800-5. 
 
Lee, C.M., Huxley, R.R., Woodward, M..et al.(2007).Asia Pacific Cohort Studies 
Collaboration. Prevalence of diabetes mellitus and population attributable fractions 
for coronary heart disease and stroke mortality in the WHO South-East Asia and 
Western Pacific regions. Asia Pacific Journal of  Clinical  Nutrition. 2007;16:187-
92. 
 
Lemogoum, D., Van Bortel, L., Leeman, M., ET AL.( 2006).Ethnic differences in 
arterial stiffness and wave reflections after cigarette smoking. Journal of 
Hypertension,24:683-9. 
 
Lewis, P.M.(2006).Ethnologue- Languages of the World. Dallas: University of 
New Mexico Press. 
 
Lhermitte, F., Gautier, J.C., Derouesne, C., et al.(1968).Ischaemic accidents in the 
middle cerebral artery territory: a study of causes in 122 cases. Archives of 
Neurology,19:248 -256. 
 
Li, H., Wallerath, T., Münzel, T., et al.(2002).Regulation of endothelial-type NO 
synthase expression in pathophysiology and in response to drugs. Nitric Oxide: 
Biology & Chemistry, 7:149 -164. 
 
180 
 
Libby, P. & Ridker, P.M.(2004).Inflammation and atherosclerosis: role of C-reactive 
protein in risk assessment. American  Journal of  Medicine,116: 9-16. 
 
Lindenstrom, E., Boysen, G.,Deyn, P.D. et al. for the TAIST Investigators  (2001). 
Tinzaparin in acute ischaemic stroke (TAIST): a randomized aspirin-controlled trial. 
Lancet, 358: 702-10. 
 
Lip, G.Y., Barnett, A.H., Bradbury, A., et al., ( 2002).Ethnicity and cardiovascular 
disease prevention in the United Kingdom: a practical approach to 
management.Journal of  Human Hypertension,21:183-211. 
 
Lip, G.Y., Luscombe, C., McCarry, M., et al.(1996).Ethnic differences in public 
health awareness, health perceptions and physical exercise: implications for heart 
disease prevention.Ethnicity & Health,1:47-53. 
 
Lip, G.Y., Rathore, V.S., Katira, R., et al.(1999).Do Indo-Asians have smaller 
coronary arteries? Postgraduate Medical Journal,75:463-6. 
 
Liu, H., Yambe, T., Zhang, X.,(2005).Comparison of brachial-ankle pulse wave 
velocity in Japanese and Russians. The Tohoku Journal of Experimental 
Medicine,207:263-70. 
 
Liu, M., Wu, B., Wang, W.Z., et al. (2007).Stroke in China: epidemiology, 
prevention, and management strategies. Lancet Neurology,6:456-64. 
 
Ludmer, P.L., Selwyn, A.P., Shook, T.L., et al (1986). Paradoxical vasoconstriction 
induced by acetylcholine in atherosclerotic coronary arteries. New England Journal 
of Medicine, 315: 1046-51. 
 
Lyratzopoulos, G., McElduff, P., Heller, R.F., et al.(2005).Comparative levels and 
time trends in blood pressure, total cholesterol, body mass index and smoking among 
Caucasian and South-Asian participants of a UK primary-care based cardiovascular 
risk factor screening programme. BMC Public Health,5:125. 
 
Macdonald, M.R., Petrie, M.C., Varyani, F.,et al.(2008). Impact of diabetes on 
outcomes in patients with low and preserved ejection fraction heart failure: An 
analysis of the Candesartan in Heart failure:Assessment of Reduction in Mortality 
and morbidity (CHARM) programme.European Heart Jouranl,4:14. 
 
Mahajan, S.K., Kashyap,R., Sood, B.R.,et al.(2004).Stroke at moderate altitude. 
Journal of Association of Physicians of India, 52:699-702. 
 
Man, K.M., Tang, K.S.,Kwong, S.(1999). Genetic Algorithms: concepts and 
designs. London: Springer. 
 
Manton, K.G.(1988). The global impact of non-communicable diseases: estimates 
and projections. World Health Stat Q, 41:255-66. 
 
181 
 
Maple-Brown, L.J., Piers, L.S., O'Rourke, M.F., et al.(2007).Increased arterial 
stiffness in remote Indigenous Australians with high risk of cardiovascular disease. 
Journal of  Hypertension,25:585-91. 
 
 
Maxwell, A.,Tsao,P.,Cooke,J. Et al.,(1998). Modulation of the nitric oxide synthase 
pathway in atherosclerosis. Experimental Physiololgy. 5:573-84. 
 
McKeigue, P.M., Shah, B., Marmot, M.G.(1991).Relation of central obesity and 
insulin resistance with high diabetes prevalence and cardiovascular risk in South 
Asians.Lancet,1991;337:382-6. 
McKeigue PM (1996) Metabolic consequences of obesity and body fat pattern: 
lessons from migrant studies. From „The origins and consequences of obesity‟. Wiley, 
Chichester (Ciba foundation Symposium 201): 54-67 
McKeigue PM, Ferrie JE, Perpoint T, Marmot MG (1993). Association of early-onset 
coronary heart disease in South Asian men with glucose intolerance and 
hyperinsulinemia. Circulation, 87: 152-161 
McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rathman S, 
Riemersma RA (1988b) Diabetes, hyperinsulinaemia, and coronary risk factors in 
Bangladeshis in East London. British Heart Journal, 60: 390-6 
McKeigue PM, Miller GJ, Marmot MG (1989). Coronary heart disease in South 
Asians overseas: a review J. Clin. Epidemiol ,42: 597-609 
Megnien, J.L., Simon, A., Valensi, P., et al.(1992).Comparative effects of diabetes 
mellitus and hypertension on physical properties of human large arteries. Journal of  
American College of Cardiology,20: 1562-1568. 
 
Melichar, V.O.(2004).Reduced cGMP signaling associated with neointimal 
proliferation and vascular dysfunction in late-stage atherosclerosis. Proceedings of 
the National Academy of Sciences,101:16671-16676. 
 
Miles, A.M., Wink, D.A., Cook,J.C.(1996).Grisham MB. Determination of nitric 
oxide using fluorescence spectroscopy. Methods in Enzymology,268:105-120. 
 
Millasseau, S.C., Kelly, R.P., Ritter, J.M. (2002).Determination of age-related 
increases in large artery stiffness by digital pulse contour analysis. Clinical Science 
(Lond), 103:371-377. 
 
Millasseau, S.C., Ritter, J.M., Takazawa, K., et al.(2006) Contour analysis of the 
photoplethysmographic pulse measured at the finger. Journal of Hypertension, 
24:1449-56. 
 
Miller GJ, Kotecha S, Wilkinson WH, Wilkes H, Stirling Y, Sanders TAB, 
Broadhurst A, Allison J, Meade TW (1988) Dietary and other characteristics relevant 
for coronary heart disease in men of Indian, West Indian and European descent in 
London. Atherosclerosis, 70: 63-72 
182 
 
 
Miller, M.A., Kerry, S.M., Dong, Y.,(2005).Circulating soluble E-selectin levels and 
the Ser 128Arg polymorphism in individuals from different ethnic groups. Nutrition 
Metabolism & Cardiovascular Disease, 15:65-70. 
 
Mitchell, G.F., Guo, C.Y., Kathiresan, S.,(2007).Vascular stiffness and genetic 
variation at the endothelial nitric oxide synthase locus. The Framingham heart study. 
Hypertension,49:1285-1290. 
 
Modena, M.G., Bonetti, L., Coppi, F., et al. (2002) Prognostic role of reversible 
endothelial dysfunction in hypertensive postmenopausal women. Journal of  
American College of  Cardiology, 40:505-510. 
 
Moncada, S., Palmer, R.M., Higgs, E.A.(1989).Biosynthesis of nitric oxide from L-
arginine. A pathway for the regulation of cell function and communication. 
Biochemical Pharmacology,1;38:1709. 
 
Montaner, A.,Rovira, A., Barra, B., et al.(2003). C-Reactive Protein Predicts Further 
Ischaemic Events in First-Ever Transient Ischaemic Attack or Stroke Patients With 
Intracranial Large-Artery Occlusive Disease. Stroke,34;2463-2468. 
 
Moulton, A.W., Singer, D.E., Haas, J.S., et al.(1991).Risk factors for stroke in 
patients with nonrheumatic atrial fibrillation: a case-control study. American 
Journal of  Medicine,91:156-61. 
 
Moussouttas, M., Aguilar, L., Fuentes, K., et al.(2006).Cerebrovascular disease 
among patients from the Indian subcontinent. Neurology,67:894-6. 
 
Mu¨nzel,A.,Daiber,A.,Ullrich,Y.(2005).Vascular Consequences of Endothelial Nitric 
Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl 
Cyclase and the cGMP-Dependent Protein Kinase.Arteriosclerosis Thrombosis & 
Vascualr Biology,25:1551. 
 
Murros, K., Fogelholm, R., Kettunen, S., Vuorela, A.L., et al.,(1992).Blood glucose, 
glycosylated haemoglobin, and outcome of ischaemic brain infarction. Journal of  
the Neurology Sciences, 111:59-64. 
 
Nandigam, K., Narayan, S.K., Elangovan, S., et al.( 2003). Feasibility of acute 
thrombolytic therapy for stroke.Neurology India,51: 470-3. 
 
National Institute of Clinical Excellence (NICE)(2006).Guidelines for 
Cardiovascular disease.Available at:from: http://guidance.nice.org.uk /topic/ 
cardiovascular  [Accessed on 2nd  August  2008]. 
 
National Statistics United Kingdom Census (2004).Available at:  
http://www.statistics.gov.uk.[Accessed on 2nd August  2006]. 
 
NHS strategic tracing service.(2006).Better Information for health, where and 
when it's needed-NHSConnecting or Health. Available from: http://www. 
connectingforhealth.nhs.uk. [Accessed on August 2nd 2008]. 
183 
 
 
Nichols, W.W.&  O'Rourke, M.F.(2005).McDonald's blood flow in arteries. 
Theoretical, Experimental and Clinical Principles. 5th ed. Oxford:Oxford University 
Press. 
 
Oblouck, G.(1987).Haemodynamic monitoring. Philadelphia: WB Saunders. 
 
Ohashi, Y., Kawashima, S., Hirata, K., et al.(1998).Hypotension and reduced nitric 
oxideelicited vasorelaxation in transgenic mice overexpressing endothelial nitric 
oxide synthase . Journal of  Clinical Investigations,102:2061- 71. 
 
Olesen, J.& Leonardi, M.(2003).The burden of brain diseases in Europe. European  
Journal of  Neurology,10:471-7. 
 
Oliver, J.J. & Webb, D.J.(2003). Noninvasive assessment of arterial stiffness and risk 
of atherosclerotic events. Arteriosclerosis  Thrombosis &  Vascular  
Biology,23:554-566. 
 
Oppenheimer, G.M.,(2001).Paradigm lost: race, ethnicity, and the search for a new 
population taxonomy. American  Journal of  Public Health, 91:1049-1055. 
 
O'Rourke, M.F. & Mancia, G.Arterial stiffness. Journal of Hypertension,17:1-4. 
 
O'Rourke, M.F., Staessen, J.A., Vlachopoulos, C., et al.(2002).Clinical applications 
of arterial stiffness: definitions and reference values. American Journal of  
Hypertension,15:426-444. 
 
Palmer, R.M., Ferrige, A.G., Moncada, S.(1987).Nitric oxide release accounts for the 
biological activity of endothelium-derived relaxing factor.Nature,327:524 -526. 
 
Pandian, J.D. Feasibility of acute thrombolytic therapy for stroke. (2004).Neurology 
India,52:126-27. 
 
Panza, J.A., Casino, P.R., Kilcoyne, C.M., et al (1993) Role of endothelium derived 
nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients 
with essential hypertension. Circulation, 87: 1468-1474. 
 
Patel, J.V., Dwivedi, S., Hughes, E.A., et al.(2008a).Premature coronary artery 
disease: an inferred cardiovascular variant or a South Asian genetic disorder? 
Thrombosis & Haemostasis.99:991-2. 
 
Patel, J.V., Gunarathne, A., Lane, D., et al. (2007).Widening access to cardiovascular 
healthcare: community screening among ethnic minorities in inner-city Britain. BMC 
Health Services & Research,;7:1. 
 
Patel, J.V., Lim, H.S., Gunarathne, A., et al.(2008b).Ethnic differences in myocardial 
infarction in patients with hypertension: effects of diabetes mellitus. Quarterly 
Journal of Medicine,101:231-6. 
 
184 
 
Patel, J.V., Vyas, A., Cruickshank, J.K., et al. (2006)  Impact of migration on 
coronary heart disease risk factors: comparison of Gujaratis in Britain and their 
contemporaries in villages of origin in India. Atherosclerosis. 185:297-306. 
 
Patel, J.V., Vyas, A., Prabhakaran, D., et al.(2005).Nonesterified fatty acids as 
mediators of glucose intolerance in Indian Asian populations. Diabetes Care, 
28:1505-7. 
 
Perticone, F., Ceravolo, R., Pujia, A., et al.(2001).Prognostic significance of 
endothelial dysfunction in hypertensive patients. Circulation,104:191-196. 
 
Pham, T.M., Fujino, Y., Tokui, N., et al.(2007).Mortality and risk factors for stroke 
and its subtypes in a cohort study in Japan.Prevention Medicine,44:526-530. 
 
Pouliot, M.C., Despre´s, J.P., Lemieux, S., et al (1994) Waist circumference and 
abdominal sagittal diameter: best simple anthropometric indexes of abdominal 
visceral adipose tissue accumulation and related cardiovascular risk in men and 
women. American Journal of Cardiology,73: 460-8. 
 
Pradhan, A.D., Manson, J.A.F., Rifai, N., et al.(2002).C-reactive protein, interleukin 
6, and risk of developing type 2 diabetes mellitus. Journal of American Medical 
Association,286:327-334. 
 
Prati, P., Vanuzzo, D., Casaroli, M., et al.(1992).Prevalence and determinants of 
carotid atherosclerosis in a general population.Stroke.23:1705-11. 
 
Prospective Studies Collaboration Group.(1995). Cholesterol, diastolic blood 
pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. 
Lancet, 346: 1647-53. 
 
Q Van Bortel, L.(2002). Focus on small artery stiffness. Journal of  Hypertension,  
20: 1707-1709. 
 
Quyyumi, A.A.(1998).Endothelail function in health and disease:new insights into 
the genesis of cardiovascular disease.American Journal of  Medicine,105:32-39. 
 
Raji, A., Gerhard-Herman, M.D., Warren, M., et al.(2004).Insulin resistance and 
vascular dysfunction in nondiabetic Asian Indians. Journal of  Clinical 
Endocrinology &  Metabolism,89:3965-72. 
 
Raleigh, V.S., Kiri, V., Balarajan, R.(1997).Variations in mortality from diabetes 
mellitus, hypertension and renal disease in England and Wales by country of birth. 
Health & Trends, 28: 122-127. 
 
Ramachandran, A., Snehalatha, C. K., Vijay, V., et al.(2001).High prevalence of 
diabetes and impaired glucose tolerance in India: the National Urban Diabetes Survey 
(NUDS). Diabetelogia, 44: 1094-101. 
 
185 
 
Ramachandran, A., Snehalatha, C., Dharmaraj, D., et al. ( 1992).Prevalence of 
glucose tolerance in Asian Indians. Urban rural difference and significance of upper 
body obesity. Diabetes Care,15: 1348-55. 
 
Ramachandran, A., Snehalatha, C., Vijay, V., et al.(1997).Rising prevalence of 
NIDDM in an urban population in India. Diabetelogia,40: 232-237. 
 
Ramaiya, K.L., Denver, E. & Yudkin, J.S., et al.(1995).Diabetes, impaired glucose 
intolerance and cardiovascular risk factors in the Asian Indian Bhatia community 
living in Tanzania and in the United Kingdom. Diabetes Medicine,12: 904-910. 
 
Rambaran, C., Jiang, B., Ritter, J.M., et al (2008) Assessment of endothelial function: 
comparison of the pulse wave response to beta 2-adrenoceptor stimulation with flow 
mediated dilatation. British Journal of Clinical Pharmacology,65: 238-43. 
 
Rao, S. (1971). Aspects of epidemiology of stroke in south India; All India 
conference on stroke 1971:25-32. 
 
Razdan, S., Koul, R.L., Motta, A., et al.,(1989).Cerebrovascular disease in rural 
Kashmir, India. Stroke,20:1691-3. 
 
Ross R.(1999).Atherosclerosis : an inflammatory disease.New England Journal of  
Medicine,340:115-126. 
 
Rossi, G.P., Cesari, M., Zanchetta, M.,et al.(2003).The T-786C endothelial nitric 
oxide synthase genotype is a novel risk factor for coronary artery disease in 
Caucasian patients of the GENICA study. 1. Journal of American College of 
Cardiology, 41:930-7. 
 
Rost, N., Wolf, P., Kase, C., et al.(2001).Plasma concentration of C-reactive protein 
and risk of ischaemic stroke and transient ischaemic attack: the Framingham Study. 
Stroke,32:2575-2579. 
 
Rothwell PM, Coull AJ, Silver LE et al.(2005) Population-based study of event-rate, 
incidence, case fatality, and mortality for all acute vascular events in all arterial 
territories (Oxford Vascular Study). Lancet, 366: 1773-83. 
 
Sacco, R.L., Boden-Albala, B., Abel, G., et al. (2001) Race-ethnic disparities in the 
impact of stroke risk factors: the northern Manhattan stroke study. Stroke, 32: 1725-
31. 
 
Safar, M.E. & O'Rourke, M.F.(2006).Handbook of Hypertension; Arterial Stiffness 
in Hypertension. Amsterdam: Elsevier. 
 
Saha, S.P., Bhattacharya, S., Das, S.K., et al., (2003) Epidemiological study of 
neurological disorders in a rural population of Eastern India. Journal of Indian 
Medical Association,101:302-4. 
 
Salomaa, V., Riley, W., Kark, J.D.(1995).Non-insulin-dependent diabetes mellitus 
and fasting glucose and insulin concentrations are associated with arterial stiffness 
186 
 
indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation, 
91: 1432-1443. 
 
Schächinger, V.& Zeiher, A.M.(2001).Prognostic implications of endothelial 
dysfunction: does it mean anything? Coronoray  Artery Disease,12:435-443. 
 
Schächinger, V., Britten, M.B., Zeiher, A.M.(2000).Prognostic impact of coronary 
vasodilator dysfunction on adverse long-term outcome of coronary heart disease. 
Circulation,101:1899-1906. 
 
Schreck, R.& Baeuerle, P.A.A role for oxygen radicals as second messengers. 
Trends in Cell Biology,1:39-42. 
 
Schroeder, S., Enderle, M.D., Ossen, R., et al.(1999).Noninvasive determination of 
endothelium-mediated vasodilation as a screening test for coronary artery disease: 
pilot study to assess the predictive value in comparison with angina pectoris, exercise 
electrocardiography, and myocardial perfusion imaging. American Heart 
Journal,138: 731-739. 
 
Schulz, U.G. & Rothwell, P.M.(2003) Differences in vascular risk factors between 
etiological subtypes of ischaemic stroke: Importance of population-based studies. 
Stroke, 34: 2050-9. 
 
Seedat, Y.K., Mayet, F.G.H., Khan, S., et al.( 1990).Risk factors for coronary heart 
disease in the Indians of Durban. South African Medical Journal,78: 447-454. 
 
Senior, P. & Bhopal, R.(1994).Ethnicity as a variable in epidemiological research. 
British Medical Journal,309:327-9. 
 
Sewdarsen, M., Vythilingum, S., Jialal, I.,(1991).Lipid and lipoprotein abnormalities 
in South African Indian men with myocardial infarction. Cardiology, 78:348-56. 
 
Sharobeem, K.M., Patel, J.V., Ritch, A.E.S., et al.(2007).Elevated lipoprotein(a) and 
Apolipoprotein B to AI Ratio in South Asian Patients with Ischaemic Stroke.  
International Journal of Clinical Practice,61: 1824-1828. 
 
Simmons, D., Williams, D.R.R. & Powell MJ.(1989).Prevalence of diabetes in a 
predominantly Asian community: preliminary findings of the Coventry diabetes 
study. British Medical Journal. 298: 18-21. 
 
Simons, F.J.(1991).Plants of life plants of death. New York:Parker Publishing 
Company. 
 
Singh, N. & Gupta, M.(2005).Clinical characteristics of South Asian patients 
hospitalized with heart failure. Ethnicity &  Diseases,15:615-9. 
 
Smith, D.E.(1966). South Asian Politics and Religion.London:Bridge University 
Press. 
 
187 
 
Sollinger, D., Mohaupt, M.G., Wilhelm, A.,et al.(2006).Arterial stiffness assessed by 
digital volume pulse correlates with comorbidity in patients with ESRD.  American 
Journal of Kidney Disease, 48:456-63. 
 
Somani, R., Grant, P.J., Kain, K.(2006).Complement C3 and C-reactive protein are 
elevated in South Asians independent of a family history of stroke.Stroke,37:2001-6. 
 
Somani,R, Grant,P.J.,Kain,K., et al.(2001).Complement C3 and C-Reactive Protein 
Are Elevated in South Asians Independent of a Family History of Stroke. 
Stroke,37;2001-2006. 
 
Sorensen, K et al.,ET AL., (1994). Impairment of endothelium-dependent dilation is 
an early event in children with familial hypercholesterolemia and is related to the 
lipoprotein (a) level. Journal of Clinical Investigation, 93; 55. 
 
Stansbury, J.P., Jia, H., Williams, L.S., et al.(2005)Vogel WB, Duncan PW. Ethnic 
disparities in stroke: epidemiology, acute care, and post-acute outcomes. Stroke, 
36:374-86. 
 
Suttner, D.M. & Dennery, P.A.(1999).Reversal of HO-1 related cytoprotection with 
increased expression is due to reactiveiron. The Federation of American Societies 
for Experimental Biology Journal, 1800-1809. 
 
Sutton-Tyrrell, K., Najjar, S.S., Boudreau, R.M.,  et al.,(2005).Health ABC Study. 
Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts 
cardiovascular events in well-functioning older adults. Circulation,111:3384-90. 
 
Syed, N.A., Khealani, B.A., Ali, S., et al.(2003).Ischaemic stroke subtypes in 
Pakistan: the Aga Khan University Stroke Data Bank.Journal of  Pakistan Medical 
Association,53:584-8. 
 
Tan, N.C.K., Venketasubramanian, N., Saw, S.M., et al.,(2002). 
Hyperhomocysteinienia and risk of ischaemic stroke among young Asian adults. 
Stroke,33: 1956-1962. 
 
The Glogal Hunger Index. (2006). International Food Policy Research Institute. 
Available at: www.ifpri.org/publication/2006-global-hunger-index. .[Accessed  on 
2nd July 2009]. 
 
The Oxford English Dictionary.Available at: http://www.oed.com.[Accessed on 2nd 
July 2009]. 
 
The World Bank. (2007).Available at: http://web.worldbank.org/southasia.html. 
[Accessed  on 2nd July 2009]. 
 
Thompson, A. & Danesh, J.(2006).Associations between apolipoprotein B, 
apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a 
literature-based meta-analysis of prospective studies. Journal of Internal 
Medicine,259:481-492. 
 
188 
 
Toikka, J.O., Niemi, P., Ahotupa, M., et al. (1999) Large-artery elastic properties in 
young men: relationships to serum lipoproteins and oxidized low-density 
lipoproteins. Arteriosclerosis Thrombosis & Vascular Biology, 19: 436-441. 
 
Tolonen, H., Mahonen, M., Asplund, K., et al.,(2002) Do trends in population levels 
of blood pressure and other cardiovascular risk factors explain trends in stroke event 
rates? WHO MONICA Stroke Project. World Health Organization Monitoring of 
Trends and Determinants in Cardiovascular Disease. Stroke, 33:2367-75. 
 
Tracey, F., Crawford, V.L., Lawson, J.T., et al.(1993).Hyperglycaemia and mortality 
from acute stroke.  Quartley Journal of Medicine,86:439-46. 
 
Tuomilehto, J., Li, N., Dowse, G., et al.(1993).The prevalence of coronary heart 
disease in the multi-ethnic and high diabetes prevalence population of Mauritius.  
Journal of Internal Medicine, 233:187-194.     
  
UK Prospective Diabetes Study Group (1994) UK prospective diabetes study XII: 
differences between Asian, Afro Caribbean and white Caucasian Type 2 diabetic 
patients at diagnosis of diabetes. Diabetic Medicine, 11: 670-677 
 
Uyyumi, A.A.( 1998).Endothelail function in health and disease:new insights into the 
genesis of cardiovascular disease.American Journal of Medicine,105:32-39. 
 
Van Bortel, L.M., Duprez, D., Starmans-Kool, M.J.,et al.(2002).Applications of 
arterial stiffness, Task Force III: recommendations for user procedures. American 
Journal of  Hypertension,15:445-452. 
 
Venketasubramanian, N., Tan, L.C., Sahadevan, S.,et al.(2005).Prevalence of stroke 
among Chinese, Malay, and Indian Singaporeans: a community-based tri-racial cross-
sectional survey.Stroke,36:551-6. 
 
Verma, N.P.S., Mehta, S.P., Madhu, S., et al.(1985).Prevalence of known diabetes in 
an urban Indian environment: the Darya Ganj diabetes survey. British Medical 
Journal,293: 423-424. 
 
Vohra, E.A., Ahmed,W.U., Ali, M.(2000).Aetiology and prognostic factors of 
patients admitted for stroke. Journal of  Pakistan  Medical Association,50:234-6. 
 
Walldius, G., Jungner, I.(2006).The apoB/apoA-I ratio: a strong, new risk factor for 
cardiovascular disease and a target for lipid-lowering therapy - a review of the 
evidence. Journal of Internal Medicine,259:493-519. 
 
Weber, M. et al.(1991).Essays in sociology.[e-book] Google.com.Available at: 
http://books.google.co.uk/books. 
 
Westerbacka, J., Seppala-Lindroos, A., Yki-Jarvinen, H.(2001) Resistance to acute 
insulin induced decreases in large artery stiffness accompanies the insulin resistance 
syndrome. Journal of  Clinical Endocrinology & Metabolism, 86: 5262?5268. 
 
189 
 
Whitty, C.J., Brunner, E.J., Shipley, M.J., et al.(1999).Differences in biological risk 
factors for cardiovascular disease between three ethnic groups in the Whitehall II 
study. Atherosclerosis,142:279-86. 
 
Wild, S. &  Mckeigue, P. (1997). Cross sectional analysis of mortality by country of 
birth in England and Wales, 1970-92. British Medical Journal,314:705-10. 
 
Wilkinson, I., Hall, I., MacCallum, H., et al., (2002).Pulse-wave analysis: clinical 
evaluation of a noninvasive, widely applicable method for assessing endothelial 
function. Arteriosclerosis Thrombosis, and Vascular Biology, 22;147–152. 
 
 
Wilkinson, I.B., Prasad, K., Hall, I.R.(2002).Increased central pulse pressure and 
augmentation index in subjects with hypercholesterolemia. Journal of  American 
College of Cardiology,39: 1005-1011. 
 
Whitty CJM, Brunner EJ, Shipley MJ, Hemingway H, Marmot MG (1999) 
Differences in biological risk factors for cardiovascular disease between three ethnic 
groups in the Whitehall II study. Atherosclerosis, 142: 279-286 
 
Williams, S.B et al., (1996). Impaired nitric oxide-mediated vasodilation in patients 
with non-insulin-dependent diabetes mellitus, Journal of the American College of 
Cardiology, 27; 567–574.  
 
Wityk, R.J., Lehman, D., Klag, M.,et al.(1996).Race and sex differences in the 
distribution of cerebral atherosclerosis. Stroke,27:1974 -1980. 
 
Wolf, A., Zalpour, C., Theilmeier, G, et al.(1997). Dietary l-arginine supplementation 
normalizes platelet aggregation in hypercholesterolemic humans. Journal of 
American College of Cardiology,29:479- 85. 
 
Wolfe, C.D., Corbin, D.O., Smeeton, N.C., et al (2006) Estimation of the risk of 
stroke in black populations in Barbados and South London. Stroke, 37:1986-90. 
 
Wolfe, C.D., Taub, N.A., Woodrow, E.J., et al.(1991).Assessment of scales of 
disability and handicap for stroke patients. Stroke,22:1242-4. 
 
Woodman, R.J.& Watts, G.F.(2003).Measurement and application of arterial stiffness 
in clinical research: focus on new methodologies and diabetes mellitus. Medical 
Science Monitor,9:81-9. 
 
Woodman, R.J., Kingwell, B.A., Beilin, L.J. et al. (2005) Assessment of central and 
peripheral arterial stiffness: studies indicating the need to use a combination of 
techniques. Hypertension.18:249-60. 
 
World Health Organization.(1973).Control of stroke in the community. 
Methodological considerations and protocol of WHO Stroke Registers. CVD S/ 73 6. 
Geneva:WHO. 
 
190 
 
World Health Organization.(2007).International Statistical Classification of 
Diseases and Related Health Problems.10th Revision.Availbale at 
http://apps.who.int/ classifications/ apps/icd/icd10online/. 
 
Yang, Z.& Ming, X.F.(2006).Recent advances in understanding endothelial 
dysfunction in atherosclerosis.Clinical Medicine & Research, 4:53-65. 
Yeboah J, Crouse JR., et al.(2007). Brachial flow-mediated dilation predicts incident 
cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 
115:2390-7 
Yasmin, C. M., McEniery, C., O'Shaughnessy, K.M., et al.(2006).Variation in the 
human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy 
individuals. Arteriosclerosis Thrombosis & Vascular  Biology, 26: 1799-1805. 
 
Young, Ge., Wang, T.W., et al.(2007). Heritability of arterial stiffness in Black and 
White American youth and young adults. American Journal of Hypertension, 
20:1065-72. 
 
Zhang, X.F., Attia, J., D'Este, C., et al.(2006).The relationship between higher blood 
pressure and ischaemic, haemorrhagic stroke among Chinese and Caucasians. 
European Journal of  Cardiovascualr  Prevention & Rehabilitation,13:429-37. 
 
Zhang, C., Sun, A., Zhang, S., et al., (2010).Effects of intensive glucose control on 
incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis. 
Annals of Medicine, 6;305-15 
 
